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CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats)-mediated
defense against invading nucleic acids is a process recently discovered in prokaryotes,
which includes recognition and incorporation of invading genetic elements,
transcription and processing of CRISPR-RNA (crRNA) and targeting the invaders
through base pair recognition. CRISPR/Cas systems are organized into three
phylogenetically distinct types (I-III), and each of these major types can be divided
into subtypes (i.e., type IA-F, type IIA-B, and type IIIA-B).
In the type I-E CRISPR/Cas system, Cse2 is proposed to provide a platform to
facilitate the targeting of the invading dsDNA by crRNA. Here we report the crystal
structure of Meiothermus ruber Cse2 (MruCse2) at 2.8 Å. MruCse2 adopts an
α-helical bundle scaffold, harbors a positive surface for nucleic acid binding and a
conserved dimer interface with strikingly low buried surface area. MruCse2
selectively binds to G-rich crRNA sequence, which is stripped off from the
Cse2-crRNA and Cascade-crRNA complexes by ssDNA or dsDNA with
complementary sequence. Stable M. ruber Cascade (Mru_Cascade) is readily formed
by co-expression of Mru_Cascade proteins together with G-rich crRNA in vitro.
Docking of MruCse2 structures into the Escherichia coli Cascade (Eco_Cascade)
cryo-EM envelope reveals a curved elongated shallow groove for ssRNA binding,
which adopts a similar dimer interface discovered by high-resolution crystal structure
of Cse2 within Eco_Cascade. Therefore, our data provides the structural insights into
viii
crRNA G-rich sequence recognition by MruCse2 and reveals the potential structural
mechanism for Mru_Cascade assembly and function.
Cse1 is another crucial subunit of Cascade that is required for binding nonspecific
DNA and also has a key role in preventing autoimmunity in type I-E systems. Here
we utilized the X-ray crystallography to study the structure of Thermobifida fusca
Cse1 (TfuCse1), which reveals a well-defined dsDNA binding site and the structural
details of the conserved phenylalanine residue in L1. The structural comparison of the
electrostatic surfaces of Cse1 shows a conserved positive patch, which is contiguous
with that of Cse2 and adjacent to Cas3 in the cryo-EM structure of dsDNA-bound
Cascade complex. In addition, the mutation of this positive patch abolishes dsDNA
binding by Cse1. Therefore, the positive patch on Cse1 might be involved in R-loop
(RNA-mediated displacement loop) formation and/or stabilization, as well as the
subsequent recruitment of Cas3 for target cleavage.
Taken together, our structural and functional efforts reveal the molecular
characterization of Mru_Cascade in G-rich crRNA binding preference, which may
highlight the flexibility and unexpectedness of Cascade assembly and target
recognition events adopted by different bacteria strains. The structural and functional
studies on TfuCse1 may shed some light on Cascade assembly, and also paves the
way toward elucidating the role of TfuCse1 in R-loop formation/stabilization and the
recruitment of Cas3 for target cleavage. Our studies could be expected to provide
useful insights to understand the mechanistic principles of CRISPR-mediated host
defence in molecular details.
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11 Chapter 1: Introduction
1.1 Discovery and characterization of the CRIPSR arrays in prokaryotic
genomes
1.1.1 Brief history of the CRISPR/Cas system
In the late 1800s, Ernest Hanbury Hankin reported that water from the Ganges and
Yamuna rivers in India contained an antibacterial agent which could kill Vibrio
cholera (Hankin, 1896). These agents were identified as potential treatments for
diseases and termed bacteriophages (from “bacteria” and the Greek word phagein, “to
devour”). In the 1980s, marine virologists reported that there are approximately ten
billion bacteriophages in one liter of sea water, and today these viruses are generally
considered as the most abundant biological agents on our planet (Bergh et al., 1989;
Suttle, 2005; Weinbauer, 2004). The selective pressures imposed by these viral
predators have a significant impact on the microbial communities (Rodriguez-Valera
et al., 2009). Therefore, bacteria and archaea have evolved various defense
mechanisms to evade infection, and many of these protective mechanisms, such as
restriction-modification systems (R-M systems), abortive infection and the
modification of virus receptors, could provide innate immunity (Samson et al., 2013).
However, the discovery of CRISPR/Cas (clustered regularly interspaced short
palindromic repeats/CRISPR-associated proteins) loci, which are contained in the
genomes of almost all archaea and about one half of the bacteria, and are responsible
for adaptive immunity, has generated great interest and encouraged research into the
2molecular basis of the mechanism of action (Makarova et al., 2013). The CRISPR
arrays, which are usually located adjacent to the cas genes, vary significantly in
sequences and lengths, but they all have a characteristic pattern of alternating repeat
and spacer sequences (Figure 1- 1).
Figure 1- 1 : Graphic representation of a CRISPR array and the adjacent cas
gene operon in a prokaryotic genome.
Cas genes are depicted as arrows, the leader sequence in grey, repeats as purple boxes
and interspersing spacers as colored, numbered boxes. Direction of transcription is
indicated by the black arrow.
CRISPR was first identified as a distinct family of interspersed short sequence repeats
(SSR), adjacent to the isozyme-converting alkaline phosphatase (iap) gene in
Escherichia coli K12 (Ishino et al., 1987). They were recognized as a defined
prokaryotic family of short regularly spaced repeats (SRSR) by Mojica et al. in 2000,
and Jansen et al. first introduced the acronym CRISPR in an initial study in 2002. In
2005, three groups independently reported that some CRISPR spacers showed
sequence homology to viruses or conjugative plasmids, which suggested that CRISPR
loci might participate in the immunity against transmissible genetic elements (Bolotin
et al., 2005; Mojica et al., 2005; Pourcel et al., 2005). Moreover, Mojica et al. (2005)
found that the foreign genetic elements such as viruses and conjugative plasmids
failed to infect CRISPR-carrier strains whose spacers were homologous to these
elements. In 2007, Barrangou et al. first achieved experimental validation of the
CRISPR function, and reported that during the generation of phage-resistant mutants,
the CRISPR loci of Streptococcus thermophilus could incorporate new spacers which
3exhibited homology with phage genomic sequences, and resistance specificity was
dependent on the spacer sequences (Barrangou et al., 2007). Moreover, it was found
that knockout of two cas genes could result in the inability of CRISPR to incorporate
new spacers and loss of phage resistance, which provided experimental evidence for
the functional role of cas genes in this process (Barrangou et al., 2007).
1.1.2 Characterization of the CRISPR loci in prokaryotic genomes
CRISPR locus, which refers to a genomic region containing CRISPRs, consists of a
series of repeat sequences separated by unique spacer sequences. The
repeat-spacer-repeat pattern, which was initially described in E. coli in 1987, is
considered to be the defining characteristic of a CRISPR locus today (Ishino et al.,
1987). Dedicated databases (CRISPRdb and CRISPI) have been developed for the
identification and annotation of CRISPRs and CRISPR-associated (cas) genes (Grissa
et al., 2007; Rousseau et al., 2009). According to the most recent reviews,
approximately 40% of sequenced bacterial genomes, and nearly 90% of the
sequenced archaea genomes, making a total of 706 genomes analyzed to date, harbor
one or more CRISPR loci (Table 1- 1) (Makarova et al., 2011b). The CRISPR locus
together with the cas genes constitutes an acquired nucleic-acid based immune system
to protect prokaryotes from infection by foreign genetic elements (Wiedenheft et al.,
2012).
i. Among different species, the repeat sequences can vary in size from 21bp to
48bp (with an average size of 32bp). A CRISPR locus contains from 2 to 375 repeats
(with an average number of 27) (Godde and Bickerton, 2006; Grissa et al., 2007).
4Since the repeat sequences can be partially palindromic, it was hypothesized that
transcripts from these regions may generate RNAs with stable hairpin structures
(Kunin et al., 2007; Makarova et al., 2006). The repeat sequences within one CRISPR
locus are conserved, but repeats in different CRISPR loci can show variable
sequences and lengths (Kunin et al., 2007). Phylogenetic analyses of CRISPR repeat
sequences have shown that CRISPRs can be classified into at least 12 clusters based
on sequence similarity and secondary structure formation of their repeat sequences
(Kunin et al., 2007). Although the repeat sequences show extreme diversity in
different CRISPR loci, most repeats have a conserved GTTTg/c motif at the 5’ end
and GAAAC motif at the 3’ end, which may serve as binding sites for the conversed
Cas proteins (Deveau et al., 2010; Godde and Bickerton, 2006; Jansen et al., 2002b;
Kunin et al., 2007).
Table 1- 1 : Taxonomic distribution of CRISPR/Cas systems in 706 analyzed
genomes (Makarova et al., 2011b).
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews
Microbiology (Makarova et al., 2011b), copyright 2011.
ii. The number of spacers can range from one to several hundred in a particular
5CRISPR locus. For example, there are 587 spacers at a specific CRISPR locus in the
myxobacterium Haliangium ocbraceum DSM 14365 (Grissa et al., 2007). Across
different species, the lengths of spacers are typically between 26bp and 72bp
(Al-Attar et al., 2011). Since a fraction of spacer sequences was found to have
significant similarity with preexisting sequences, either chromosomal or within
transmissible genetic elements, such as phage DNA or conjugative plasmids, it was
concluded that the spacer sequences originate from these foreign genetic elements
(Mojica et al., 2005; Pourcel et al., 2005). Remarkably in lactic acid bacteria CRISPR
loci, about 40% of the spacers were found to be homologous to streptococci phage
genomes and the respective conjugative plasmids (Bolotin et al., 2005). Spacer
sequence homology was found not only in the sense and anti-sense strands, but also
in the gene coding and intergenic regions of phage genomes (Shah et al., 2009).
iii. An adenine and thymine (AT)-rich sequence called a leader, which can range in
size from 100bp to 550bp, has been detected in association with several (but not all)
CRISPR loci. The leader sequences which are located directly upstream of the cluster
exhibit similarity between related species, but are generally not conserved between
distantly related species (Jansen et al., 2002a). Available data indicate that the
transcription of entire CRISPR loci, containing the full set of CRISPR repeats and
embedded spacer sequences, initiates within the leader region (Hale et al., 2009;
Lillestol et al., 2006). Moreover, the leader regions are considered as transcription
promoters for the sense strand of the CRISPR loci since putative promoter motifs
were identified in leader regions of Sulfolobus acidocaldarius and E. coli K12
6(Lillestol et al., 2006; Pul et al., 2010). Comparative analyses revealed that spacer
sequences nearest the leader region are most diverse, whereas spacers farthest from
the leader region (known as the trailer) are often degenerate (Jansen et al., 2002a;
Pourcel et al., 2005). This initial observation of leader-end diversity and trailer-end
degeneracy indicated that CRISPR loci had polarity defined by the position of the
leader. Both the comparative analysis (Lillestol et al., 2006) and genetic studies in
Stretococcus thermophilus (Barrangou et al., 2007) showed that novel spacers are
incorporated with a novel repeat and inserted into the leader proximal end of the
CRISPR loci. Therefore, leader regions seem to play a critical role in controlling
CRISPR transcription and new sequence acquisition by interacting with appropriate
proteins.
iv. In addition to the leader sequence, comparative analyses also identified a
variable cassette of cas genes typically located adjacent to a CRISPR locus with a
generally conserved orientation. The orientation, order and groupings of cas genes
appear to be extremely variable, and around 45 different gene families were
commonly found in association with CRISPRs (Haft et al., 2005). Notably, there are
no homologues of cas genes found in eukaryotic or CRISPR-negative genomes. A cas
gene region, which comprises as many as 20 different, tandem-arranged genes, can be
found on either side of a CRISPR locus with no preferential direction of the reading
frame (Godde and Bickerton, 2006; Jansen et al., 2002a; Lillestol et al., 2006). Six of
these cas genes (cas1-cas6) are widely conserved and considered as core cas genes,
but only cas1 and cas2 are universally present in genomes that contain CRISPR loci
7(Haft et al., 2005; Makarova et al., 2006). The cas genes will be discussed in more
detail in the following section.
Figure 1- 2: Features of CRISPR/Cas adaptive immune system.
The cas genes (gray arrows) encode proteins required for new spacer sequence
acquisition (stage 1), crRNA biogenesis (stage 2), and target interference (stage 3).
Each CRISPR locus is flanked by a leader sequence, followed by a series of direct
repeats (black boxes) separated by unique spacer sequences acquired from invading
protospacers. Long pre-crRNA are processed into short crRNAs that guide Cas
proteins to invading nucleic acids through complementary base pairing.
Mechanistically, the CRISPR-Cas defense process can be separated into three stages:
spacer acquisition, CRISPR-Cas expression and DNA interference (Figure 1-2). In
the acquisition stage, a short segment of DNA (known as protospacer) from the
foreign virus or plasmid is integrated into the host genome as a new spacer
specifically at the leader end of the CRISPR locus (Barrangou et al., 2007). In the
expression stage, CRISPR is transcribed into a long precursor (pre-crRNA) and
processed into mature CRISPR-derived RNAs (crRNAs) that consist of a single
spacer surrounded by partial CRISPR repeat sequences on one or both sides (Brouns
8et al., 2008). In the final interference stage, crRNAs can associate with Cas proteins
to form large ribonucleoprotein complexes that target DNA (or RNA) for degradation,
thereby preventing the propagation of foreign viruses and plasmids (van der Oost et
al., 2014). The discrete stages of this mechanism will be presented in more detail in
the following sections.
1.2 CRISPR-associated protein families and current classification of the
CRISPR/Cas system
The neighborhood of cas genes (consisting of more than 20 genes) was initially
discovered in most archaea and some bacteria during a systematic analysis of
conserved gene context in prokaryotic genomes (Makarova et al., 2002). However, it
was wrongly considered as a novel DNA repair system specific for thermophiles
since CRISPR was not detected at that time (Makarova et al., 2002). Almost
simultaneously, Jansen et al. identified four genes located in the vicinity of CRISPR
loci (cas1-4) by in silico analysis (Jansen et al., 2002a), which were then extended to
include cas5 and cas6 (Bolotin et al., 2005; Haft et al., 2005). In 2005, Haft and
colleagues identified a guild of 45 Cas protein families by Hidden Markov models,
and defined eight different CRISPR/Cas subtypes based on the conserved Cas1
protein and the operonic organization of cas genes (Haft et al., 2005). In 2006,
Makarova et al. performed an updated analysis of Cas proteins taking into account
genomic context analysis and sensitive methods (iteration approaches), resulting in 25
Cas protein families (Makarova et al., 2006). These families are hypothesized to be
involved in a mechanism of defense against foreign phages and plasmids that
9functions analogously to the eukaryotic RNA interference (RNAi) systems (Makarova
et al., 2006).
Figure 1- 3: Outline of the three major types and ten subtypes of the
CRISPR/Cas systems and their phylogenetic relations (Makarova et al., 2011b).
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews
Microbiology (Makarova et al., 2011b), copyright 2011. The typical, simplest operon
architectures are shown for each type and subtype of CRISPR/Cas systems, but
numerous variations exist. The signature genes for CRISPR/Cas types are highlighted
in green boxes, and those for subtypes are highlighted in red boxes.
With the rapid growth of identification of novel CRISPR systems in more prokaryotic
genomes, it has become apparent that the initial categories cannot handle the
extensive variability that exists in cas operons, organisms that contain multiple
CRISPR loci and relationships between homologous but distantly related Cas proteins.
As a result, Makarova et al. proposed an updated and unified classification system
based on multiple criteria, including gene composition, cas operon organization and
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the phylogenetic and functional relationships between cas genes (Makarova et al.,
2011b). According to this novel classification that integrates phylogeny, sequence,
locus organization, and content, CRISPR/Cas systems are organized into three
phylogenetically distinct types (I-III), and each of these major types can be divided
into subtypes (i.e., type IA-F, type IIA-B, and type IIIA-B) (Makarova et al., 2011b).
The classification is summarized in Figure 1- 3 and the subtypes distribution in Table
1- 1.
Although most cas genes are highly divergent and located in certain CRISPR loci,
cas1 and cas2 are conserved in almost all CRISPR-containing species. Cas1 and Cas2
are found to be required for the integration of new spacers, as confirmed by both
genetic experiments and spacer acquisition assays in E. coli K12 (Datsenko et al.,
2012; Yosef et al., 2012). Cas1 is a metal-dependent endonuclease on single-stranded
DNA (ssDNA), double-stranded DNA (dsDNA) and branched DNA with a
sequence-independent manner (Babu et al., 2011; Wiedenheft et al., 2009). Crystal
structure of the homodimeric Cas1 protein (from Pseudomonas aeruginosa) shows
that it consists of an N-terminal β-stand domain and a C-terminal α-helical domain
(Figure 1- 4a) (Babu et al., 2011; Wiedenheft et al., 2009). The C-terminal domain
contains a conserved divalent metal ion binding site, which is involved in DNA
degradation in vitro and spacer acquisition in vivo (Yosef et al., 2012). The
metal-binding site is surrounded by a cluster of basic residues that form a positively
charged surface, which plays a role in DNA binding and might position the substrates
close to the metal ion in the active site (Wiedenheft et al., 2012; Wiedenheft et al.,
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2009).
Figure 1- 4: Crystal structures of Cas1 (from Pseudomonas aeruginosa; PDB
accession 3GOD) and Cas2 (from Desulfovibrio vulgaris, PDB accession 3OQ2)
(van der Oost et al., 2014).
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews
Microbiology (van der Oost et al., 2014), copyright 2014. Cas1 is a metal-dependent
endonuclease with an amino-terminal β-strand domain and a carboxy-terminal
α-helical domain. Sequence conservation (indicated by colour intensity) reveals that
the metal ion-binding site is highly conserved among Cas1 family proteins. Cas2 is a
metal-dependent endonuclease with a metal-binding site at the interface of the two
subunits.
Cas2 is a metal-dependent nuclease which contains a RAMP (Repeat-Associated
Mysterious Proteins)-like fold within a typical βαββαβ arrangement (Figure 1- 4b)
(Beloglazova et al., 2008; Nam et al., 2012b; Reeks et al., 2013a; Samai et al., 2010).
The conserved residues which play a role in metal-binding and nuclease activity are
positioned along the Cas2 dimer interface, which is formed by β-sheets from two
Cas2 protomers (Nam et al., 2012b). Several studies have reported Cas2 proteins are
endoribonuclease, whereas other Cas2 proteins are mainly considered as
deoxyribonuclease since they can catalyze the cleavage of dsDNA (Beloglazova et al.,
2008; Nam et al., 2012b). The role of these core proteins in the current scheme of the
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CRISPR-mediated immune system will be discussed later.
1.2.1 Type I CRISPR-Associated Systems
Type I systems are widely distributed in bacteria and archaea (Makarova et al.,
2011b). In type I systems, the mature crRNA associates with multiple Cas proteins to
form a CRISPR-associated complex for antiviral defense (Cascade), which has the
ability to target complementary DNA sequences and recruit a trans-activating
nuclease-helicase (Cas3) for unwinding and cleavage target DNA (Sinkunas et al.,
2013; Westra et al., 2012c). Type I systems encompass six subtypes (A-F), all of
which encode a cas3 gene (Figure 1- 3 and Figure 1- 5a).
Cas3 typically contains an N-terminal HD nuclease domain and a C-terminal type A
(3’-to-5’) superfamily 2 (SF2) helicase domain (Makarova et al., 2006; Makarova et
al., 2011b). Recently, the crystal structures of T. fusca Cas3 bound to ssDNA have
been reported, which captured the SF2 helicase domain in open conformation with or
without an ATP molecule bound, and revealed that the conserved residues in the HD
nuclease coordinate two catalytic iron cofactors for ssDNA cleavage (Figure 1- 6)
(Huo et al., 2014). The ATP binding and hydrolysis in the Cas3 helicase domain
induce conformational change, which leads to the inchworm movement of the
helicase driving the 3’-to-5’ unwinding of dsDNA and feeding the substrate into the
HD nuclease active site (Huo et al., 2014). The Cas3 helicase domain also plays a role
in the recruitment of the Cascade activity through physical interactions with the CasA
component of the R-loop-presenting Cascade (Huo et al., 2014). Concomitantly, the
HD nuclease domain strengthens the Cas3-Cascade interaction with its strong ssDNA
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binding affinity (Huo et al., 2014).
Figure 1- 5: Structural and functional differences among the three CRISPR/Cas
types (Sorek et al., 2013).
Reprinted by permission from Annual Review of Biochemistry (Sorek et al., 2013),
copyright 2013. Protospacers in type I systems are flanked by a 5’ PAM (a) while in
type II systems are flanked by a 3’ PAM (b), but PAM sequences have not been
identified in type III systems (c). The long pre-crRNA are processed by
CRISPR-specific endoribonucleases (i.e., Cas6 family proteins) in type I and III
systems, whereas the type II systems require a trans-activating crRNA (tracrRNA) to
hybridize the repeat sequence in the crRNA and RNase III to cleave the short
duplexes. The type I and II systems target double-stranded DNA, while the type III-A
and type III-B are expected to target DNA and RNA, respectively. Target interference
in type I systems require a crRNA-guided surveillance complex and Cas3 to degrade
the target, while in type II systems, only Cas9 and two RNAs (i.e., crRNA and
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tracrRNA) are responsible for target degradation.
Type I systems also contain multiple subtype-specific Cas proteins, which are
suggested to form crRNA-guided surveillance complexes that are involved in the
interference step (Brouns et al., 2008). Many of these proteins (Cas5, Cas6, Cas7)
belong to distinct RAMP superfamily, which are predicted to have RNA-binding
activity (Makarova et al., 2011b). Cas6 has been shown to possess metal-independent
nuclease activity that catalyzes cleavage through a mechanism involving a 2’-3’
cyclic intermediate and generates mature crRNAs bearing a unique spacer-derived
sequence flanked by repeat-derived sequences at both ends (Brouns et al., 2008; Carte
et al., 2008; Haurwitz et al., 2010; Jore et al., 2011). A series of studies has concluded
that the targets for type I systems are DNA viruses and plasmids (Brouns et al., 2008;
Marraffini and Sontheimer, 2008; Garneau et al., 2010).
Figure 1- 6: Domain
organization and crystal
structure of ssDNA-bound T.
fusca Cas3 (Huo et al., 2014).
Reprinted by permission from
Macmillan Publishers Ltd: Nature
Structural and Molecular Biology
(Huo et al., 2014), copyright 2014.
The structure is colored as follows:
HD domain (silver), RecA1
domain (cyan), RecA2 domain
(green), linker domain (pink),
CTD (magenta), bound ssDNA
substrate (yellow).
The large multisubunit Cascade surveillance complex from E. coli K12 was the first
crRNA-guided surveillance complex described (Brouns et al., 2008; Jore et al., 2011).
Biochemical and structural analysis of Cascade enabled further understanding of the
molecular mechanism which mediates specific interference in the CRISPR system
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(Jore et al., 2011). The type I-E CRISPR/Cas system from E. coli K12 contains eight
cas genes and a downstream CRISPR locus (Figure 1- 7a) (Brouns et al., 2008; Jore
et al., 2011). Among them, Cas1 and Cas2 form a stable heterocomplex which are
involved in spacer acquisition (Nunez et al., 2014; Yosef et al., 2012), while Cas3
mediates duplex unwinding and degradation of target DNA as described above
(Westra et al., 2012c). Eleven subunits of five functionally essential Cas proteins [one
copy of Cse1 (CasA), two copies of Cse2 (CasB), six copies of Cas7 (CasC), one
copy of Cas5e (CasD) and one copy of Cas6e (CasE)] assemble together with a 61-nt
crRNA into the 405 kD Cascade complex, which could target the invading nucleic
acids bearing a sequence complementary base pairing with the crRNA (Jore et al.,
2011). The Cascade complex then could recruit the trans-activating nuclease-helicase
Cas3 for unwinding and DNA cleavage.
Using cryoelectron microscopy (cryo-EM), the structures of Eco_Cascade complex
before and after binding to a 32-nt single-stranded RNA (ssRNA) substrate mimic,
have been determined and appear to have an asymmetric “seahorse” shaped
architecture (Wiedenheft et al., 2011a). In the Eco_Cascade, six copies of Cas7 form
a filament-like bundle as the backbone, Cas6e is located at the head, Cse1 and Cas5e
are located at the tail, whereas two copies of Cse2 are located in the middle of the
complex. Upon binding to ssRNA substrate mimic, Cascade undergoes a concerted
conformational change in Cse1, Cas6e, Cse2 and Cas7. Overall, the cryo-EM
structures have provided a detailed description of the Cascade organization and
explained how crRNA is protected by Cas proteins from degradation and maintains
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the availability for complementary base pairing with the invading nucleic acids.
Figure 1- 7: Crystal structures of E. coli (K12) Cascade in the pre-target-bound
state and ssDNA-bound state (Jiang and Doudna, 2015).
Reprinted from Current Opinion in Structural Biology (Jiang and Doudna, 2015),
Copyright 2015, with permission from Elsevier. (a) The type I-E CRISPR-mediated
immune system in E. coli K12 consists of eight cas genes and one CRISPR locus. (b)
Two structures of pre-target-bound Cascade complex projected in the same
orientation (left panel, PDB ID: 1VY8; right panel: 4U7U). (c) Left: overall structure
of Cascade-crRNA-ssDNA complex (PDB ID: 4QYZ). Right: structure
superimposition of the pre-target-bound state and ssDNA-bound state. (d) Six
β-hairpins serve as ‘wedges’ and introduce a kink every 6-nt within the guide region
of crRNA in the pre-target-bound (left) and ssDNA-bound (right) conformations. (e)
Left: Close-up view of L2 loop in the pre-target-bound (orange) and ssDNA-bound
(teal) conformations. Right: Close-up view of the well-ordered Cse1 L1 loop in the
pre-target-bound state (orange) and its base-specific interactions with the AAC triplet
of 5’-handle crRNA (black).
Subsequently, further structural studies have provided more details on the
crRNA-guided surveillance machine that targets dsDNA, which included three
atomic-resolution Cascade structures and one low-resolution cryo-EM based
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reconstruction of Cascade bound to a 72-nt dsDNA target (Hochstrasser et al., 2014b;
Jackson et al., 2014b; Mulepati et al., 2014; Zhao et al., 2014). Both Cas6e and Cas5e
make sequence-specific interactions with portions of the CRISPR repeat sequence,
whereas Cas7 proteins polymerize along the crRNA through non-specific interactions.
Remarkably, each Cas5e and Cas7.2-Cas7.6 protein contains a long protruding
β-hairpin which is a putative unwinding element that has been implicated in helicases
(Figure 1- 7b-d) (Buttner et al., 2007; Lucic et al., 2011). These β-hairpins insert into
the gap between the last stacked base and its adjacent splayed counterpart, and thus
serve as ‘wedges’ which divided the crRNA spacer region into five equal fragments,
with each fragment containing five stacked bases flanked by one flipped out base
(Jackson et al., 2014b; Zhao et al., 2014). The splayed out bases at the kink sites
adopt a distorted configuration that is not suitable for base pairing, while the 5-nt
segments extending outwards are organized into an A-form helix and are poised for
base pairing with target DNA. Consistent with this finding, functional tests
demonstrate that mismatches at the kink position have a much less effect on the target
binding affinity than mismatches located elsewhere (Jackson et al., 2014b; Zhao et al.,
2014).
A 3-Å crystal structure of Cascade bound to a 40-nt single-stranded DNA target
consisting of a 32-nt protospacer sequence and a 5’ PAM (protospacer adjacent motif)
sequence (5’-CAT-3’), as well as a 5-nt 3’ extension was reported and revealed DNA
interactions with the Cascade complex (Mulepati et al., 2014). Superimposition of the
unbound and ssDNA-bound Cascade complex reveals a concerted conformational
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rearrangement in Cas6e, Cse1 and the Cse2 homodimer, as previously observed in the
ssRNA-bound Cascade structure (Figure 1- 7c). Strikingly, the crRNA-ssDNA
heteroduplex is highly distorted from canonical A-form, which is necessary for the
hybrid to remain continuous throughout the guide region since the geometry of an
A-form duplex is incompatible with the spacing between kink regions. Genetic and
biochemical assays identified a seed region in the crRNA guide (positions 1-5, 7 and
8 nucleotides) that is required for high-affinity binding to target (Semenova et al.,
2011b). Six β-hairpins formed by Cse5e and Cas7 could interrupt the crRNA-DNA
duplex at the unpaired positions, while maintain continuous base pairing within each
5-nt segment of the crRNA. This unique architecture could increase the fidelity of
target recognition through a conformational proofreading mechanism similar to that
employed by RecA which catalyzes strand exchange in homologous recombination
(Chen et al., 2008; Kowalczykowski, 2008; Savir and Tlusty, 2010).
Comparative structural analysis reveals that the Cse1 L2 loop (residues 401-410)
becomes ordered upon target binding and moves closer to the ssDNA strand via
making direct contacts with the phosphate backbone around the PAM motif (Figure
1- 7e). This observation suggests that Cse1 L2 loop may play a role in stabilizing the
target DNA strand. Interestingly, in pre-target bound Cascade crystal structures, the
Cse1 L1 loop (residues 130-143) is well ordered and makes base-specific contacts
with the 5’ handle of the crRNA, whereas in ssDNA-bound Cascade crystal structure,
the Cse1 L1 loop becomes disordered, suggesting that this region is mobile in the
absence of dsDNA (Figure 1- 7e). Consistent with this possibility, the ~9-Å cryo-EM
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reconstruction of dsDNA-bound Cascade revealed that dsDNA binding triggers Cse1
to adopt a relative position within Cascade distinct from that observed in the
pre-target bound and ssDNA-bound states (Hochstrasser et al., 2014b). In the
dsDNA-bound state, the Cse1 L1 loop contacts the entering duplex at the
approximate location of the PAM (Figure 1- 8). Additionally, negative-stain EM
analysis of Cas3-bound dsDNA-Cascade revealed that Cas3 is localized near Cse1
(Figure 1- 8) (Hochstrasser et al., 2014b). These structural findings, together with
biochemical observations which revealed that Cas3 is unable to cleave the DNA
duplex when the Cse1 L1 loop is disturbed, demonstrated that Cse1 plays a crucial
role in Cas3 recruitment, target recognition and degradation (Hochstrasser et al.,
2014b).
Figure 1- 8: EM structures of E. coli (K12) Cascade in the pre-target-bound state
and target-bound state (Jiang and Doudna, 2015) (same view as Figure 1- 7).
Reprinted from Current Opinion in Structural Biology (Jiang and Doudna, 2015),
Copyright 2015, with permission from Elsevier. (a) Left: the 8-Å cryo-EM
pre-target-bound structure of Cascade complex (EMD-5314). Right: docking of the
crystal structure of Cascade-ssDNA complex (PDB ID: 4QYZ) into the
pre-target-bound EM density map (EMD-5314). (b) Left: the 9-Å cryo-EM
reconstitution of dsDNA-bound Cascade (EMD-5929). Middle: the 20-Å
negative-stain EM reconstitution of Cas3-bound dsDNA-Cascade complex
(EMD-5930). Right: docking of the crystal structure of Cascade-ssDNA complex
(PDB ID: 4QYZ) into theCas3-bound dsDNA-Cascade EM density map.
In the proposed model, Cas6e is responsible for processing pre-crRNAs and remains
tightly bound to the 3’ handle of the mature crRNA after cleavage, while Cas5e binds
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the 5’ handle of crRNA. The Cas6e-crRNA-Cas5e subcomplex may serve as a
platform to further recruit other Cas proteins. The target DNA is recognized initially
by Cse1 via a short PAM motif (Semenova et al., 2011b). Upon target binding, the
Cascade undergoes a concerted conformational change of its Cse1, Cse2 and Cas6e
subunits. Then the complementary base pairing of the crRNA to the protospacer
should generate an R-loop formation (Jore et al., 2011). Once the R-loop formation,
the Cascade would recruit the nuclease-helicase Cas3, likely via interactions with two
conserved loops in Cse1, to nick the displaced strand (Mulepati and Bailey, 2013;
Sinkunas et al., 2013). Cas3 then unwinds and cleaves both strands processively to
fully degrade the foreign DNA (Hochstrasser et al., 2014b).
Besides type I-E Cascade complex from E. coli, large crRNA-guided surveillance
complexes have also been isolated in other type I systems, and low-resolution EM
structures are available for the complexes from Sulfolobus solfataricus (type I-A)
(Lintner et al., 2011), Bacillus balodurans (type I-C) (Nam et al., 2012c) and P.
aeruginosa (type I-F) (Wiedenheft et al., 2011b). Although these structures reveal a
similar Cas7-based helical platform, the complex from each subtype remains visibly
distinct and the properties of their nucleic binding are also different.
1.2.2 Type II CRISPR-Associated Systems
Type II systems have been found only in bacteria (Makarova et al., 2011b). Compared
with type I systems, type II CRIPSR loci are more minimal and consist of only four
cas genes: cas1, cas2, csn2 (type II-A) or Cas4 (type II-B) and the type II hallmark
gene cas9 (Figure 1- 5b, Figure 1- 9a) , although additional bacterial factors such as
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tracrRNA and RNase III contribute to the function of this system (Deltcheva et al.,
2011). Cas9 is a large multifunctional protein which participates in both crRNA
biogenesis and in the destruction of viral DNA or invading plasmids (Deltcheva et al.,
2011; Garneau et al., 2010; Jinek et al., 2012). Cas9 contains two nuclease domains:
HNH-nuclease domain is responsible for the cleavage of the DNA complementary
strand (target strand), and RuvC-like nuclease domain is responsible for the cleavage
of the non-complementary strand (non-target strand) (Figure 1- 9b) (Gasiunas et al.,
2012; Jinek et al., 2012). Cas9 proteins are abundant in bacterial kingdom, and have
been classified into three subtypes: type II-A, type II-B, and type II-C, despite their
variable size and limited sequence similarity (Chylinski et al., 2014). Both type II-A
and type II-C Cas9 proteins are found to introduce double strand breaks in the DNA
targets and are used as genome engineering tools in eukaryotes (Esvelt et al., 2013;
Hou et al., 2013).
Remarkably, unlike most other systems of type I and type III which use a dedicated
Cas endoribonuclease to cleave the precursor crRNA (pre-crRNA) at the repeat
unions, type II systems employ an elaborate and unique processing mechanism of
pre-crRNA, including endogenous RNase III and tracrRNA. These tracrRNAs are
encoded within or in the vicinity of the cas operon and the CRISPR array and
characterized by an anti-repeat sequence which is homologous to cognate CRISPR
repeats. Firstly, the tracrRNA hybridizes with the pre-crRNA guided by repeat
sequences in the presence of Cas9 and form RNA duplexes which are cleaved by
RNase III (Deltcheva et al., 2011). The intermediate crRNAs then undergo a second
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processing event resulting in the formation of the Cas9 protein and crRNA:tracrRNA
duplex complex (Deltcheva et al., 2011; Jinek et al., 2012).
Figure 1- 9: Crystal structures of Cas9 proteins in the apo state (Jiang and
Doudna, 2015).
Reprinted from Current Opinion in Structural Biology (Jiang and Doudna, 2015),
Copyright 2015, with permission from Elsevier. (a) A typical structure of CRISPR
locus in type II CRISPR/Cas system. (b) Cartoon schematic of polypeptide sequence
and domain organization for the type II-A Cas9 protein from S. pyogenes (SpyCas9,
PDB ID: 4CMP) and the type II-C Cas9 protein from A. naeslundii (AnaCas9, PDB
ID: 4OGE). (c) Orthogonal views of the overall structures of SpyCas9 and AnaCas9
shown in ribbon representation.
Similar to the type I system, a well-defined short PAM sequence which is located
immediately downstream of protospacer, is also required for both spacer acquisition
and for target recognition and cleavage, as well as R-loop formation (Jinek et al.,
2012). Upon binding to a PAM sequence, Cas9 interrogates the target DNA by
complementary base pairing between guide RNA and target DNA bearing PAM
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sequence. Furthermore, after PAM recognition, Cas9 initiates the R-loop formation at
the 3’ end of the guide RNA adjacent to the PAM site, triggers the directional and
sequential unwinding of target DNA via a proposed Brownian ratchet motion model
(Sternberg et al., 2014).
Structural studies of type II-A Cas9 protein from Streptococcus pyogenes (hereafter
referred to as SpyCas9) and type II-C Cas9 protein from Actinomyces naeslundii
(hereafter referred to as AnaCas9) showed the functional domain organization and
defined the molecular architecture of the Cas9 enzyme family (Figure 1- 9c) (Jinek et
al., 2014). Both Cas9 structures maintain an auto-inhibited conformation in the apo
state, while undergoing conformational rearrangement upon binding to guide RNA
and/or target DNA to convert into an active conformation for target surveillance. The
negative staining EM reconstructions of SpyCas9-nucleic acid complexes show that
the RNA loading serves as a key conformational switch in the activation and
regulation of Cas9 enzymes (Jinek et al., 2014). The superposition of the crystal
structure of SpyCas9 in complex with a sgRNA and a partially duplexed target DNA
with the apo structure also reveals a substantial conformational rearrangement of
Cas9 upon binding to guide RNA and target DNA (Figure 1- 10a) (Nishimasu et al.,
2014). The ternary complex structure reveals a unique T-shaped architecture formed
by the sgRNA and the target DNA (Figure 1- 10a). Based on the structural analysis
and biochemical observations, the guide RNA:ssDNA hybrid is recognized by Cas9
in a sequence-independent manner, while the sgRNA outside of the guide region,
including the repeat:anti-repeat duplex is recognized in a sequence-dependent
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manner.
The crystal structure of SpyCas9 in complex with a sgRNA and a partially duplexed
target DNA containing a 5’-TGG-3’ PAM sequence provides more detailed insight
into PAM-dependent target dsDNA recognition and unwinding (Anders et al., 2014).
Specifically, the ternary complex structure reveals that the conserved GG dinucleotide
PAM residues are read out by making base-specific hydrogen-bonding interactions
with two conserved arginine residues from the C-terminal domain of Cas9 (Figure
1- 10b). The PAM recognition by Cas9 protein is not only a critical determinant of
initial target DNA binding, but contributes as a licensing element in local strand
separation and guide-RNA-target-DNA hybridization (Anders et al., 2014).
Figure 1- 10: Crystal structures of SpyCas9 in the target-bound states (Jiang and
Doudna, 2015).
Reprinted from Current Opinion in Structural Biology (Jiang and Doudna, 2015),
Copyright 2015, with permission from Elsevier. (a) Left: Ribbon representation of the
Cas9-sgRNA-ssDNA complex (PDB ID: 4OO8). Middle: Stereo view of the apo
structure of SpyCas9 after superimposition onto the structure of
SpyCas9-sgRNA-ssDNA complex (not shown). Right: Structure of the
sgRNA:ssDNA complex. (b) Left: Ribbon representation of the
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SpyCas9-sgRNA-DNA complex (PDB ID: 4UN3). The partially duplexed target
DNA contains a 5’-TGG-3’ PAM sequence. Middle: Structure of the
sgRNA:partically duplex DNA complex. Right: Close-up view of PAM binding
region and +1 phosphate (+1 P).
1.2.3 Type III CRISPR-Associated Systems
Type III systems are most common in archaea. There are two subtypes identified:
type III-A and type III-B, in which a multiprotein complex called Csm or Cmr
complex binds the crRNA and functions as the interference complex, respectively
(Makarova et al., 2011b). The core cas1 and cas2 genes are usually in operon-like
structures with the other cas genes but are occasionally missing from type III operons,
but they are found to co-exist with other CRISPR systems in the same genome. The
type III-B system is only found in conjugation with other CRISPR systems (Figure
1- 5c). In type III systems, the pre-crRNA is most likely cleaved at the repeat
sequence by Cas6 and followed by 3’-end processing in a ruler-like mechanism by an
unknown nuclease to generate mature crRNA (Hatoum-Aslan et al., 2011). The two
subtypes appear to target different targets. Genetic evidence indicates that the Csm
complex targets DNA (Marraffini and Sontheimer, 2008), whereas biochemical
analyses show that the complex cleaves RNA (Staals et al., 2014; Tamulaitis et al.,
2014). In comparison, the Cmr complex from Pyrococcus furiosus and S. solfataricus
cleave target RNA, indicating the polymorphic nature of CRISPR/Cas systems, even
within type III systems (Hale et al., 2009; Hale et al., 2012; Zhang et al., 2012b).
Up until now, cryo-EM reconstruction of four functional type III interference
complexes have been reported which includes two Csm complexes derived from S.
solfataricus (Rouillon et al., 2013) and Thermus thermophilus (Staals et al., 2014),
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and two Cmr complexes derived from T. thermophilus (Staals et al., 2013; Taylor et
al., 2015) and P. furiosus (Spilman et al., 2013). Recently, a 2.1 Å crystal structure of
the Cmr1-deficient, functional Cmr complex which consists of P. furiosus
Cmr2dHD-Cmr3, Archaeoglobus fulgidus Cmr4-Cmr5-Cmr6, and 39-mer
Pf7.01-crRNA (referred to as ChiCmrΔ1) in complex with a 31-mer ssDNA
complementary to the crRNA guide has been reported, which reveals the detailed
structural basis for the RNA degradation mechanism by the Cmr complex (Figure
1- 11) (Osawa et al., 2015). The overall shape of the complexes is strikingly similar to
the Cascade complex from the type I system. The central backbone of the complexes
consists of 4-6 copies of Cas7(-like) proteins and a smaller Cas5(-like) protein which
is contributed in 5’-end-crRNA binding, and their base is commonly formed by Cas10
which interacts with Cmr3 in the Cmr complex or Csm3 and Csm4 in the Csm
complex. Despite these similarities, the type I and type III-A systems show different
mechanisms in target recognition. The type III-A system prevents autoimmunity by a
self-discrimination versus non-self-discrimination mechanism relying on base pairing
with the 5’ repeat-derived fragment of crRNA (Carte et al., 2008; Marraffini and
Sontheimer, 2010), i.e., by “self-inactivation” (van der Oost et al., 2014). In
comparison, the type I systems use a PAM-dependent targeting mechanism which is
not based on complementarity (Westra et al., 2013), i.e., by “non-self-activation”.
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Figure 1- 11: Crystal structure of the ChiCmrΔ1-ssDNA complex (Osawa et al.,
2015).
Reprinted from Current Opinion in Molecular Cell (Osawa et al., 2015), Copyright
2015, with permission from Elsevier. The overall structure of ChiCmrΔ1 bound to
ssDNA. The 5’ and 3’ ends of the crRNA are shown, and the color codes of each
molecule are indicated.
The signature Cas protein for the type III system is Cas10. Csm1 from the Csm
complex and Cmr2 from the Cmr complex which are the largest subunit in the two
interference complexes share sequence homology and belong to the Cas10 family
(Makarova et al., 2011a). The two proteins were initially considered as nucleases that
contribute to the cleavage of target nucleic acids since the HD domain
(histidine-aspartate) of Cas10 is found in a superfamily of enzymes with
phosphohydrolase activity (Aravind and Koonin, 1998). Remarkably, the catalytic
activity within the Cas10 family is not uniform, for example, Cmr2 of P. furiosus is
catalytically inactive (Cocozaki et al., 2012), Csm1 of S. solfataricus exhibits no
nuclease activity (Rouillon et al., 2013), whereas Csm1 of Staphylococcus
epidermidis shows ssDNA and ssRNA exonuclease activity with the GGDD motif of
the ATP binding domain rather than HD domain (Hatoum-Aslan et al., 2014; Ramia
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et al., 2014a), Csm1 of Thermococcus onnurineus possesses ssDNA-directed
nuclease activity on the HD domain (Jung et al., 2015b). All these findings seem to
reflect a great versatility of the CRISPR/Cas systems and appear to point to diversity
even within the type III CRISPR/Cas system.
1.3 The three stages of the CRISPR/Cas mode of action
The mechanism of protection in CRISPR/Cas systems can be divided into three
mechanistically distinct stages: CRISPR adaptation (i.e., new spacer acquisition),
crRNA biogenesis and crRNA-guided interference (Makarova et al., 2006). The
current understanding of the molecular mechanisms and protein machinery taking
part in these three stages are described below.
1.3.1 Stage I: Spacer selection and integration into CRISPR locus
The acquisition of new invader-derived spacers is the first step of CRISPR-mediated
immunity and enables the swift adaptation of the prokaryotic cells into the dynamic
environmental pool of mobile invader genetic elements. During this stage, a short
segment of DNA from the invading virus or plasmid (known as protospacer) is
integrated in a polarized manner at the leader-end of the CRISPR locus, which results
in a chronological record of previously encountered foreign nucleic acids (Barrangou
et al., 2007; Garneau et al., 2010).
The first experimental evidence of novel spacer acquisition and the implications for
CRISPR/Cas immune system was provided in Streptococcus thermophilus (type II
CIRSPR/Cas system) (Barrangou et al., 2007). Phage-challenge experiments in S.
thermophilus indicates that a small number of the cells will typically incorporate a
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single virus-derived sequence in a polarized fashion at the leader end of the CRISPR
locus, and the addition of a repeat sequence accompanied each new spacer to
maintain the repeat-spacer-repeat architecture (Barrangou et al., 2007; Deveau et al.,
2008; Garneau et al., 2010; Horvath et al., 2008). Naturally acquired phage-derived
spacer sequences were derived from either strand of the invading DNA (sense and
antisense), and the number of spacers is related with the degree of phage resistance.
Successive phage challenges in S. thermophilus demonstrated that the iterative
addition of new spacers could expand the repertoire of phage protection (Deveau et
al., 2008). However, occasional loss of repeat-spacer units has also been observed,
which usually occur toward the trailer end (opposite the leader end) of the CRISPR
locus. This observation suggests that the CRISPR/Cas system may eliminate the old
spacers targeting ancient phages or plasmids while maintaining the more
contemporary spacers at the leader end.
The CRISPR/Cas system targets suitable spacers by detecting the specific PAM
sequence, and then processing the DNA targets into spacer precursors of a defined
size (Deveau et al., 2008; Mojica et al., 2009; Shah et al., 2013; Swarts et al., 2012).
In addition to DNA derived from mobile genetic elements (MGEs, that is, ‘non-self’
DNA), fragments of chromosomal DNA (that is, ‘self’ DNA) are occasionally
integrated into the genome as novel spacers. However, the presence of self-targeting
spacers in the genome is typically associated with a modified PAM or an inactivated
CRISPR/Cas system because of cytotoxicity, suggesting that the CRISPR/Cas system
could distinguish self and non-self DNA via an unknown mechanism directly or via
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interaction with other defense systems (such as R-M systems) indirectly (Stern et al.,
2010; Vercoe et al., 2013).
1.3.1.1 The involvement of Cas1 and Cas2 in spacer acquisition
Gene deletion experiments in both S. thermophilus and E. coli suggest a role for Cas1
and Cas2 in the integration of foreign DNA into the CRISPR locus (Babu et al., 2011;
Brouns et al., 2008; Sapranauskas et al., 2011). Biochemical assays with Cas1 from P.
aeruginosa and E. coli indicate that Cas1 is a metal-dependent endonuclease that
interacts with nucleic acids in a non-sequence-specific manner (Babu et al., 2011;
Wiedenheft et al., 2009). Despite the relatively low sequence identity, crystal
structures of all Cas1 proteins seem to share a two-domain architecture consisting of
an N-terminal β-stand domain and a C-terminal α-helical domain (Figure 1- 4a) (Babu
et al., 2011; Wiedenheft et al., 2009). The C-terminal domain contains a conserved
divalent metal ion binding site, which participates in Cas1-catalysed DNA
degradation (Yosef et al., 2012). The metal ion is surrounded by a cluster of basic
residues that form a positively charged surface, which may serve as an electrostatic
snare to position the substrates close to the metal ion in the active site (Wiedenheft et
al., 2012; Wiedenheft et al., 2009). The Cas1 proteins could form a stable homodimer
through interactions between the two β-strand domain, which are related by a
pseudo-two-fold axis of symmetry (Babu et al., 2011; Wiedenheft et al., 2009). The
β-hairpins of this saddle-like structure can be modeled on opposite faces of the
dsDNA (like stirrups on a saddle). Consistently, comparative analysis of the available
Cas1 structures reveals conserved positively charged residues locate along each of the
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β-hairpins that are considered to contact the phosphate backbone. Thus, the two
β-hairpins may play a role in sequence-specific interactions with the CRISPR repeat,
whereas the positively charged surface on the C-terminal α-helical domain might be
responsible for the high-affinity, non-specific interactions that have already been
observed in vitro.
Cas2 was considered to take part in this stage together with Cas1 and form the core of
the three types of CRISPR system. Cas2 is a metal-dependent nuclease which
contains a RAMP-like fold within a typical βαββαβ arrangement and cleaves
preferentially in U-rich regions (Figure 1- 4b) (Beloglazova et al., 2008; Nam et al.,
2012b; Reeks et al., 2013a; Samai et al., 2010). The physiological state of Cas2 is a
homodimer with a central cleft formed by the tandem arrangement of β-sheets from
two monomers, and the conserved residues which play a role in metal-binding and
nuclease activity are positioned along the Cas2 dimer interface (Nam et al., 2012b).
Several studies have reported that Cas2 is an endoribonuclease, whereas other Cas2
proteins are mainly considered as deoxyribonuclease since they can catalyze the
cleavage of dsDNA (Beloglazova et al., 2008; Nam et al., 2012b). The recently
reported crystal structure of Cas1-Cas2 complex reveals a crablike architecture
consisting of a Cas2 dimer and two Cas1 dimers (Nunez et al., 2014). Moreover, the
mutational studies in vivo reveal that Cas1 functions as a bona fide nuclease involved
in the acquisition stage, whereas the catalytic activity of Cas2 seems not necessary for
integration of novel spacers into CRISPR locus in vivo (Nunez et al., 2014). However,
Cas1 and Cas2 assemble into a stable complex which is conserved across divergent
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CRISPR systems and is essential for spacer acquisition in vivo and CRISPR locus
binding. The Cas1-Cas2 complex is uniquely required for recognizing the CRISPR
leader-repeat sequence without the participation of other proteins.
A further study using Cas1-Cas2 complex, protospacers and accepter plasmid DNA
has provided more evidence on the mechanistic basis for foreign DNA acquisition
during CRISPR/Cas adaptive immunity (Nunez et al., 2015). The mechanism was
proposed with two-step integration process (Figure 1- 12). Firstly, the C 3’-OH
attacks the minus strand of the CRISPR repeat and results in a half-site intermediate.
Secondly, the 3’-OH on the opposite strand of the integrating DNA attacks the plus
strand of the CRISPR repeat 28bp away on the opposite site leading to full integration
of the protospacer (Figure 1- 12). This model is consistent with spacer integration
intermediates observed in vivo, in which protospacers are integrated such that
staggered cleavage at each end of the repeat produces single-stranded gaps that
ensure the repeat duplication (Arslan et al., 2014). The mechanism of protospacer
integration shares similarity with retroviral integration and DNA transposition, in
which the integrase/transposase enzyme uses the 3’-OH ends of donor DNA to target
and make a staggered cut at the DNA target site, which concurrently joins the donor
DNA to target its 5’-phosphates (Engelman et al., 1991; Mizuuchi and Adzuma,
1991). To complete the full integration reaction, a DNA polymerase is required to fill
in sequence gaps and a DNA ligase is needed to seal the phosphodiester backbone
(Craigie and Bushman, 2012). Similarly, to complete CRISPR acquisition in vivo,
such polymerase and ligase are required, but the specific enzymes have not been
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identified yet.
Figure 1- 12: Model of protospacer integration during CRISPR/Cas adaptive
immunity (Nunez et al., 2015).
Reprinted by permission from Macmillan Publishers Ltd: Nature (Nunez et al., 2015),
copyright 2015. The first nucleophilic attack event occurs on the minus strand of the
first repeat by the 3’-OH end of the protospacer, distal to the leader, while the second
integration event occurs on the opposite strand at the leader-repeat border. The
resulting DNA gaps are sealed by yet uncharacterized mechanisms and the
protospacer is fully integrated with the first G at its 5’ end.
1.3.1.2 Other factors involved in spacer acquisition
In addition to the participation of Cas1 and Cas2, a variable set of accessory factors
might be involved in spacer acquisition. The results of pulldown assays have
indicated that E. coli Cas1 protein interacts with RecBCD and RuvB which are
housekeeping proteins involved in general DNA repair and recombination (Babu et
al., 2011). Moreover, the gene fusion and conserved gene clustering suggest that
additional Cas proteins such as Csn2, Cas4, Csa1 and Cas3 might be required for
spacer acquisition (Table 1- 2) (Makarova et al., 2011b; van der Oost et al., 2009).
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The putative roles of several of these proteins in CRISPR acquisition are discussed
below.
Mutational studies of cas genes in the type II-A system of S. thermophilus have
demonstrated that csn2 is required for new spacer acquisition (Barrangou et al., 2007).
Several biochemical and structural studies have shown that Csn2 is a
calcium-dependent dsDNA-binding protein which forms a tetrameric ring-shaped
complex with a positively charged central cavity binding to and sliding along DNA
fragments (Arslan et al., 2013; Ellinger et al., 2012; Koo et al., 2012; Lee et al., 2012;
Nam et al., 2011). The fact that Csn2 lacks catalytic activity suggests that it might
have an accessory role during spacer acquisition or it might be responsible for the
recruitment of additional factors (Arslan et al., 2013). The csn2 gene is replaced by
cas4 in type II-B system (Haft et al., 2005; Makarova et al., 2006; Makarova et al.,
2011b). Cas4 contains RecB-type and AddB-type nuclease-helicase domains which
share amino acid sequence similarity with Csa1 (Makarova et al., 2006; Zhang et al.,
2012a). The Cas4 protein from S. solfataricus is a ring-shaped decamer which shows
5’ to 3’ exonuclease activity (Lemak et al., 2013; Zhang et al., 2012a). Moreover,
some Cas4 homologues show both endonuclease and helicase activities (Lemak et al.,
2013; Zhang et al., 2012a). In addition, fusion of Cas4 and Cas1 occur in several type
I and type III systems, suggesting that the two proteins may be functionally related
(Makarova et al., 2011b; van der Oost et al., 2009). Cas4 of Thermoproteus tenax has
been shown to form a complex with Cas1-Cas2 fusion protein and Csa1 in vitro
(Plagens et al., 2012). However, such complexes have not been isolated using a
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natural system yet, suggesting that these protein interactions may only provide a
“snapshot” in vivo in the whole process, and that the fusion proteins like Cas4-Cas1
and Cas1-Cas2 may play a role in stabilizing these complexes (Makarova et al., 2006;
Plagens et al., 2012).
Cas3 is a multidomain protein which is fused to Cas2 in type I-F systems (Table 1- 2)
(Jackson et al., 2014a). A direct interaction between Cas1 and Cas2-Cas3 fusion
protein has been observed in the type I-F system from Pectobacterium atrosepticum,
suggesting that Cas3 may have a dual role, functioning during both CRISPR
interference and spacer acquisition process (Richter et al., 2012). The proposed dual
role of Cas3 might be related to a phenomenon called “primed spacer acquisition”,
which refers to a positive feedback loop accelerating new spacer acquisition from
previously encountered genetic elements (Datsenko et al., 2012; Fineran et al., 2014;
Swarts et al., 2012). Many proteins participate in this process in type I-E system
including Cas1, Cas2, Cas3 and Cascade, but the mechanism is still poorly
understood.
Table 1- 2: Overview of Cas proteins (van der Oost et al., 2014).
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Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews
Microbiology (van der Oost et al., 2014), copyright 2014. Numbers indicate the
following: [1] Cas2-Cas3 fusion protein; [2] Cas8 homologue replaced by Cas10
homologue; [3] small subunits proposed to be fused to Cas8 or Cas10d. Different
colors indicate the following: yellow, nucleases and/or recombinases involved in
spacer acquisition; pink, ribonucleases that catalyze processing of crRNA guides;
blue, proteins that assemble with the RNA guide to form the crRNP complexes;
purple, nucleases that are responsible for target degradation.
1.3.2 Stage II: CRISPR expression and biogenesis of crRNAs
Spacer acquisition is important to the immunization, but the CRISPR loci need to be
transcribed and processed into short crRNAs to obtain a successful protection from
bacteriophage and plasmid challenge. The maturation of crRNA included at least two
distinct steps. CRISPR loci are initially transcribed as long pre-crRNAs, which are
subsequently processed into mature crRNA species by subtype-specific enzymes
(Figure 1- 13).
1.3.2.1 Processing of crRNA guides in type I and type III systems
In type I and type III systems, a diverse family of CRISPR-specific
endoribonucleases are responsible for the primary processing of the pre-crRNA
through interaction with the repeat sequences from their associated CRISPR loci
(Carte et al., 2008; Carte et al., 2010; Gesner et al., 2011; Hatoum-Aslan et al., 2011;
Haurwitz et al., 2012; Haurwitz et al., 2010; Sashital et al., 2011; Sternberg et al.,
2012). The CRISPR-specific endoribonuclease was initially identified in E. coli (type
I-E) and called Cas6e (formerly known as Cse3 or CasE) (Brouns et al., 2008). Cas6e
specifically binds and cleaves within the repeat sequence of the pre-crRNA,
generating a library of crRNAs containing a unique spacer sequence flanked by
fragments of adjacent repeats. Cas6e is a member of a large family referred to as
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RAMPs, which contain at least one RNA recognition motif (RRM) (also referred to
as a ferredoxin-like fold) and a conserved glycine-rich loop (G-loop) (Haft et al.,
2005; Makarova et al., 2006; Wang and Li, 2012). RRMs consist of a conserved
β1α1β2β3α2β4 arrangement which is found in a variety of RNA-binding proteins and
the conserved residues positioned along the open face of the β-sheet are responsible
for RNA binding (Maris et al., 2005). The Cas6e protein contains a double
ferredoxin-like fold which interacts with specific RNA repeat and does not associate
with other sequences like DNA or CRISPR RNAs containing a non-cognate repeat
sequence (Brouns et al., 2008; Ebihara et al., 2006; Gesner et al., 2011; Sashital et al.,
2011). Co-crystal structures of Cas6e bound to a crRNA repeat reveal the
noncanonical binding mechanism of substrate recognition that involves a combination
of sequence- and structure-specific interactions (Gesner et al., 2011; Sashital et al.,
2011). The repeat sequence of E. coli CRISPR is partially palindromic, resulting in
RNAwith a stable 7-nt stem capped by a GCGU tetraloop (Brouns et al., 2008; Kunin
et al., 2007). The major groove of the RNA duplex interacts with the positively
charged β-hairpin in Cas6e and positions its 3’ strand of the stem along a conserved,
positively charged cleft on one face of the protein (Figure 1- 13). RNA binding
induces a conformational change by disrupting the bottom base pair of the stem and
positioning the scissile phosphate in an extended conformation in the enzyme active
site (Sashital et al., 2011). The cleavage mechanism is metal-independent and occurs
at the base of the stem, generating a mature crRNA containing a 5’ hydroxyl and a
cyclic 2’-3’ phosphate (Jore et al., 2011). The 61-nt mature crRNAs consist of a 32-nt
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spacer flanked by 8-nt of the repeat sequence on the 5’ end (referred to as 5’ handle)
and 21-nt of the remaining repeat sequence on the 3’ end (Figure 1- 13). Cas6e
remains bound to the 3’ end and serves as a nucleation point that could recruit other
Cas proteins and form a large surveillance complex called Cascade required for target
silencing in the next stage (Figure 1- 13) (Brouns et al., 2008; Jore et al., 2011;
Wiedenheft et al., 2011a).
Figure 1- 13: Biogenesis of crRNAs and assembly of crRNA-guided surveillance
complexes (Sorek et al., 2013).
Reprinted by permission from Annual Review of Biochemistry (Sorek et al., 2013),
copyright 2013. In type I and type III systems, pre-crRNA processing relies on a
diverse family of CRISPR-specific endoribonucleases. Crystal structures of these
proteins in apo state (Cas5d, PDB ID: 4F3M) or in crRNA-bound state (Cas6e, PDB
ID: 2Y8W; Cas6f, PDB ID: 2XLK) reveal unique tertiary folds and distinct
mechanisms for RNA recognition. In contrast, in type III-B systems, the repeat
sequences are predicted to be unstructured and wedged in a positively charged cleft of
Cas6 (PDB ID: 3PKM) formed by opposing β-sheets in each RRM. In type II systems,
pre-crRNA processing relies on a host-encoded RNase III enzyme (PDB ID: 2EZ6)
and a tracrRNA.
Crystallographic studies of the Cas6 protein from P. furiosus (type III-B, I-A) reveal
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the same duplicated ferredoxin-like fold observed in Cas6e protein, but with a
different mode of RNA recognition involving the more canonical (β-sheet) face of the
protein (Carte et al., 2008; Wang et al., 2011; Wang et al., 2012). The crRNA repeat
sequences associated with this system are predicted to be unstructured, and its 5’ end
is wedged in a positively charged cleft formed by opposing β-sheets in each RRM
(Figure 1- 13) (Wang et al., 2011). Although the RNA is disordered in the enzyme
active site, biochemical studies have shown that cleavage occurs specifically 8
nucleotides upstream of the spacer sequence, resulting in a 5’ handle similar in length
but different in sequence compared with crRNA generated in the E. coli system (Carte
et al., 2010). Remarkably, Cas6-mediated cleavage in this system results in a 69-nt
crRNA intermediate which is further processed by nucleolytic 3’-end trimming
generating two distinct mature crRNAs (39- and 45-nt long) that lack the 3’-repeat
sequence (Figure 1- 13) (Carte et al., 2008; Carte et al., 2010; Hale et al., 2008; Hale
et al., 2009; Hale et al., 2012). Whereas the Cas6e in E. coli remains associated with
the 3’-repeat sequence, the crRNA in P. furiosus is loaded into Cmr complex with its
5’ handle (Hale et al., 2009; Hale et al., 2012). Compared with the type III-B system
in P. furiosus, type III-A system in S. epidermidis harbors a similar mechanism that
initially involves Cas6-mediated cleavage of the pre-crRNA followed by 3’-end
trimming, which generates two crRNA species (37- and 43-nt long) containing a
3’-hydroxyl group rather than a 2’-3’-cyclic phosphate characteristic of the
intermediate (Hatoum-Aslan et al., 2011). It is still not clear why both type III
systems produce mature crRNAs with two different lengths, but this may offer a
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common structural explanation for the ruler mechanisms defining these two crRNA
species.
Crystal structures of CRISPR-specific endoribonucleases from other immune systems
type I-C and type I-F have also been determined. The repeat sequences associated
with these two systems are partially palindromic, but the proteins binding these
repeats are structurally distinct. The Cas6f protein (also known as Csy4) from P.
aeruginosa has a two-domain architecture, which consists of an N-terminal RRM
structurally similar to Cas6e and Cas6, but its C-terminal domain is structurally
distinct. Specifically, unlike Cas6e and Cas6, Cas6f uses its structurally unique
C-terminal domain, which contains an arginine-rich α-helix, and inserts itself into the
major groove of the crRNA duplex, forming a complex network of hydrogen-bonding
interactions which are highly sensitive to the helical geometry of the crRNA substrate
(Haurwitz et al., 2012; Haurwitz et al., 2010; Sternberg et al., 2012). Upon binding by
arginine-rich helix, the base of the crRNA stem is positioned for sequence-specific
hydrogen-bonding contacts in the RNA major groove. These contacts position the
scissile phosphate of crRNA in the enzyme active site so that cleavage occurs 8
nucleotides upstream of the spacer sequence, generating a similar 8-nt 5’-handle on
mature crRNAs (Haurwitz et al., 2012; Haurwitz et al., 2010; Sternberg et al., 2012).
In type I-C systems, Cas6 is substituted by a Cas5 variant (known as Cas5d) to cleave
the pre-crRNA (Garside et al., 2012; Koo et al., 2013; Nam et al., 2012c). The Cas5d
protein from B. balodurans specifically cleaves the crRNA repeat at the 3’ base of the
stem-loop, generating a crRNA species with an 11-nt 5’-handle (rather than the 8-nt
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handle generated by Cas6) and 21-nt stem-loop at the 3’ end. A crystal structure of
Cas5d shows an N-terminal ferredoxin-like fold extended by two more β-strands,
creating a β1α1β2β3β4β5α2β6 architecture which is different from the canonical
β1α1β2β3α2β4 architecture of this fold (Nam et al., 2012c). Like Cas6e and Cas6f,
Cas5d remains associated with its crRNA product and assembles with other Cas
proteins to form into a multisubunit Cascade complex (Nam et al., 2012c). Cas5-like
proteins are also found in other type I systems with a very low sequence identity,
suggesting these Cas5 homologues may not possess a similar enzymatic activity.
However, the catalytically inactive Cas5 homologues are proposed to interact with 5’
handle of crRNA in Cascade complex (Wiedenheft et al., 2011a).
The catalytic mechanism used by all characterized Cas6-like enzymes seems to rely
on an invariant histidine residue, a tyrosine or serine residue and, in some cases, a
lysine residue, all of which are necessary for acid-base catalysis. However, the
relative positions of these residues are poorly conserved, providing an explanation for
the observed functional variations in Cas6 activity (see above) (Reeks et al., 2013b;
Sashital et al., 2011; Wiedenheft et al., 2012). However, all these proteins rely on
distinct sequence- and structure-specific mechanisms for RNA recognition,
suggesting the versatility of the characterized duplicated ferredoxin-like fold and
illustrating the co-evolution of CRISPR repeat sequences and Cas proteins. To
summarize, the generated mature crRNA consists of three elements: the conserved
repeat-derived 5’ handle responsible for assembly within Cascade-like effector
complexes and target recognition through a self-nonself discrimination mechanism;
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the spacer sequence responsible for target recognition by complementary base pairing;
the heterogeneous repeat-derived 3’ end with a length range from 0 to 22-nt (Brouns
et al., 2008; Carte et al., 2008; Hale et al., 2009; Haurwitz et al., 2010; Lintner et al.,
2011). However, the processing events that lead to 3’ end trimming and the functional
significance of this heterogeneity are still unidentified.
1.3.2.2 Processing of crRNA guides in type II systems
In contrast to crRNA processing in type I and III systems, processing of pre-crRNA
relies on a completely different mechanism in type II systems (Figure 1- 13)
(Deltcheva et al., 2011). In addition to CRISPR locus and cas operon, the type II
systems also include a gene encoding a tracrRNA, which contains a 25 nucleotide
sequence complementary to the repeat region of the pre-crRNA (Deltcheva et al.,
2011). Base pairing between the two RNAs creates a double-stranded region which
could be recognized and cleaved by the housekeeping ribonuclease RNase III (Figure
1- 13). The primary crRNA processing also requires Cas9 probably for binding and
positioning the RNA molecule for cleavage by RNase III (Deltcheva et al., 2011;
Fonfara et al., 2014; Jinek et al., 2012). After initial processing by RNase III, the
crRNA undergoes further trimming at the 5’ end of the crRNA spacer by an unknown
nuclease, which typically results in a spacer with the length of 20 nucleotides
(Deltcheva et al., 2011). The mature crRNA:tracrRNA duplex assembles Cas9 and
forms a functional complex involved in the next step of target interference (Jinek et
al., 2012).
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1.3.3 Stage III: Recognition of invade sequences and target interference
Target interference is the third stage of CRISPR-mediated immunity. All crRNAs
associate with cognate Cas proteins to form large CRISPR ribonucleoprotein (crRNP)
complexes, but how do they recognize target sequences complementary to the crRNA
in a dramatically crowded intracellular environment packed with gigabases of
distracting (non-targeting DNA or RNA) nucleic acids? The targeting of invading
MGEs by the different crRNP complexes seems to proceed in a stepwise manner
which includes scanning of the invader DNA, discriminating self from non-self, base
pairing between the 7-8 seed region of the spacer and the complementary protospacer,
followed by extended base pairing between the spacer and protospacer which
eventually results in complete strand displacement (Sashital et al., 2012; Sorek et al.,
2013; Westra et al., 2012a). Hybridization of crRNA to the target strand generates an
R-loop structure which has been shown to trigger a conformational change in the
crRNP complexes (Hochstrasser et al., 2014b; Jore et al., 2011; Spilman et al., 2013;
Wiedenheft et al., 2011a). This structural re-arrangement may provide a signal that
recruits a trans-activating nuclease or may lead to the activation of intrinsic nuclease
activity (Figure 1- 14).
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Figure 1- 14: Target surveillance and interference by crRNP complexes (van der
Oost et al., 2014).
Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews
Microbiology (van der Oost et al., 2014), copyright 2014. (a) In type I systems, the
Cascade complex searches for a complementary protospacer in the invading nucleic
acids through recognition of the PAM sequence by a ‘non-self activation’ strategy. (b)
In type II systems, the Cas9 bound to the crRNA-tracrRNA duplex, and follows a
similar mechanism of PAM-dependent recognition of the invading DNA. (c) In type
III-A systems, the crRNA-bound Csm complex targets DNA in a PAM-independent
process via a ‘ self inactivation’ strategy. (d) In type III-B systems, the
crRNA-guided Cmr complex targets invading RNA in a PAM-independent process.
The type I systems use Cas3 to mediate target degradation, while all other systems are
thought to involve non-Cas nucleases for complete target degradation.
1.3.3.1 Target surveillance and interference in type I systems
Target recognition by CRISPR systems involves the hybridization between crRNA
spacer sequence and a complementary nucleic acid target, presenting a potential
problem that the secondary structures of RNAmay occlude the target binding sites. In
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type I-E systems, the Cascade complex from E. coli preferentially binds to long
dsDNA that is negatively supercoiled (Westra et al., 2012c). In negatively
supercoiling dsDNA, sequences separated by long distances along the contour of the
DNA can be positioned in close proximity in 3D space, which could dramatically
accelerate the search process for some dsDNA-binding proteins, and negative
supercoiling could also introduce torsional tension that facilitates strand separation
(Gowers and Halford, 2003).
Scanning of foreign nucleic acids seems to strongly rely on nonspecific interactions
between the crRNP complexes and invading DNA. In type I-E systems, the Cse1
subunit of Cascade is required for binding nonspecific DNA and also has a key role in
preventing autoimmunity (Jore et al., 2011; Sashital et al., 2012; Westra et al., 2013).
The PAM sequence which is required for efficient target binding is not
complementary to the crRNA, suggesting that protein interactions may mediate
recognition of this sequence (Semenova et al., 2011b). Although high-resolution
crystal structures of the Cse1 protein do not reveal an obvious DNA binding site, a
flexible loop in Cse1 appears to interact with the 3 nucleotide PAM motif when
docking into the cryo-EM reconstruction of the Cascade complex, which is further
confirmed by chemical probing experiments (Mulepati et al., 2012; Sashital et al.,
2012). Detection of the PAM sequence requires a phenylalanine residue within this
loop, reminiscent of mechanisms observed in the type II restriction endonuclease
HinP1I and the DNA repair enzyme MutM, in which the phenylalanine intercalates
into the major groove resulting in a local distortion of the B-form helix and a
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separation of the two strands (Banerjee et al., 2006; Horton et al., 2006; Sashital et al.,
2012). Thus a similar distortion of the DNA by Cse1 may provide a possible
mechanism and enable the crRNA to access the target DNA for hybridization
(Sashital et al., 2012). For successful interference, base pairing between the seed
region of the crRNA spacer and the target complementary protospacer at the positions
closest to the PAM is most important for target binding. Single-nucleotide mutations
in target sequences complementary to the seed generally escape detection by Cascade
(Semenova et al., 2011b). In contrast, multiple mutations in the target at the non-seed
regions could bind with crRNA in a high affinity and maintain their effectiveness
during phage challenge (Semenova et al., 2011b). Upon PAM recognition and
successful seed base pairing, crRNA-guided strand invasion into the target dsDNA
proceeds in an ATP-independent manner, generating an R-loop that might be
stabilized by the positively charged surface of the Cse2 dimer in the Eco_Cascade
complex (Westra et al., 2013; Wiedenheft et al., 2011a).
The formation of the R-loop triggers a conformational change in the Cascade
complex coinciding with bending of the target DNA (Jore et al., 2011; Westra et al.,
2012b; Westra et al., 2012c; Wiedenheft et al., 2012). In type I system, these
structural changes trigger recruitment of Cas3 protein that is a nuclease-helicase
responsible for degradation of dsDNA (Westra et al., 2012c). The single-particle EM
reconstitutions of dsDNA-bound Cascade have revealed that the kinked DNA duplex
is positioned in a way that the PAM sequence contacts the Cse1 subunit, and Cse1
provides a site in close proximity to Cas5e for docking of Cas3 (Figure 1- 8b)
47
(Hochstrasser et al., 2014b). Although the observed density of Cas3 in this
reconstruction corresponds only to part of the Cas3 protein (Hochstrasser et al.,
2014b), its binding site on Cascade is consistent with some natural Cas3 fusions, such
as Cse1-Cas3 in type I-E systems (Westra et al., 2012c) and Cas5-Cas3 in type I-B
systems (van der Oost et al., 2014).
Cas3 consists of a histidine-aspartate (HD) nuclease domain and a Superfamily 2
(SF2) helicase domain. These two enzymatic units may be fused as a single HD-SF2
polypeptide or expressed by separate genes as Cas3’ (SF2 helicase) and Cas3” (HD
nuclease) (Jackson et al., 2014a; Makarova et al., 2011b). The ATP-dependent
helicase activity together with metal-dependent nuclease activity mediates complete
degradation the target DNA by Cas3 (Sinkunas et al., 2013; Westra et al., 2012c).
However, the variation in optimal reaction conditions especially in cofactor
requirements and substrate specificities of HD nuclease have also been reported. Cas3
from S. thermophilus type I-E system cleaves ssDNA dependent on magnesium and
transitional metal ions with ATP hydrolysis to translocate DNA strands with 3’ to 5’
direction (Sinkunas et al., 2011). Cas3” HD nuclease from Methanocaldococcus
jannaschii type I-A system degrades ssDNA both endo-nucleolytically and 3’ to 5’
exo-nucleolytically in the presence of magnesium, and degrade ssRNA in the
presence of Mn2+ ions (Beloglazova et al., 2011). Cas3” HD nuclease from T.
thermophilus HB8 type I-E system cleaves ssDNA endo-nucleolytically with Mn2+ or
Ni2+ dependence (Mulepati and Bailey, 2011). For E. coli type I-E system, Cas3
catalyzes nicking of the displaced strand of the R-loop dependent on Mg2+ and
48
transition metal ions, after which ATP-dependent unwinding of the target allows for
the exo-nucleolytic degradation on the nicked ssDNA in the 3’ to 5’ direction (Figure
1- 14a) (Mulepati and Bailey, 2011; Mulepati and Bailey, 2013; Sinkunas et al., 2011;
Westra et al., 2012b; Westra et al., 2012c). Overall, the nucleolytic activity of most
Cas3 is transition metal ion-dependent.
1.3.3.2 Target surveillance and interference in type II systems
Unlike type I systems, interference in type II is mediated by the Cas9-RNA complex
consisting of Cas9 and two RNAs (crRNA and tracrRNA) (Figure 1- 14b) (Deltcheva
et al., 2011; Garneau et al., 2010; Gasiunas et al., 2012; Jinek et al., 2012). Recent
crystal structures and electron microscopic reconstructions of Cas9 and its DNA- and
RNA-bound complexes reveal that the aforementioned sgRNA triggers a structural
rearrangement of a central channel that facilitates target DNA binding (Jinek et al.,
2014; Nishimasu et al., 2014). Next, the Cas9-RNA complex scans the DNA for a
PAM motif, which resides on the displaced strand of the target DNA and is located
close to the 3’ handle of the crRNA guide. The recently reported crystal structure of S.
pyogenes Cas9 in complex with an sgRNA and a target DNA containing a 5’-TGG-3’
PAM sequence provided insights into the molecular mechanism of PAM recognition
in Cas9 (Anders et al., 2014). Based on the structural analysis, the PAM GG
dinucleotide is read out in the major groove by base-specific hydrogen-bonding
interactions with R1333 and R1335, respectively, provided by a β-hairpin from the
C-terminal domain of Cas9, and substitution of these residues with alanine resulted in
substantially reduced target DNA binding in vitro (Anders et al., 2014). PAM
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recognition is a critical aspect of Cas9-mediated DNA targeting, which is required for
ATP-independent strand separation and guide-RNA-target-DNA heteroduplex
formation (Sternberg et al., 2014). Base pairing progresses over a 12 nucleotide seed
sequence and completes at the distal end of the target sequence with little room for
mismatch (Jiang et al., 2013; Sternberg et al., 2014). During the final stage of
interference, Cas9 uses its intrinsic nucleolytic activity to cleave DNA. Endonuclease
activity is catalyzed by both the HNH-like domain that cleaves the target strand, and
the RuvC-like domain that is responsible for cleavage of the displaced strand (Jinek et
al., 2012; Jinek et al., 2014). Cas9-mediated interference produces blunt
double-stranded end at a specific site which is typically 3 nucleotides from the 3’ end
of the protospacer (Garneau et al., 2010; Magadan et al., 2012).
1.3.3.3 Target surveillance and interference in type III systems
The type III-A systems typically consist of five subtype-specific cas genes, called csm
genes, and crRNAs with conserved 8 nucleotide 5’ handles and variable 3’ ends
(Table 1- 2) (Hatoum-Aslan et al., 2013; Rouillon et al., 2013). Type III-A systems
discriminate self DNA from non-self DNA in a PAM-independent manner, which
possibly requires Cas10-like protein Csm1 in this stage (Hatoum-Aslan et al., 2014;
Marraffini and Sontheimer, 2010). The 5’ end of the spacer region of the crRNA has
been proposed to contain a seed sequence that is similar to some type I systems
(Figure 1- 14c) (Hatoum-Aslan et al., 2014). The Csm complex has been shown to
target DNA in vivo (Marraffini and Sontheimer, 2008), but RNA in vitro (Staals et al.,
2014; Tamulaitis et al., 2014). These studies open up the question of whether DNA,
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RNA, or both are the natural targets of the type III-A systems, but several recent
studies may provide some pieces of the puzzle. (1) A type III-A system of Sulfolobus
islandicus has shown to degrade plasmid DNA in the presence of Csm6 (Csx1) (Deng
et al., 2013). (2) Csm6, which is a member of a highly variable protein family sharing
a CARF domain (CRISPR/Cas-associated Rossmann fold), is strongly associated
with the type III CRISPR/Cas systems (Makarova et al., 2014). (3) Csm6 of P.
furiosus has been revealed to associate with both dsDNA and dsRNA (Kim et al.,
2013). (4) Deletion of the csm6 gene in S. epidermidis and mutations of conserved
residues in the Palm polymerase domain of Csm1 prevented CRISPR immunity in
vivo, suggesting their involvement in target degradation (Hatoum-Aslan et al., 2014).
(5) Csm1 of S. epidermidis cleaves ssDNA and ssRNA in vitro (Ramia et al., 2014a).
(6) Given that the clustering of the genes encoding the Csm complex consist of the
five genes and the gene encoding Csm6, it is possible that the Csm complex uses a
similar Csm6-dependent and transcription-dependent DNA-targeting mechanism
(Makarova et al., 2014). Furthermore, the Csm complex of S. epidermidis has been
shown to proceed in a transcription-dependent fashion, which confers resistance to
lytic viruses (Goldberg et al., 2014). (7) RNA targeting by the T. thermophilus and S.
thermophilus Csm complexes shows that their RNase activity resides on the Csm3
subunit (Staals et al., 2014; Tamulaitis et al., 2014). (8) The biochemical analysis of T.
onnurineus Csm1 reveals ssDNA-specific nuclease activity (Jung et al., 2015a). All
these studies suggest a role for the type III-A system in degrading transcriptionally
active MGEs, and reflect the great versatility of the type III-A CRISPR/Cas system.
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Type III-B systems are unique among CRISPR/Cas systems in that they target RNA
rather than DNA (Hale et al., 2009). RNA targeting relies on a large ribonucleoprotein
assembly called the Cmr complex which consists of at least six proteins (Cmr1-Cmr6)
(Table 1- 2). It has recently been shown that cleavage of the target RNA by the T.
thermophilus Cmr complex occurs progressively in 6 nucleotide intervals via a 5’
ruler mechanism (Staals et al., 2013). The regularly 6 nucleotide spaced cleavage
pattern corresponds well with the observed distance between two adjacent Cmr4
subunits, suggesting that Cmr4 might fulfill this role (Staals et al., 2013). Recently,
several papers have reported the crystal structure of P. furiosus Cmr4 and revealed
Cmr4-associated features suggestive of RNA cleavage centers (Benda et al., 2014;
Hale et al., 2014; Ramia et al., 2014b; Zhu and Ye, 2015). Mutagenesis studies also
confirmed the structural elements of Cmr4 essential for crRNA binding as well as
target RNA cleavage. However, unlike T. thermophilus Cmr complex, P. furiosus Cmr
complex appears to cleave the substrate at multiple sites that does not follow a
specific direction. Remarkably, different gene clusters in S. islandicus encode two
different Cmr complexes (Cmr-α and Cmr-β). The Cmr-α complex (which is
composed of Cmr1-Cmr6) was reported to target plasmid DNA in vivo via a
Csx1-dependent mechanism that requires the transcription of its target. This
mechanism seems to be a functional analogue of the aforementioned Csm complex of
the type III-A systems (Deng et al., 2013). By contrast, the Cmr-β complex (which is
composed of Cmr1-Cmr7) of S. solfataricus targets RNA in vitro and cleaves the UA
dinucleotide in a sequence-dependent manner, which differs substantially from the
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type III-B systems of P. furiosus and T. thermophilus (Zhang et al., 2012b). These
studies suggest remarkably different mechanisms and functional diversity among type
III-B CRISPR/Cas systems (Deng et al., 2013).
1.4 Applications of CRISPR/Cas systems
The genetic polymorphorphism of cas genes and the functional diversity of Cas
proteins they encode between different subtypes, in combination with the features and
natural functions of CRISPR/Cas systems, have triggered a revolution in which
researchers around the world are using the technology for innovative applications in
biology. The current and potential applications of the CRISPR/Cas system are
described below.
1.4.1 Using CRISPR diversity for genotyping
Spacer content can be used for genotyping bacteria of industrial importance, and the
conservation of ancestral spacers has granted the spacer content involved in defining
the common origin of strains (Barrangou and Horvath, 2012). CRISPR loci have been
used for genotyping of several bacteria, including Yersinia, Mycobacterium,
Eschertichia, Corynebacterium, Legionella, Streptococci, Salmonella, Pseudomonas
and Lactobacillus (Barrangou and Horvath, 2012; Shariat et al., 2013). This approach
can also provide insights into the relatedness of strains of pathogenic interest, such as
E. coli and Salmonella (Shariat et al., 2013). Besides single-strain phylogeny,
CRISPR loci also represent an efficient tool to probe complex ecological populations
and determine the diversity of both host and virus populations in complex systems as
documented in natural habitats (Andersson and Banfield, 2008; Heidelberg et al.,
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2009; Held and Whitaker, 2009; Tyson and Banfield, 2008), and human samples
(Pride et al., 2011). Further analyses of CRISPR sequences using metagenomic deep
sequencing technologies have been shown to be a powerful force for studying the
coevolutionary dynamics and evolutionary trajectories of both host and virus
populations (Levin et al., 2013; Paez-Espino et al., 2013; Sun et al., 2013). The broad
applications of CRISPR in genotyping or epidemiological surveys, industrial
surveillance and clinical diagnostics will provide valid insights into a diverse set of
genera and species of interest.
1.4.2 Building resistance to viruses in industrial cultures
There is a tremendous need for building phage resistance in industrially relevant hosts
that are at risk of phage attacks. The risk of phage attack and impact of phage
outbreaks can result in financially catastrophic and significant losses to the industrial
bioprocessing plants which rely on bacteria to generate bioproducts of interest
(therapeutics and enzymes) and foods (daily products). It has been shown that using a
set of genetically diverse phages to optimize the breadth and depth of phage
resistance is efficient to the iterative buildup of viral resistance (Barrangou and
Horvath, 2012; Barrangou et al., 2013). Additionally, the ability to transfer
CRISPR/Cas systems (either naturally or by using genetic engineering) in
prokaryotes (Sapranauskas et al., 2011) and eukaryotes (Cong et al., 2013; Mali et al.,
2013b) demonstrates the widespread potential of CRISPR-mediated viral resistance in
designing and synthesizing spacer to reprogram Cas nucleases. Beyond viral
resistance, this technology also has the potential to vaccinate bacterial strains against
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the uptake and dissemination of undesirable genetic elements such as plasmids
carrying antibiotic resistance genes (Garneau et al., 2010) and virulence traits (Bikard
et al., 2012). Moreover, CRISPR has the potential to ensure the maintenance, integrity
and stability of the genomes of industrial workhorses via targeting transposons and
other mobile elements that contribute to genome plasticity.
1.4.3 Genome engineering
An explosion of reports in 2013 demonstrated that CRISPR-Cas9 represents an
efficient tool for genome editing, genetic screens, and modulation of gene expression
(Pennisi, 2013). Unlike type I and III CRISPR/Cas systems which rely on a large,
multimeric, crRNA-Cas ribonucleoprotein complex, type II systems use only a single
endonuclease Cas9 with chimeric sgRNAs to generate predictable dsDNA breaks into
the target sequence (Jinek et al., 2012; Sapranauskas et al., 2011). Although direct
comparisons are difficult to assess, some analyses have shown that the efficiency of
Cas9-mediated editing can reach 80% or more, which is as high as or even higher
than levels observed using zinc finger nucleases (ZFNs) or transcription-activator-like
effector nuclease (TALENs) (Hwang et al., 2013; Kim et al., 2014).
Depending on which endogenous DNA repair pathway is engaged to repair the
dsDNA break, different types of mutations can be obtained. A high-fidelity,
homologous recombination (HR) pathway can be triggered when the dsDNA break
occurs in the presence of a co-introduced, editing template (i.e., donor DNA fragment
which shares homology with target DNA); this pathway could replace, remove, or
alter (e.g., correct) the target gene in a manner specified by the editing template. In
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contrast, cells typically repair the dsDNA by the relatively error-prone mechanism of
nonhomologous end joining (NHEJ) without the editing template, which typically
leads to shot gene insertions or deletions (INDELs) and can yield gene inactivation
mutations. Cas9 has been exploited to act as a powerful and efficient tool to introduce
INDELs and knock out virtually any gene, provided that it contains the corresponding
PAM sequence (Cong et al., 2013; Jinek et al., 2013). In addition, Cas9 can also be
employed to generate site-directed, single-nucleotide substitutions in the presence of
a suitable template that can recombine with the target sequence (Cong et al., 2013;
Mali et al., 2013b). Moreover, the coexpression of Cas9 and sgRNAs can be exploited
to generate multiple mutations in one single multiplexing step (Cong et al., 2013;
Wang et al., 2013).
There is an unresolved issue for this technology, which is the frequency of off-target
effects (i.e., the probability of Cas9 cleavage of a sequence partially homologous to
the sgRNA). The independent mechanisms by which Cas9 uses different nuclease
active sites (RuvC and HNH domains) to cut each DNA strand, have provided a
distinct advantage. The RuvC active site can be inactivated (by mutation), which
converts Cas9 into a nickase, optimally exploited using two paired guides that direct
nicking at two adjacent sites only in the intended target sequence (Mali et al., 2013a;
Ran et al., 2013). Single-strand nicking variants of Cas9 used for genome editing
have been shown to lower NHEJ DNA repair and favor more predictable changes as
the results of HR DNA repair in human cells (Cong et al., 2013; Mali et al., 2013b).
Therefore, the wild type Cas9 can cut target dsDNA, whereas Cas9 with active site
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mutants cleave a single strand which offers reliable introduction of predictable
mutations into genomes (Table 1- 3).
Table 1- 3: Cas9 variants for genome editing or gene expression control
applications (Terns and Terns, 2014).
Reprinted from Trends in Genetics, Copyright 2014 (Terns and Terns, 2014), with
permission from Elsevier.
1.4.4 Control of gene expression using dCas9
Cas9 can be converted into a RNA-guided dsDNA binding protein (known as dCas9)
by mutation of both RuvC and HNH nucleolytic active sites (Gasiunas et al., 2012;
Jinek et al., 2012). This feature has been exploited to activate or repress gene
expression in bacteria and mammalian cells. Repression can be achieved by directing
dCas9 to bind promoter sequences, thus sterically hindering RNA polymerase (RNAP)
machinery (Qi et al., 2013), likely by stalling transcriptional elongation. In
prokaryotic genomes, the repression function of CRISPR-based interference
(CRISPRi) can be enhanced by tethering dCas9 to transcriptional repressor domains
like KRAB or SID effectors, which promote epigenetic silencing (Gilbert et al., 2013;
Konermann et al., 2013). However, the dCas9-based eukaryotic transcription
repressors work less efficiently; even the addition of functional domains can result
only in partial transcriptional knock-down (Gilbert et al., 2013; Konermann et al.,
2013). On the other hand, the activation of gene expression requires the fusion of
Cas9 to an activation domain. In bacteria, Cas9 can be fused to the omega (ω) subunit
of RNAP (rpoZ) in a ΔrpoZ background in E. coli, and generates dCas9-ω fusion that
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can be directed to promoter sequences using an appropriate guide RNA to recruit
RNAP and activate transcription (Bikard et al., 2013). In mammalian cells, dCas9 can
be fused to other transcriptional activators such as VP64 and the p65 activator domain
(Figure 1- 15) (Gilbert et al., 2013; Maeder et al., 2013; Mali et al., 2013a). The
addition of other functional domains (such as recombinases, methylases, and
histone-modifying enzymes) to dCas9 can expand the uses of the programmable DNA
binding capability of this enzyme and will undoubtedly create new opportunities for
this technology (Figure 1- 15).
Figure 1- 15: Cas9-based genetic applications (Barrangou and Marraffini, 2014).
Reprinted from Molecular Cell, Copyright 2014 (Barrangou and Marraffini, 2014),
with permission from Elsevier. Wild-type Cas9 loaded with sgRNA generates dsDNA
breaks that can introduce target mutations. A catalytically dead Cas9 (dCas9) can be
used as an RNA-guided DNA binding protein that can repress both transcription
initiation when bound to the promoter sequences or transcription elongation when
bound to the template strand within an open reading frame. dCas9 can also be fused
to other functional domains to bring enzymatic activities and reporters to specific
sites of the genome.
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1.5 Type I-E CRISPR/Cas system in Meiothermus ruber and Thermobifida
fusca
Meiothermus ruber is the type species of the genus Meiothermus, whose members
share relatively low degrees of 16S rRNA gene sequence similarity. This thermophilic
genus constitutes a separate evolutionary lineage from members of the genus
Thermus, from which they can be generally distinguished by their slightly lower
temperature optima (Tindall et al., 2010). Thermobifida fusca is a moderately
thermophilic soil bacterium belonging to Actinobacteria. It is wildly studies as a
model organism for thermostable extracellular cellulases (Lykidis et al., 2007). Based
on the CRISPI database, Cas systems in M. ruber and T. fusca belong to subtypes I-E
and III-B with multiple operons for each subtype (Rousseau et al., 2009). The type
I-E CRISPR/Cas systems in these two organisms are illustrated in Figure 1- 16.
Figure 1- 16: Type I-E CRISPR/Cas system in M. ruber (top) and T. fusca
(bottom).
The type I-E CRISPR/Cas systems in M. ruber contains eight cas genes (labeled in
each arrow) and a downstream CRISPR locus; but in T. fusca, it consists of seven
genes and a downstream CRISPR locus. The Cas2 gene, although universally present
in all CRISPR/Cas systems, hasn’t been found in T. fusca. The CRISPR locus
comprises of a series of 29-nt repeats (black diamonds) flanked by 74 unique spacers
in M. ruber (blue squares) and 11 in T. fusca (pink squares). The Cascade complex in
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each organism is encoded by five genes, cse1, cse2, cas7, cas5e, and cas6e (the
alternative nomenclature and stoichiometry are up the gene) and a 61-nt crRNA.
1.6 Research aims and significance
1.6.1 Research aims
Although considerable progress has been achieved regarding the structural
mechanisms of CRISPR-mediated host defence in E. coli (Type I-E), no general
molecular features of pre-crRNA recognition, crRNA loading, target pairing and
cleavage are revealed so far because of the highly variable sequences of Cas proteins
and crRNAs among CRISPR subfamilies and even within the same CRISPR/Cas
subfamilies. Our current knowledge on Cascade-mediated interference mechanisms is
largely based on cryo-EM and X-ray crystal structures of Eco_Cascade. However,
whether or not the molecular principles revealed by Eco_Cascade structure are
applicable to other Cascade systems are largely unknown, given the highly variable
sequences of Cascade proteins and crRNA repeats. It is conceivable that other
Cascade structures from the same subfamilies may display different structural
features for pre-crRNA recognition, crRNA loading and target RNA
pairing/degradation. Moreover, the detailed molecular mechanisms underlying the
role of Cse2 in Cascade assembly and DNA target selection remain elusive. Therefore,
the structural and functional efforts targeting to the MruCse2 and Mru_Cascade in
Chapter 3 should provide more information on the diverse mechanisms of the
CRISPR RNA-mediated gene silencing pathway. More specifically, the objectives of
this project are:
i. To explore the functional roles of Cse2 in Cascade assembly and DNA target
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selection;
ii. To investigate the structural properties of Cse2 in nucleic acid binding;
iii. To examine the Mru_Cascade assembly strategies and functions in target
recognition.
Although five high resolution crystal structures of Cse1 (three from T. thermophilus,
one from Acidimicrobium ferrooxidans, and one from E. coli) have been solved, the
target binding site was not revealed in these crystal structures due to its flexibility.
Based on molecular docking of T. thermophilus Cse1 (TthCse1) into the cryo-EM
structure of E. coli ssRNA-bound Cascade (EMD-5315), a flexible loop called L1,
was shown to reside just below the crRNA-target duplex, and was considered to
contact the PAM sequence. Notably, a three amino acid motif, particularly a
conserved phenylalanine residue in L1, has been characterized to be involved in
dsDNA destabilization, probably through DNA intercalation and helical distortion.
However, how can a single phenylalanine residue bind stably to DNA? There should
be other structures involved in stabilizing the dsDNA interaction. Therefore, the
structural and functional studies of TfuCse1 in Chapter 4 would provide solid insights
into the mechanism of target recognition by TfuCse1 based on the structural studies
of the conserved residues in TfuCse1 L1. More specifically, the objectives of this
project are:
i. To investigate the mechanism of target recognition by Cse1;
ii. To study the conserved residues in TfuCse1 L1;
iii. To explore the role of TfuCse1 in Cascade assembly, R-loop formation and
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Cas3 recruitment.
1.6.2 Significance of this study
The recent structural studies of Eco_Cascade and a dozen of crystal structures of Cas
proteins have revealed many important aspects regarding target recognition and
crRNA binding. However, current structural analysis at this field is mainly focused on
individual proteins; and very few structures of large protein complexes are available.
Our work in establishing the expression and in vivo assembly of Mru_Cascade and
molecular characterization of Mru_Cascade in G-rich crRNA binding preference may
highlight the flexibility and unexpectedness of Cascade assembly and target
recognition events adopted by different bacteria strains. Our studies could be
expected to provide useful insights to explore the assembly events for other Cascade
complexes and encourage the research to discover the similarities and differences
related to the evolution of the diverse type I Cascade machineries.
The structural and functional studies on TfuCse1 should provide relevant structural
details regarding target recognition. Our study may shed some light on T. fusca
Cascade (Tfu_Cascade) assembly, and also paves the way toward elucidating the role
of TfuCse1 in R-loop formation/stabilization and the recruitment of Cas3 for target
cleavage.
Both studies could expand our knowledge of the CRISPR-mediated host defence
systems in prokaryotes.
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1.7 Organization of this thesis
This dissertation presents the structural and functional studies of two proteins, Cse2
fromM. ruber and Cse1 from T. fusca. The organization of this thesis is as follows:
In Chapter 1, we have introduced the CRISPR/Cas systems mainly from the
perspective of structural studies of the key components, the classification, the three
stages, the application, and the aims and significance of this thesis. Chapter 2
provides a detailed description of the materials and methods used in this thesis.
Chapter 3 presents the crystal structures of MruCse2, the in vivo assembly of
Mru_Cascade and molecular characterization of Mru_Cascade in G-rich crRNA
binding preference. Chapter 4 reports the crystal structure of TfuCse1 and illustrates
the mechanism of dsDNA target binding by Cse1 based on the structural studies of
the residues located in L1. Chapter 5 gives a conclusion and discusses the limitations
of this thesis.
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Chapter 2: Materials and Methods
2.1 Cloning procedures
2.1.1 Polymerase Chain Reaction (PCR)
The gene-of-interest was amplified by PCR using the pre-mixed, ready to-use Taq
PCR Master Mix Kit (Qiagen, Cat #201445) that contains Taq DNA polymerase, PCR
buffer, MgCl2, and dNTP at optimized concentrations, and the genomic DNA of M.
ruber (ATCC® No.: 35948D-5TM) and T. fusca (ATCC® NO.: BAA-629D-5TM) was
used as the template for amplification. The primers (Integrated DNA Technologies)
flanked with the appropriate restriction site were designed as listed in Table S-1. The
PCR reaction mixture (50 μl) contains 25 μl PCR mix solution, 1 μl forward primer
(10 μM), 1μl reverse primer (10 μM), 1μl DNA templates (~50 ng/μl), and 22 μl
distilled water. The reaction was carried out with the following thermo-cycling
conditions: an initial denaturation at 98°C for 1 min; 35 cycles of denaturation at
98°C for 10 s, annealing at 55°C for 20 s and extension at 72°C for 30 s/kb; a final
extension at 72°C for 5 min; and then stored at 4°C. The PCR products were analyzed
by agarose-gel electrophoresis and resolved using 1% agarose gel in
Tris-Acetate-Ethylenediaminetetraacetic acid (TAE) buffer under 120 V for 20 min.
The target bands were illuminated and excised under the Safe ImagerTM2.0
Blue-Light Transilluminator (Invitrogen, Cat #G6600), and purified using the




Mutants were created based on structural analysis of the crystal structures of
MruCse2, TfuCse2, and TfuCse1 solved in this project. Mutated genes were
synthesized via a two-step overlapping extension PCR process. Two internal primers
that are reversing complementary were designed with the desired mutation flanked by
unmodified sequences on both ends as listed in Table S-1. The first PCR involves the
synthesis of two separate fragments that contain an overlapping region as defined by
the primers. The two fragments from the first round were combined and worked as
template in the second round PCR. The complementary ends were allowed to
hybridize to generate the final full length product by overlapping extension and
verified by DNA sequencing.
2.1.3 Restriction digestion and ligation
Restriction digestion was performed using FastDigest restriction enzymes (Thermo
Scientific) according to the restriction sites. The DNA (PCR fragment or plasmid
vector) was incubated with the enzymes and FastDigest buffer at 37°C for 30 min,
after which, the digested fragments were purified using 1% agarose gel and extracted.
After purification of digested products, the Rapid DNA Ligation Kit (Roche, Cat
#11635379001) was used for ligation, which was performed at room temperature for
30 min. The amplified gene was cloned into an expression vector with an N-terminal
tag to facilitate purification of the protein. The pET28b(+) (Novagen) and pMal-c2
(NEB) were used to express an N-terminal His6-tag and MBP-tag, respectively. The
recombinant plasmids used in this study is listed in Table S-2.
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2.1.4 Preparation of E. coli competent cells
A single freshly grown E. coli colony from LB agar plates was inoculated into 100 ml
of SOB media (2% Bacto®-tryptone, 0.5% Bacto®-yeast extract, 10 mM NaCl, 2.5
mM KCl, 10 mM MgCl2, 10 mM MgSO4) without antibiotics and then grown at 20°C
with shaking at 250 rpm to an OD600 value of 0.5~0.6. The cells were transferred to
an ice-water bath for 10 min and spun down by centrifugation at 4,000 rpm for 10
min at 4°C. The pellet was resuspended gently in 20 ml of ice-cold Inoue
transformation buffer [55 mM MgCl2, 15 mM CaCl2, 250 mM KCl, 10 mM PIPES
(PH6.7)]. The cells were then mixed with 1.5 ml DMSO and stored on ice for 10 min.
After a second round of centrifugation at 4,000 rpm for 10 min at 4°C, the cell pellets
were resuspended by 4 ml ice-cold Inoue transformation buffer. Aliquots (100 μl) of
resuspended cells were flash frozen in liquid nitrogen and then stored at -80°C.
2.1.5 E. coli bacteria culture
E. coli strains DH5α and BL21/DE3/RILP were used for gene cloning and protein
expression, respectively. Both strains were cultured in autoclaved LB media (1%
Bacto®-tryptone, 0.5% Bacto®-yeast extract, 1% NaCl) with shaking at 250 rpm or on
LB plates at 37°C. LB plates were prepared by supplemented LB media with 1.5%
Bacto®-agars before autoclave.
2.1.6 Transformation
The ligation constructs were transformed into E. coli DH5α competent cells via ice
treatment for 30 min followed by heat shock at 42°C for 90 s and second ice
treatment for 2 min. 1 ml LB media without antibiotics was added and the bacteria
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was allowed to recover at 37°C for 1 hr before plated on the appropriate antibiotics
resistance LB plates. The plates were incubated at 37°C overnight and several single
colonies were picked and each colony was inoculated into a separate test tube
containing 3 ml LB media. Cells were cultured overnight and plasmids were extracted
using the QIApre Spin Miniprep Kit (Qiagen, Cat #27106) according to the
manufacturer’s instruction. The extracted plasmids were subjected to double
restriction enzyme digestion for identification. DNA sequencing was then done to
further verify the presence and sequence of the gene-of-interest.
2.1.7 Cloning of co-expression clones
The pQLinkN (Addgene) and pACYCDuet-1 (Novagen) vectors were used to express
Mru_Cascade complex. Briefly, the digested gene products cse1, cse2, cas7, and
cas5e were cloned into pQLinkN, respectively. Co-expression plasmids were cloned
according to Scheich et al. (Scheich et al., 2007). To produce a co-expression plasmid
from two pQLinkN plasmids, 0.2–0.5 mg of one plasmid was cleaved overnight with
5 units PacI in 10 μl at 37°C while the other was digested with 5 units SwaI at 25°C.
Enzymes were inactivated at 65°C for 20 min and 5 μl DNA was treated with 1.3
units LIC qualified T4 DNA polymerase (Merck Biosciences) in 20 ml solution (50
mM Tris-HCl, pH 8.0, 10 mM MgCl2, 5 mg/ml BSA, 5 mM DTT, 2.5 mM dCTP for
the PacI digest and 2.5 mM dGTP for the SwaI digest). After incubation at 25°C for
30 min and heat inactivation at 65°C for 20 min, the two plasmids were then mixed
and heated to 65°C and cooled to room temperature for annealing. 2 μl of 25mM
EDTA were added, followed by E. coli transformation. All constructs generated in
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this thesis are listed in Table S-2. According to this method, the plasmids were
digested and combined one by one in the order of Cas7, Cse2, Cas5e and Cse1 to
make a pQLinkN plasmid co-expressing M. ruber Cse1, Cse2, Cas7 and Cas5e.
Meanwhile, MruCas6e and crRNA were co-expressed by inserting the corresponding
DNAs into the pACYCDuet-1 vector. The crRNA sequences used in this experiment
are listed in Table S-1. Finally, the plasmids of pQLinkN-Cas7-Cse2-Cas5e-Cse1 and
pACYCDuet-1-Cas6e-crRNA were co-transformed to E. coli BL21/(DE3) to express
the Mru_Cascade complex.
2.2 Protein expression
2.2.1 Small scale protein expression
The plasmid with the gene-of-interest was re-transformed into E. coli
BL21/DE3/RILP competent cells. Before large scale protein expression, the protein
solubility was tested at small scale, for which a single colony was inoculated into 5
ml LB media with appropriate antibiotics. The cells were cultured at 37°C to an
OD600 of 0.6, and protein expression was induced overnight at 20°C with 0.4 mM
isopropyl-β-D-thiogalactopyranoside (IPTG). After additional 16 hrs, both control (no
IPTG was added) and induced cells were spun down. The induced cells were
resuspended in 200 μl buffer Z [25 mM Tris (pH7.4), 25 mM KH2PO4 (pH6.8), 500
mM NaCl, 10% Glycerol, 1 mM DTT] and lysed by sonication for 12 min (6×2min).
After centrifugation at 12,000 rpm (Thermo Scientific, Cat #75003424) for 10 min,
the supernatants were mixed with Sodium dodecyl sulphate-polyacrylamide gel
electrophoresis (SDS-PAGE) loading buffer. Meanwhile, the control pellets were
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mixed with SDS-PAGE loading buffer and boiled on a 100°C heat block for 5-10 min
and then all mixtures were subjected to SDS-PAGE.
2.2.2 Large scale protein expression
If proteins were expressed and soluble in the small scale test, the large scale
expression was then performed to obtain more proteins enough for crystallization.
Similar to small scale expression, for large scale protein expression 10 ml overnight
starter cultures were inoculated into 1 L LB (plus antibiotics) cultures in 2-litre flasks,
which were incubated at 37°C, 250 rpm until the cells reached OD600 value of ~0.4,
then the temperature and speed of the shaker were reduced to 20°C, 200 rpm,
respectively. After ~15 min, the cells were induced and harvested in the same way as
described for small scale expression, except that the pellets of co-expression cells
were resuspended in a different lysis buffer [20mM Tris (pH8.0), 100mM NaCl].
Then the cells were lysed using a high pressure homogeniser (Avestin) for five times.
The cell debris was removed by ultracentrifugation at 40,000 rpm (Beckman Type 45
Ti), 4°C for 1 hr, and the supernatant was collected. The expression conditions of the
Cas protein in this thesis are summarized in Table S-3.
2.3 Protein purification
All proteins in this thesis were purified at 4°C by using a BioLogic DuoFlow
chromatography system (Bio-Rad) and ÄKTA Xpress automatic protein purification




2.3.1.1 Immobilisedmetal ion affinity chromatography (IMAC)
IMAC was applied to proteins that are fused with polyhistidine (HIS) tag. The
supernatant of the cell lysate containing His6-tagged proteins was loaded onto
Nickel(II) Sepharose HisTrap High Performance (HP) columns (GE Healthcare)
pre-equilibrated with Buffer EQ [10 mM Tris-HCl (pH 7.4), 250 mM NaCl, and 10%
glycerol] at the flow rate of 1 ml/min. After loading, the non-specifically bound
proteins were washed out, while the specifically bound proteins were eluted by
stepwise increments of imidazole (pH 7.0) concentration (0.03 M, 0.25 M, 0.5 M,
0.75 M and 1 M). An additional washing step was performed before elution using
Buffer EQ with 2 M NaCl for proteins intended to be used in Electrophoretic
Mobility Shift Assay (EMSA) so as to remove the nucleic acids bound to the proteins.
After elution, the column was re-equilibrated with EQ buffer. SDS-PAGE was
performed to verify the presence of the protein-of-interest in the fractions
corresponding to A280 absorption peaks, using a 12% arcylamide SDS gel. The
fractions containing the target protein were pooled together and subjected to the
cleavage of His6-tag by the thrombin protease and dialyzed against appropriate
dialysis buffer, overnight at 4°C. After dialysis, the mixture was applied to an
equilibrated with affinity binding buffer His column in order to remove the cleaved
His6-tag, the histidine tagged thrombin protease and other contaminants. The column
flow-through, containing the untagged target protein was collected.
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2.3.1.2 MBP affinity chromatography
MBP (maltose-binding protein) affinity chromatography was applied to proteins
fused with a MBP tag. The supernatant of the cell lysate containing MBP-tagged
proteins was loaded onto the MBPTrap HP columns (GE Healthcare) pre-equilibrated
with Column Buffer [20 mM Tris-HCl (pH 7.4), 200 mM NaCl, 1 mM EDTA and 1
mM DTT] at the flow rate of 2 ml/min. The non-specific proteins were washed off by
Column Buffer. The MBP-tagged proteins were eluted by Column Buffer + 10 mM
maltose. SDS-PAGE was run to verify the presence of the protein corresponding to
A280 absorption peaks. The fractions containing the target protein were pooled
together and dialyzed against appropriate dialysis buffer.
2.3.2 Gel Filtration (GF) or Size Exclusion Chromatography (SEC)
Gel filtration was applied to separate proteins based on their different molecular size.
The fractions obtained by affinity chromatography containing the protein-of-interest
were pooled and subjected to GF using HiLoad 26/60 Superdex 75 prep grade column
(GE Healthcare, Cat #17-1070-01) and HiLoad 26/60 Superdex 200 prep grade (GE
Healthcare, Cat #17-1071-01) equilibrated with Buffer GF [25 mM Tris-HCl (pH 7.4),
500 mM NaCl, 0.5 mM EDTA and 4 mM DTT]. Superdex 75 column was applied to
separate proteins with lower molecular weights ranging 3-70kD, while Superdex 200
column was selected for proteins with higher molecular weights ranging 10-600kD.
The fractions containing the protein-of-interest were confirmed with SDS-PAGE and
pooled together for overnight dialysis in 25 mM Tris-HCl (pH 7.4) and 100 mM NaCl




The efficiency of the procedure and the purity of the sample at each purification step
was confimed by SDS-PAGE, and Bio-Rad SDS-PAGE apparatus was used for
SDS-PAGE gel running. The gels were prepared according to standard protocol and
run in the 1×SDS-PAGE running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS)
and then stained by Coomassie Brilliant Blue staining after electrophoresis.
2.4.2 Protein concentrationmeasurement
The concentrations of proteins prepared for crystallization experiments were roughly
measured by the Bradford method: firstly, 500 μl of Bradford reagent (Sigma,Cat
#B6916) was mixed with 500 μl of sterile H2O in a disposable cuvette (Sigma, Cat
#C5416); secondly, 1 μl of protein sample was added into the mixture; finally, the
absorbance of the sample was measured in a spectrophotometer at 595 nm after
blanking, and the protein concentration was determined according to the
manufacturer’s instructions using a BSA standard curve. Alternatively, the
concentrations of proteins could also be accurately measured by NanoDrop 2000
UV-Vis Spectrophotometer (Thermo Scientific). The concentration of each sample
was measured for three times and averaged for analysis.
2.4.3 Analytical gel filtration
Analytical gel filtration using Superdex 200 10/300 GL column (GE Healthcare) was
applied for high-resolution small-scale preparative and analytical separations of
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biomolecules with molecular weights between 10 kD and 600 kD. It offers a variety
of applications including protein purification, studies of complex formation, and
studies of protein-protein interactions and screening of uncharacterized samples. In
this thesis, analytical gel filtration was used to purify and analysis Mru_Cascade
(sub)complexes and their characters. 1 ml of the protein complex sample was run
through the Superdex 200 10/300 GL column pre-equilibrated with 20 mM Tris-HCl
(pH 8.0), and 100 mM NaCl at a flow rate of 0.2 ml/min. For stripping off experiment,
1 µM purified Mru_Cascade was incubated with 1 µM foreign dsDNA (72bp) with
PAM sequence, complementary to M. ruber crRNA (Mru_crRNA), foreign dsDNA
with mutant PAM sequence, foreign dsDNA with mutant protospacer sequence and
foreign dsDNA with non-related sequence, respectively. The reaction was conducted
at room temperature for 30 min, followed by running through Superdex 200 10/300
GL column pre-equilibrated with 20 mM Tris-HCl (pH 8.0), and 100 mM NaCl. The
foreign dsDNA sequences used in this experiment are listed in Table S-1. Equal
amounts of the two proteins were incubated together in a 1 ml reaction sample at
room temperature for 30 min. The sample was then run through the Superdex 200
10/300 GL column pre-equilibrated with 25 mM Tris-HCl (pH 7.4), 100 mM NaCl,
and 0.5 mM imidazole at a flow rate of 0.2 ml/min. The eluted peak fractions were
analysed by SDS-PAGE.
2.5 Crystallization and crystal optimization
The purified proteins were dialyzed against stabilization buffer containing 20 mM
Tris-HCl (pH 7.4) and 100 mM NaCl and concentrated to 10~15 mg/ml in a
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Centriprep-30 (Amicon) for subsequent crystallization. The optimal concentration for
crystallization screens was determined by pre-screening tests using the Grid Screen
Kits from Hampton Research (Table S-4). After concentration of the protein to an
optimal point, at which around 1/2~1/3 of the drops should show precipitation in the
pre-screening tests, the proteins were subsequently subjected to crystallization trials.
The screen kits from Hampton Research, Qiagen and Crystalgen which were prepared
according to their formulation sheets, were used to determine initial crystallization
conditions and listed in Table S-4. All crystallization trials were set up by using the
hanging drop vapor diffusion method at 20°C. Screening experiments with 2 μl drops
(1 μl of the protein solution plus 1 μl of the crystallization buffer) were set manually
on 24-well crystallization plates. The crystal trays were kept at 20°C and examined
regularly under an optical microscope. Once microcrystals or crystalline precipitant
were observed, the crystallization conditions were selected for optimization trials in
which a screen of the precipitant concentration or buffer pH was designed around the
initial conditions in order to get diffraction-quality crystals. The conditions in which
crystals grew were further optimized by adding additives (Hampton). The screens
were set manually using the hanging drop vapor diffusion method, and the reservoir
volume was set to 600 μl. The crystal trays were sealed, kept at 20°C and examined
under an optical microscope.
2.6 Data collection and structure determination
The MruCse2 crystals were soaked in the above reservoir solution supplemented with
1 mM HgAc2 for 12 hours and flash frozen (100 K) in liquid nitrogen with
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cryo-protectant (the reservoir solution supplemented with 30% glycerol). The
TfuCse1 crystals were flash frozen in liquid nitrogen with the above reservoir
solution supplemented with 30% glycerol. The data of MruCse2 and TfuCse1 were
collected at the National Synchrotron Light Source of Brookhaven National
Laboratory (X29A, NSLS). One-wavelength data set (total 180˚ with 1˚ oscillation)
were collected at wavelength 1.007 Å on each crystal of MruCse2, whereas a total of
360 frames with 1° oscillation were collected at wavelength 1.075 Å on each crystal
of TfuCse1. Both data sets were processed by HKL2000 (http://www.hkl-xray.com/).
The structure of MruCse2 was determined by SAD method using
SHARP/autoSHARP (Vonrhein et al., 2007), whereas the structure of TfuCse1 was
determined by molecular replacement using the crystal structure of A. ferrooxidans
Cse1 (AfeCse1) (PDB ID: 4H3T) as the search model. Structure models were built by
using the program O (http://xray.bmc.uu.se/alwyn) and refined using
REFMAC/CCP4 (www.ccp4.ac.uk). The crystallographic statistic details of these
structures are listed in
Table 3- 1 and Table 4- 1. The coordinates were deposited in the PDB with the
following accession codes: 3WA8 for MruCse2 and 3WVO for TfuCse1. The data
collection for TfuCse2 was performed at the corefacility of Department of Biological
Sciences in National University of Singapore, and processed using HKL2000.
2.7 Negative-Stain electron microscopy
The Mru_Cascade complex in buffer containing 20 mM Tris-HCl (pH 8.0), and 100
mM NaCl were applied to glow-discharged 400-mesh continuous carbon grids. After
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absorption for 1 min, the samples were stained consecutively with 6 μL of 5% PTA
for 30 seconds. Then the residual stain was blotted off and the sample was air-dried
under the lamp. Data were acquired using a JEOL JEM 2010F transmission electron
microscope operated at 200 kV at a nominal magnification of 100,000× using
low-dose exposures (~10 e-· Å2) with a random defocus ranging from -1 μm to -3 μm.
The images of Cascade were automatically recorded on 4k x 4k Gatan Ultrascan
US4000 camera.
2.8 Cryo-electron microscopy
Purified Cascade sample were loaded onto a Quatifoil 2/1 grid, blotted with filter
paper (two times, two seconds each time), and then cooled by plunging into liquid
ethane to make cryo-EM grids. Cryo-EM images were taken from the frozen grids in
a Tecnai T12 cryo electron microscope from FEI Company operated at 120 kV, with a
magnification of 47,000× and a pixel size of 1.81 Å/pixel. Measured defocus values
of cryo-EM images range from −1 μm to −3μm.
2.9 Northern blotting assay
Northern blot is used to study gene expression by detection of RNA in a sample. In
this thesis, we performed northern blots to detect the expression level of Mru_crRNA
in protein co-expression cells. The Mru_Cascade protein samples were resolved on a
10% TBE-Urea gel, and the bound crRNA was electro-blotted onto Hybond-N+ (GE
healthcare) and cross-linked. Biotinylated oligo deoxyribonucleotides complementary
to crRNA sequences were purchased from Sigma to be used as probe and listed in
Table S-1. The probe was hybridized with the membrane in ULTRAhybTM (Ambion)
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overnight at 60°C, and subsequently washed with 2×SSC buffer containing 0.1% SDS
for 30 min, and 0.1×SSC buffer containing 0.1% SDS for 30 min and then detected
using LightShift Chemiluminescent EMSA kit (Thermo Fisher Scientific Inc., USA)
according to the manufacturer’s protocols.
2.10 In vitro transcription of RNA substrates
The primers for amplifying the DNA templates are listed in Table S-1, and the
forward primers contained the T7 promoter sequence that guaranteed the generated
templates can be directly used for in vitro transcription. The annealing products was
purified by gel extraction (QIAquick Gel Extraction Kit) and quantified by NanoDrop.
The unlabeled RNA molecules were synthesized by using the RiboMAXTM Large
Scale RNA Production System T7 (Promega, Cat #P1300) according to the
manufacturer’s instructions, while the biotin-labeled RNA molecules were
synthesized by replacing rNTP in the Promega package with 2 μl of the Biotin RNA
Labeling Mix, 10×conc. (Roche, Cat #11685597910). The mixture was incubated at
37°C for 3 hrs, after which 2 μl DNase was added into the reaction and incubated for
another 15 min at 37°C. The reaction was stopped by adding 2 μl of 0.2 M EDTA (pH
8.0). Before loading the sample was heated at 100°C for 10 min and mixed with
5×RNA Loading Dye. The RNA products were fractioned using 12% denaturing
polyacrylamide gel electrophoresis. After electrophoresis, the gels were post-stained
by SYBR® Safe (Invitrogen, Cat #S33102) and imaged under the Safe ImagerTM2.0
Blue-Light Transilluminator. The bands with correct size were excised and preceded
to purification step.
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For RNA purification, 400 μl RNA elution buffer [0.3 M sodium acetate (pH 5.5), 1
mM EDTA and 1% SDS] was added into the 1.5 ml tube and ensure to cover the gel
slices, followed by incubating on a 42°C heat shock overnight. The RNA products
were extracted by ethanol precipitation following Narry Kim’s protocol (Han et al.,
2004). RNAs were re-suspended in RNAase-free H2O and stored at -20°C, and the
RNA concentration was measured by NanoDrop.
2.11 RNA cleavage assay
The purified recombinant MruCas6e protein were incubated with RNA substrate
(purchased from IDT) at 55°C in buffer solution containing 20 mM HEPES (pH 7.0),
250 mM KCl, 0.75 mM DTT, 1.5 mM MgCl2 for 30 min. Cleavage reaction
contained 1 µM RNA substrate and 20 µM protein sample, and the volume of the
total reaction system is 10 μl. After the addition of 5 μl 5×RNA Loading Dye, the
mixture was boiled at 100°C for 20 min and centrifuges at 12,000 rpm (Thermo
Scientific, Cat #75003424) for 5 min. The cleavage products were separated on 20%
polyacrylamide gel containing 8 M urea, visualized by SYBR® Safe staining and
analyzed by Genesnap software.
2.12 Urea-PAGE for RNA analysis
Urea-PAGE was performed for RNA fractionation after in vitro transcription and
RNA cleavage assays. The 10%~20% Urea-PAGE gels were prepared following the
standard protocols. After solidification for 30 min, the gels were pre-run at 100 V for
at least 1 hr in 0.5×TBE buffer [45 mM Tris, 45 mM Boric Acid, 1 mM EDTA (pH
8.3)], and the wells were thoroughly rinsed before samples were loaded. The RNA
78
samples were mixed with the 10×RNA Loading Dye (95% deionized formamide,
0.025% bromophenol blue, 0.025% xylene cyanol, 5 mM EDTA and 0.025% SDS)
and boiled at 100°C for 10-20 min and then loaded into the wells. The gels were run
at 100 V until the bromophenol blue reached the bottom of the gel. After
electrophoresis, the gels were subjected to either staining or membrane transfer.
2.13 Electrophoretic mobility shift assay (EMSA)
Gels mobility shift assays were performed to detect DNA or RNA binding by the Cas
proteins, in which protein-nucleic acid complexes are observed as their migration rate
on native polyacrylamide gels is slower than for free oligonucleotides.
In the case of Cse2, purified MruCse2 and TfuCse2 were mixed with biotin-labeled
target nucleic acids in a buffer containing 20 mM HEPES (pH 7.5), 100 mM NaCl, 1
mM DTT and 2 mM EDTA, and incubated at 25°C for 15 min. DNA duplexes were
prepared by mixing equal amount of each strand, and denatured at 100°C for 5 min
then cooled slowly to room temperature. Samples containing Cse2-nucleic acids were
run on 5% polyacrylamide native gels at 100 V for 90 min. The resolved nucleic
acids were electro-blotted onto Hybond-N+ and cross-linked. Blocking, detection and
washing of the membrane were performed according to the instruction of LightShift
Chemiluminescent EMSA kit (Thermo Fisher Scientific Inc., USA). The data was
collected on the Image Quant LAS 4000 biomolecular imager (GE Healthcare).
In the case of Mru_Cascade and Mru_CasACE (Cse1-Cas7-Cas6e) subcomplex, they
were mixed with DNA in a buffer containing 25 mM Tris (pH 8.0), 100 mM NaCl, 10
mM MgCl2, 1 mM DTT and 5% (v/v) Glycerol, and incubated at 37°C for 30 min.
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The reaction samples were run on 5% polyacrylamide native gels at 100 V for 90 min.
The gels were post-stained by SYBR® Safe diluted in 0.5 M TBE buffer for 10 min,
and the bands were visualized under UV.
In the case of TfuCse1, high performance liquid chromatography (HPLC) purified
DNA oligomers (Integrated DNA Technologies) were used for EMSA. Purified
TfuCse1 was incubated with DNA in a buffer containing 25 mM Tris-HCl (pH 7.4)
and 100 mM NaCl at room temperature for 30 min. The reaction samples were run on
5% polyacrylamide native gels at 100 V for 90 min. The gels were post-stained by
SYBR® Safe diluted in 0.5 M TBE buffer for 10 min, and the bands were visualized
under UV.
The nucleic acid sequences used in EMSA experiments are listed in Table S-1.
2.14 Analytical ultracentrifuge
The AUC velocity experiment was performed to determine the molecular masses of
MruCse2 and TfuCse2 in solution. Sedimentation velocity (SV) experiments were
conducted at 20°C on a Beckman XL-A analytical ultracentrifuge, equipped with
absorbance optics and an An60-Ti rotor. Cse2 proteins were diluted to 1 mg/ml in
PBS buffer (pH 7.4). The rotor speed was set at 60,000 rpm for the highest resolution.
The sedimentation coefficient and f/f0 were obtained with c(s) method using the
Sedfit software (Schuck, 2000). The observed molecular weights of MruCse2 and
TfuCse2 are ~28 kD and ~27 kD, respectively, determined by SV method.
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3 Chapter 3: Structural insights into specific crRNA G-rich
sequence binding byMeiothermus ruber Cse2
3.1 Introduction
There is intensive interest in structural studies of key components involved in the
CRISPR/Cas immune systems. Among all the Cas proteins, Cse2 can be found only
in the most well-studied type I-E CRISPR/Cas system, and is essential for
maintaining resistance against phage λ infection (Brouns et al., 2008). Crystal
structures of Cse2 from T. fusca and T. thermophilus have been reported, both of
which adopt an α-helical bundle scaffold and harbor a positive surface for nucleic
acid binding (Agari et al., 2008; Nam et al., 2012a). However, structural comparison
of these two proteins shows a different dimer interface with equal low buried surface
area. Strikingly, the T. thermophilus Cse2 (TthCse2) dimer interface observed in
crystal structure resembles the one located in Eco_Cascade determined by cryo-EM
(Wiedenheft et al., 2011a) and X-ray crystallography (Jackson et al., 2014b; Zhao et
al., 2014). Furthermore, docking of TfuCse2 structure into cryo-EM envelope reveals
an elongated curve within a continuous positive patch, which is complementary to the
Cas7-crRNA spine. Such observations suggest that TfuCse2 may play a role in
stabilizing the crRNA/target strand DNA duplex in the R-loop structure (Nam et al.,
2012a; Wiedenheft et al., 2011a).
According to previous studies, both TfuCse2 and TthCse2 were proposed to be
general nucleic acid binding proteins regardless of sequence, length and type (Agari
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et al., 2008; Nam et al., 2012a). Notably, cryo-EM structure of Eco_Cascade suggests
that Cse2 is not directly involved in crRNA binding, which is further supported by the
crystal structure of Eco_Cascade (Jackson et al., 2014b; Wiedenheft et al., 2011a;
Zhao et al., 2014). However, crystal structure of Eco_Cascade shows that Cse2 dimer,
harboring two tracks of positively charged surfaces, is located along the inner surface
of the crRNA-Cas7 spine (Jackson et al., 2014b; Zhao et al., 2014). Such
observations strongly suggest that Cse2 dimer could be involved in crRNA
recognition and/or target dsDNA binding, at least, at a certain stage of the
crRNA-mediated dsDNA degradation process. Although the crystal structures of
TfuCse2 and TthCse2 have been reported, the detailed molecular mechanisms
underlying the role of Cse2 in Cascade assembly and DNA target selection along with
different crRNA sequences remain elusive. Here, we utilized X-ray crystallography
and cryo-EM to study the structures of MruCse2 and Mru_Cascade. Moreover,
functional characterization of MruCse2 and the complex will be presented alongside
the structural data, in order to elucidate their role in CRISPR interference and the
molecular basis of crRNA-mediated DNA recognition in this subtype.
3.2 Bioinformatics analysis of MruCse2 and TfuCse2
Multiple sequence alignment analysis illustrates that MruCse2 has relatively high
sequence similarity with other Cse2s, such as EcoCse2, TfuCse2 and TthCse2 (Figure
3- 1). Moreover, secondary structure prediction of MruCse2 shows that it contains
nine α helices, similar to the known Cse2s. Alignment of the Cse2 sequences
indicates that the residues lying on the secondary structure elements are highly
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conserved. Given the fact that both TfuCse2 and TthCse2 act as general nucleic acid
binding proteins (Agari et al., 2008; Nam et al., 2012a), we hypothesized that
MruCse2 may directly bind to nucleic acids.
Figure 3- 1: Sequence alignment of MruCse2 with other Cse2s.
Secondary structure elements are drawn on the basis of MruCse2 structure and are
shown at the top of the aligned sequences. The α-helices are shown as bars in red.
Residues involved in nucleic acid binding are indicated as stars in red at the top of the
aligned sequences. The invariable residues are highlighted in yellow.
3.3 Expression and purification of recombinant MruCse2 and
TfuCse2
Proteins were expressed as described in Chapter 2 and purified to homogeneity with a
two-step purification scheme which included affinity (nickel-chelating) and
size-exclusion chromatography, from which they eluted as a monomer, but this does
not necessarily reflect the protein’s state within the Cascade complex. Protein identity
was confirmed by mass spectrometry.
The expression levels of recombinant Cse2s were very high and the proteins were
highly soluble with only a small amount of the total expressed protein lost in the
insoluble cell fraction. This can be attributed to aggregation due to the high amounts
of the expressed proteins in the cell. The outcome of the gel-filtration purification
step can be seen in Figure 3- 2. The proteins’ estimated molecular weight from
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SDS-PAGE analysis is in agreement with the calculated molecular weight of 26 kD
for MruCse2 and 27 kD for TfuCse2. The proteins eluted as a single monodispersed
peak in the gel filtration chromatography, which is a prerequisite to continue on with
crystallographic studies of the Cse2 proteins. Consistently, an AUC analysis showed
that the measured molecular weight of MruCse2 and TfuCse2 were determined as
~28 kD and ~27 kD, which suggested that both the MruCse2 and TfuCse2 were
monomers in solution (Figure 3- 2).
Figure 3- 2: Purification of Cse2s.
(a) Chromatogram of MruCse2 purification by gel filtration chromatography and
peak fractions containing pure MruCse2. M, protein size marker. (b) AUC result of
MruCse2. (c) Chromatogram of TfuCse2 purification by gel filtration
chromatography and peak fractions containing pure TfuCse2. (d) AUC result of
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TfuCse2. The Cse2s display a monomeric form instead of dimeric form, which is
consistent with structural observation.
3.4 Crystallographic study of MruCse2
3.4.1 Crystallization and crystal optimization of MruCse2 and TfuCse2
The crystal conditions were set up manually as described in Chapter 2 and
microcrystals were observed in 15% PEG 5000 MME, 3% Tascimate and 100 mM
HEPES (pH 7.0), 10% PEG 8000 (Index) for MruCse2, and 0.2 M NaCl, and 0.1 M
CHES (pH 9.5) (Wizard I) for TfuCse2, respectively. Stochastic optimization screens
were designed around these conditions, varying the following parameters: the
precipitant type and concentration, the salt and its concentration, the buffer pH, the
concentration of additives and the protein concentration in order to enable the
formation of single, well-ordered crystals. The growth of MruCse2 small crystals was
observed in 10 mg/ml protein, 15% PEG 5000 MME，1 mM DTT, 3% Tascimate and
100 mM HEPES (pH 6.8) and the crystals grew to a maximum size of 0.3 mm0.3
mm0.1 mm over the course of 3 days, while TfuCse2 crystals were obtained in 10
mg/ml, 10% PEG 8000, 0.2 M NaCl, and 0.1 M CHES (pH 9.6) and grew to a
maximum size of 0.5 mm0.1 mm0.1 mm over the course of 7 days (Figure 3- 3).
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Figure 3- 3: Crystallization of Cse2s.
(a) SDS-PAGE analysis of the purified MruCse2 protein (~10 mg/ml) used for
crystallization. (b) Crystals of MruCse2. (c) X-ray diffraction pattern of MruCse2
crystal. (d) SDS-PAGE analysis of the purified TfuCse2 protein (~10 mg/ml) used for
crystallization. (e) Crystals of TfuCse2. (f) X-ray diffraction pattern of TfuCse2
crystal.
3.4.2 Overall structure of MruCse2
After collecting the diffraction data, we determined the crystal structure of both
MruCse2 and TfuCse2. The crystal of TfuCse2 was diffracted up to 2.5 Å. However,
the crystal structure of TfuCse2 had been reported at a resolution of 1.9 Å (PDB ID:
4H79) just before we solved our structure. Therefore, our structural analysis will be
focused on MruCse2 only, with the high-resolution structure of TfuCse2 (space group
P61) from the literature used for structural comparison (Nam et al., 2012a). The
MruCse2 structure was determined from crystals in the P212121 space group and
refined to 2.8 Å, with unit-cell dimensions of a=71.82 Å, b=75.38 Å, c=112.67 Å.
Two monomers of MruCse2 were found in the asymmetric unit of the crystal, with
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each monomer comprising residues 4-83 and 98-196 of the protein (Figure 3- 4b).
The detailed crystallographic statistics are summarized in Table 3- 1.










Resolution (Å) a 2.8 (2.85-2.8)
Rsym (%) a 5.6 (51.3)
I/(I) 26.6 (2.9)
Completeness (%) a 100 (99.9)














Bond lengths (Å) 0.015




Residues in the model
(aa.)
4-83, 98-196
a Values for the highest-resolution shell are in parentheses.
The refined structure of MruCse2 protomer reveals an α-helix bundle architecture
with the dimensions of 35 Å × 40 Å × 40 Å (Figure 3- 4a). The structure is roughly
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comprised of two domains connected by a disordered loop (aa. 84-97) (Figure 3- 4a).
Numerous hydrophobic interactions are observed to play a crucial role for structural
stabilization among the interior α-helix bundles. Structural comparison of MruCse2
with TthCse2 (PDB ID: 4H7A) and EcoCse2 (PDB ID: 4U7U) showed an overall
good tertiary structural agreement among these Cse2 proteins with root mean square
deviations (r.m.s.d) of 1.4 Å (227 Cα atoms), and 4.6Å (238 Cα atoms), respectively
(Figure 3- 5a). Although MruCse2 has a low theoretical isoelectric point of ∼5.15, the
electrostatic surface calculations reveal a positive elongated basic patch on one side
of its surface, which is highly conserved among Cse2 structures (Figure 3- 4b-e). The
two monomers exhibit slight structural variation, indicating a certain degree of
conformational flexibility. In the MruCse2 structure, the highly conserved residues
R28, R29, Q125 and R141 in α2 and α7, respectively, are located at the conserved
basic patches with the side chains protruding from the elongated groove, which are
suggested to interact with nucleic acids directly (Figure 3- 4b).
The putative dimer interface of MruCse2 shows ~750 Å2/monomer buried surface
area, which is considerably low in comparison with those of the authentic
physiological dimers. Consistent with the structural observation, the apparent
dominant molecular masses of MruCse2 and TfuCse2 were determined as ~28 kD
and ~27 kD in solution by analytical ultracentrifugation (AUC) experiments, which
correspond to MruCse2 monomer and TfuCse2 monomer, respectively (Figure 3- 2).
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Figure 3- 4: Overall structural comparison of Cse2s.
(a) The α-helical bundle architecture in the crystal structure of MruCse2. (b) (Left
panel): Cartoon view of MruCse2 dimer observed in crystal structure, and the key
residues involved in nucleic acid binding are shown in stick and colored in black.
(Right panel): Electrostatic potential view of MruCse2 dimer with the same view as
that of the left panel. The positively charged residues are colored in blue, the
negatively charged residues are colored in red, and the neutrally charged residues are
colored in white. The key residues involved in nucleic acid binding are indicated and
labeled in yellow. (c) (Left panel): Cartoon view of TthCse2 dimer observed in
crystal structure. (Right panel): Electrostatic potential view of TthCse2 dimer with
the same view as that of the left panel. (d) (Left panel): Cartoon view of EcoCse2
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dimer observed in crystal structure. (Right panel): Electrostatic potential view of
EcoCse2 dimer with the same view as that of the left panel. (e) (Left panel): Cartoon
view of TfuCse2 monomer observed in crystal structure. (Right panel): Electrostatic
potential view of TfuCse2 monomer with the same view as that of the left panel.
3.4.3 Cse2 dimer model
The putative MruCse2 dimer observed in the crystal structure superimposed perfectly
well with the TthCse2 dimer reported in literature (r.m.s.d 1.4 Å, total 227 Cα atoms)
(Agari et al., 2008), and the buried surface areas for these two Cse2 dimers are
equally low (< 750 Å2/monomer) (Figure 3- 5a). This unexpected observation
prompted us to ask whether the MruCse2 dimer arrangement has physiological
implications.
To investigate this hypothesis, we downloaded the cryo-EM density map of
the Eco_Cascade, manually selected the densities corresponding to EcoCse2 dimer,
and automatically docked the MruCse2 dimer structure into the densities using
Chimera (Goddard et al., 2007) (Figure 3- 5b). Although the sequence identity and
similarity between MruCse2 and EcoCse2 are only 14.8% and 25.6%, respectively,
the MruCse2 dimer structure agrees well with the EcoCse2 dimer arrangement inside
the Cascade complex except for a ~15˚ rotation along the dimer interface (Figure
3- 5b). To further confirm the docking result, the crystal structure of the MruCse2
dimer was aligned against the crystal structure of the EcoCse2 dimer within
Eco_Cascade (PDB ID: 4U7U) (Zhao et al., 2014). Surprisingly, the MruCse2 dimer
displays close dimer arrangement to that observed from the EcoCse2 dimer trapped at
Eco_Cascade with an r.m.s.d of 4.6 Å (238 Cα atoms) (Figure 3- 5a). Since
significant conformational changes in the EcoCse2 dimer interface have been
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detected after nucleic acids binding, the structural re-alignment of MruCse2 dimer
interface could be induced by the binding of nearby Cascade proteins and/or crRNA
(Jackson et al., 2014b; Mulepati et al., 2014; Wiedenheft et al., 2011a; Zhao et al.,
2014). Nevertheless, both the original and re-aligned MruCse2 dimer interfaces
reveal an extensive curved basic shallow groove on one surface of the α-helical
bundle (Figure 3- 4b). This shallow groove displayed by the original MruCse2 dimer
trapped in crystal structure is approximately ~40 Å in length with a ∼60˚ kink (Figure
3- 4b), which matches the structural features of the helical Cas7-crRNA subunit
observed in the Eco_Cascade complex structures determined by cryo-EM and X-ray
crystallography, respectively (Jackson et al., 2014b; Wiedenheft et al., 2011a; Zhao et
al., 2014). Consistent with the structural observations, the similar conserved basic
patches on the surface of the α-helical bundle were proposed for nucleic acids binding
for both TthCse2 and TfuCse2 (Figure 3- 4c, e) (Agari et al., 2008; Nam et al.,
2012a).
Notably, the MruCse2 dimer was perfectly docked at the top of the belly of the
Eco_Cascade after the superimposition of the MruCse2 dimer onto the EcoCse2
dimer in the Eco_Cascade crystal structure (PDB ID: 4U7U) (Figure 3- 5c).
Furthermore, the structural model shows that most of the conserved positively
charged residues of MruCse2 are located near the bound crRNA molecule (Figure
3- 5c). Such structural observations strongly suggest a functional role of the
conserved residues at the surface of the Cse2 dimer in nucleic acid binding, although
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in the current Eco_Cascade structure, the EcoCse2 dimers were reported not to
directly contact the bound crRNA (Jackson et al., 2014b; Wiedenheft et al., 2011a;
Zhao et al., 2014).
Figure 3- 5: Structural comparison of Cse2 dimers.
(a) (Left panel): Cartoon view of structural superimposition of the MruCse2 dimer with
the TthCse2 dimer (PDB ID: 4H7A) (r.m.s.d 1.4 Å, total 227 Cα atoms). (Right panel):
Cartoon view of the MruCse2 dimer superimposed with the Cse2 dimer from
Eco_Cascade crystal structure (PDB ID: 4U7U) (r.m.s.d 4.6 Å, total 238 Cα atoms). (b)
Cartoon view of the MruCse2 dimer superimposed with Cse2 dimer density envelope
obtained from Eco_Cascade cryo-EM structure. A rotation of ~15° along the dimer
interface is needed for proper docking. The density envelope of EcoCse2 dimer is
drawn in isomesh format and colored in white. (c) (Left panel): Cartoon view of the
MruCse2 dimer docked onto the Eco_Cascade crystal structure (PDB ID: 4U7U) by
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superimposing on EcoCse2. The Cas proteins and crRNA are colored as follows: light
blue: MruCse2; yellow: EcoCse2; light grey: other E. coli Cas proteins; dark blue:
Eco_crRNA. (Right panel): Electrostatic potential surface model of MruCse2 dimer in
complex with Eco_crRNA. The conserved positively charged residues are indicated and
labeled in yellow, and Eco_crRNA is shown in stick mode.
3.5 MruCse2 and TfuCse2 display different nucleic acids
binding properties
To assess the nucleic acid binding abilities of the recombinant MruCse2 and TfuCse2
proteins, we performed EMSA with various DNA or RNA substrates. In order to
determine whether the protein exhibits sequence specificity, DNA or RNA
oligonucleotides corresponding to the CRISPR spacer sequences of the CRISPR loci
of M. ruber and T. fusca were incubated with serial dilutions of the proteins at room
temperature (25˚C) prior to separation by native polyacrylamide gel electrophoresis.
All the substrate sequences can be found in Chapter 2, Table S-2. Representative gels
from multiple experiments are shown in Figure 3- 6.
Notably, MruCse2 and TfuCse2 displayed binding preference for different types of
nucleic acids. The MruCse2 has a preference for binding to ssRNA rather than
dsDNA, ssDNA, or RNA/DNA hybrid, even though these sequences were derived
from its endogenous crRNA sequence (Figure 3- 6a). By contrast, TfuCse2 has a
preference for ssRNA, dsDNA and RNA/DNA hybrid rather than ssDNA (Figure
3- 6b). These results are largely unexpected, given that the function of Cse2 should be
relatively conserved. Nevertheless, the conserved ssRNA binding affinity displayed
by both MruCse2 and TfuCse2 strongly suggests that Cse2 could play an important
role in Cascade assembly.
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3.6 Identification of critical residues for Cse2-nucleic acid
interaction
Comparison of the surface electrostatic potential of the MruCse2 and TfuCse2
structures allowed identification of a conserved, elongated basic patch on the surface
of the α-helix bundle (Figure 3- 4b, e). This surface involves residue in α2- (R28 and
R29), α7- (Q125 and R126), and α8-helices (R141 and R143). Among them, R28 and
R29 are especially conserved among the Cse2 family (Figure 3- 1). The equivalent
residues in TfuCse2 are R45, R46, R132, R148, R150. To investigate whether these
residues may be important for the nucleic acid binding function of Cse2, an alanine
mutagenesis scan was carried out. We performed EMSA to measure the binding
affinities of MruCse2 and its mutants with different types of nucleic acids (Figure
3- 6a, c). As a comparison, we also performed EMSA to measure the binding affinities
of TfuCse2 and its mutants with different types of nucleic acids (Figure 3- 6b, d).
Introduction of R141A, Q125A single mutations or R28A/R29A, R141A/R143A,
Q125A/R141A double mutations on MruCse2 completely abolished ssRNA binding
(Figure 3- 6c). Similarly, introduction of R148A single mutation or R45A/R46A,
R148A/R150A double mutations on TfuCse2 completely abolished ssRNA binding
(Figure 3- 6d). By contrast, introduction of R126A single mutation on MruCse2 or
introduction of R45A, R46A, R150A single mutations on TfuCse2 showed
comparable ssRNA binding affinity to those of wild-type Cse2s (Figure 3- 6c, d).
Taken together, mutagenesis confirmed that the conserved basic patches are indeed
involved in nucleic acids binding, presumably through direct contacts between the
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conserved residues and the nucleic acids.
Figure 3- 6: MruCse2, TfuCse2 and their mutants bind to nucleic acids in vitro.
(a) EMSA on MruCse2 binding to different types of nucleic acids. A 2-fold titration of
MruCse2 from 2 to 16 μM was incubated with 0.4 μM biotin-labeled nucleic acids at
25˚C for 30 min. (b) EMSA on TfuCse2 binding to different types of nucleic acids. A
2-fold titration of TfuCse2 from 5 to 40 μM was incubated with 0.5 μM biotin-labeled
nucleic acids at 25˚C for 30 min. (c) EMSA on MruCse2 and its mutants binding to a
G-rich ssRNA derived from Mru_spRNA 3. (d) EMSA on TfuCse2 and its mutants
binding to a non G-rich ssRNA derived from Tfu_spRNA 1. The protein loading controls
are shown in the bottom panel.
3.7 MruCse2 selectively binds to G-rich ssRNA
To further investigate ssRNA binding features of MruCse2, we systematically
screened the binding affinity of MruCse2 with different ssRNAs derived from
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Mru_crRNA sequences. As an initial effort, we transcribed several spacer sequences
from M. ruber CRISPR arrays (Rousseau et al., 2009) in vitro to test whether these
sequences could be recognized by MruCse2. Surprisingly, MruCse2 binds specifically
to G-rich ssRNA derived from Mru_crRNA spacers (spRNA) rather than from other
spacer sequences in the form of ssRNA (Figure 3- 7a).
This unique feature prompted us to check through all M. ruber CRISPR spacer
sequences. Strikingly, almost 50% of M. ruber CRISPR spacer sequences are G-rich
sequences. Most of these G-rich sequences are triple-Gs, quadruple-Gs and even
quintuple-Gs. To uncover the minimal length and unique G-rich sequences needed for
MruCse2 binding, we compared all the G-rich sequences we used for MruCse2
binding and speculated that a G5 (GGGGG) sequence would be sufficient for
MruCse2 binding.
To test this hypothesis, we performed EMSA binding assays on ssRNA starting with
G5 (GGGGG) sequence, followed by an introduction of C/A/U at different positions.
As expected, MruCse2 strongly binds to G5 (GGGGG) and tolerates the introduction
of either “A”, “C” or “U” in the middle position (Figure 3- 7b, top panel). By contrast,
the introduction of C/A/U at either “5’” or “side-wing” abolished the tight binding
between G5 and MruCse2 (Figure 3- 7b, middle panel). Interestingly, the binding
affinity between G5 and MruCse2 decreased gradually after introduction of “C”, “CC”
and “CCC” to replace the middle “G” (Figure 3- 7b, bottom panel). Taken together,
MruCse2 selectively binds to G-rich ssRNA, preferable to G5 sequence or tandem G2
sequences.
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Figure 3- 7: MruCse2 selectively binds to G-rich ssRNA sequences in vitro.
(a) EMSA on MruCse2 binding specifically to G-rich Mru_spRNA, rather than other
spacer sequences in the form of ssRNA. Ten out of 74 spRNA were chosen for the
binding assay. The spRNA sequences are listed in Table S-1 and the G-rich spRNA
are highlighted in red. We incubated 10 μM MruCse2 with 0.4 μM biotin-labeled
spRNA at 25°C for 30 min. (b) EMSA on MruCse2 binding to G-rich ssRNA
sequences. The ssRNA sequences are shown in the left panel whereas the EMSA data
are shown in the right panel. A 2-fold titration of MruCse2 from 2 to 32 μM was
incubated with 0.4 μM biotin-labeled nucleic acids at 25˚C for 30 min.
3.8 Structural insights into ssRNA binding by MruCse2
To investigate the unique structural properties of G5 (GGGGG) binding by MruCse2,
we compared crystal structures of MruCse2 with TfuCse2. As expected, the
conserved R28, R29, Q125 and R141 residues in MruCse2 are located at similar
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positions to the corresponding residues in TfuCse2 (Figure 3- 4b, e). However, the
size and width of the basic patches, which were proposed for nucleic acid binding,
differ significantly. In the MruCse2 monomer structure, the approximate dimension of
the shallow basic groove is 20 Å × 10 Å × 10 Å, which is suitable for single-stranded
RNA binding instead of RNA duplex binding (Figure 3- 4b). By contrast, in the
TfuCse2 structure, many positive patches are mapped to the TfuCse2’s surface with
the dimensions of the basic patches broad enough to accommodate a duplex (Figure
3- 4e). In addition, in the MruCse2 structure, the key residues involved in G5 binding,
such as R28, R29, Q125 and R141, are spotted along the concave surface suitable to
accommodate the base/ribose moieties of a 5-nt G-rich ssRNA with extended
conformation (Figure 3- 4b). To visualize this possibility, we manually docked a 5-nt
G-rich (AGGGU) ssRNA model from the NMR structure of KSRP KH3 in complex
with AGGGU (PDB ID: 4B8T) (Nicastro et al., 2012). As expected, the 5-nt G-rich
sequence fits into the groove well, with the base/ribose moieties inserted into the
concaved surface formed by the conserve R28, R29, Q125 and R141 residues (Figure
3- 8). At current stage, we are unable to obtain the structural details of G instead of
A/C/U recognition by MruCse2. However, we speculate that the 5’ and 3’ Gs are
crucial for G5 anchoring, whereas the middle G could have the freedom of adopting
different conformations and even mutations without significant impact on binding.
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Figure 3- 8: Structural model of GGGGG binding by MruCse2.
(a) Electrostatic potential view of the structural model of MruCse2 in complex with
single-stranded GGGGG model. The docked GGGGG model is shown in stick and
the key residues involved in ssRNA binding are indicated and highlighted in yellow.
The structural model of GGGGG is directly derived from the NMR structure of
AGGGU in complex with KSRP-KH3 (PDB ID: 4B8T) without simulation
refinement. The base/ribose moieties of GGGGG are recognized by the positively
charged concave surface. (b) Electrostatic potential view of the structure of human
KSRP-KH3 in complex with single-stranded AGGGU molecule (PDB ID: 4B8T).
The AGGGU molecule is shown in stick and the key K368 residue determining the
G3 specificity is indicated and highlighted in yellow. The base/ribose moieties of
AGGGU are recognized by the positively charged concave surface.
3.9 Expression and purification of recombinant MruCas6e
The M. ruber Cas6e gene was PCR amplified and cloned into the pET-28b expression
vector as described in Chapter 2. The construct was sequenced to confirm it was free
of base pair mutations and the protein was expressed in host E. coli BL21 (DE3). The
protein was purified by a two-step purification scheme, which consisted of affinity
(nickel-chelating) and size exclusion chromatography. Protein identity was verified
by mass spectrometry.
Protein expression levels were high and only a minimum portion of the expressed
protein was found in the insoluble fraction. The observed molecular weight of
MruCas6e on SDS-PAGE analysis confirmed the calculated molecular weight of 26
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kD (Figure 3- 9). The protein migrated as a monomer during gel filtration which was
performed on a Superdex 75 column (Figure 3- 9), but as explained for Cse2, this
does not necessarily reflect the protein’s state within the Cascade complex.
Figure 3- 9: Purification of MruCas6e.
Chromatogram of MruCas6e purification by gel filtration chromatography and peak
fractions containing pure MruCas6e. M, protein size marker.
3.10 Characterization of secondary structure of Mru_crRNA
The notion that MruCse2 specifically binds to single-stranded G-rich crRNA
fragment prompted us to speculate that the G-rich motif might play a certain role in
determining the secondary structure of crRNA. However, mfold server and crRNA
database suggest two different secondary structures for the M. ruber repeat crRNA
sequence (Mru_reRNA) (Figure 3- 10b). To determine the cleavage product derived
from Mru_reRNA sequence in Mru_Cascade system, we performed cleavage assays
using repeat crRNA as the substrate and MruCas6e as the catalytic enzyme.
Surprisingly, in addition to two dominant bands at around 21-nt and 23-nt, RNA
ladders were observed between 23-nt to 29-nt, indicating that cleavage predominantly
occurred between G21 and G22 or between G23 and G24 of the 29-nt repeat
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sequence (Figure 3- 10a). This result suggests that multiple secondary structures of
Mru_reRNA coexist or that the MruCas6e enzyme may have a more relaxed
specificity, at least in vitro. Nevertheless, the dominant 21-nt cleavage product
indicates that the dominant cleavage site of Mru_reRNA is the same as that identified
from S. epidermidis, P. furiosus, Sulfolobussol fataricus and T. thermophilus,
suggesting that CRISPR repeat RNA adopts a similar secondary structure regardless
of the presence of G or non-G rich sequence embedded within the crRNA sequence
(Brouns et al., 2008; Hale et al., 2009; Juranek et al., 2012; Marraffini and
Sontheimer, 2008; Zhang et al., 2012b). Notably, in the E. coli Cascade system,
almost 80% of cloned crRNAs starts with the last 8-nt of the repeat sequence
(AUAAACCG, i.e., crRNA 5’ handle), followed by a complete spacer sequence (32-
or 33-nt) and the 3’ handle with variable length originating from the next repeat
(Brouns et al., 2008). Thus, the present model of the mature Mru_crRNA contains a
61-nt-long sequence, which includes an 8-nt 5’ handle, a 32-nt spacer and a 21-nt 3’
handle comprising a hairpin (Figure 3- 10c).
Figure 3- 10: Identification of the secondary structure of Mru_crRNA.
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(a) Mru_reRNA (1 μM) was incubated in the absence (-) or presence of Cas6e (20
μM). Products were resolved by denaturing gel electrophoresis and visualized by
SYBR safe staining. The main cleavage products are indicated by a triangle or star. (b)
The secondary structure of Mru_reRNA with cleavage site indicated by a star is
shown in the left panel. The secondary structure of Mru_reRNA predicted by mfold
server is shown in the right panel. (c) Model of crRNA generated from the M. ruber
CRISPR cluster, co-expressed with Cascade.
3.11 Biochemical reconstitution of Mru_Cascade in E. coli
The M. ruber type I-E system consists of eight cas genes and a CRISPR locus
encompassing 74 unique spacers (Figure 1- 16). Recombinant Mru_Cascade
complexes were generated by the co-expression of Mru_Cascade proteins and
Mru_crRNA with five consecutive G-rich or non G-rich crRNAs in two sets of
compatible plasmids. A purification scheme based on the structural stability, size and
physicochemical properties of the complex was designed, including three successive
chromatographic steps: one affinity chromatography on a 5 ml Histrap HP column
and two successive analytical gel filtration on a Superdex 200 10/300 GL column.
3.11.1 Step 1: Affinity chromatography
Affinity purification of the tagged Cas6e enabled the identification of a protein
complex composed of five Cas proteins: Cse1, Cse2, Cas7, Cas5e, and Cas6e (Figure
3- 11). Bound proteins were eluted over a 0-1 M imidazole gradient in 5 ml fractions
and stored on ice until needed. The respective fractions were pooled together and
applied to the next column. As can be seen in Figure 3- 11, the Cascade complex
eluted at approximately 500 mM imidazole, indicating a tight interaction with the
column.
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Figure 3- 11: First step of Mru_Cascade purification by affinity
chromatography.
(a) Elution profile of Mru_Cascade (with 5 consecutive G-rich crRNA) with 0-1 M
imidazole gradient. The light green line indicates the imidazole gradient (0.05 M,
0.25 M, 0.50 M, 0.75 M and 1 M, respectively). (b) A representative fraction of the
peak with approximately 500 mM imidazole. The schematic representation of the
G-rich crRNA is shown below and labeled in red. (c) Elution profile of Mru_Cascade
(with 5 consecutive non G-rich crRNA) with 0-1 M imidazole gradient. (d) A
representative fraction of the peak with approximately 500 mM imidazole. The
schematic representation of the non G-rich crRNA is shown below and labeled in
blue.
3.11.2 Step 2: First analytical gel filtration
The Cascade-containing fractions pooled from the Histrap HP column were
concentrated to an appropriate volume in a Millipore concentrator with 10 kD cutoff
limit, and loaded on a Superdex 200 10/300 GL column. As observed in Figure 3- 12,
the complexes were eluted in a broad peak containing other high molecular-weight
molecules. Remarkably, the Mru_Cascade with G-rich crRNA seems to elute as a
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more stable complex than the Mru_Cascade with non G-rich crRNA, indicating
possible dissociation of the Mru_Cascade with non G-rich crRNA during the run
(Figure 3- 12b, d). To investigate our hypothesis and obtain a purified Mru_Cascade
complex, we performed a second analytical gel filtration.
Figure 3- 12: Second step of Mru_Cascade purification by analytical gel
filtration.
(a) Analytical gel filtration elution profile of Mru_Cascade with G-rich crRNA. (b)
Protein samples from the respective elution peaks in (a) were run on SDS-PAGE. (c)
Analytical gel filtration elution profile of Mru_Cascade with non G-rich crRNA. (d)
Protein samples from the respective elution peaks in (c) were run on SDS-PAGE.
3.11.3 Step 3: Second analytical gel filtration
The pooled fractions from the first analytical gel filtration chromatography were
collected and loaded on a Superdex 200 10/300 GL column again. Strikingly, the
Cascade complex co-expressed with G-rich crRNA indeed formed a stable complex,
as confirmed by the second size-exclusion chromatography and SDS-PAGE analysis
(Figure 3- 13a). By contrast, in the case of non G-rich crRNA, Mru_Cascade was
mostly dissociated into free Cse2, Cas5e and a Cse1-Cas7-Cas6e subcomplex
(Mru_CasACE) (Figure 3- 13b). Northern analysis revealed that the crRNA was
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detected as a single discrete band around 61-nt in the G-rich crRNA case (Figure
3- 13c). In comparison, for the non G-rich crRNA case, the crRNA was detected
binding with the Mru_CasACE subcomplex rather than the free Cse2 and Cas5e
proteins (Figure 3- 13b, c). These results demonstrate that a stable complex forms
more easily in the presence of G-rich crRNA rather than non G-rich crRNA.
Therefore, we speculate that MruCse2 could be essential in M. ruber G-rich
crRNA-Cascade assembly. Further experiments are required to explore this
hypothesis.
Figure 3- 13: Third step of Mru_Cascade purification by analytical gel filtration.
(a) Size exclusion elution profile and SDS-PAGE analysis of Mru_Cascade complex
with G-rich crRNA (lane 1). (b) Size exclusion elution profile and SDS-PAGE
analysis of M. ruber Cascade subcomplex with non G-rich crRNA (lane 1-10). (c)
Denaturing polyacrylamide gel showing the crRNA isolated from purified
Mru_Cascade and its components. Lane 1: Mru_Cascade (with G-rich crRNA); lane
2: Mru_CasACE (with non G-rich crRNA); lane 3: MruCas5e and MruCse2.
To investigate the structural and molecular similarities/differences within type I-E
CRISPR/Cas system, we performed negative-stain EM and cryo-EM with the purified
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M. ruber G-rich crRNA-Cascade complex. The raw micrographs are shown in Figure
3- 14. The Mru_Cascade showed heterogeneous features, which indicated that
subcomplexes coexist in one sample. Hence, further efforts are required to optimize
the purification protocols. The integrity and functions of Mru_Cascade will be further
validated by in vitro RNA binding and cleavage assays after structural determination.
Structural and functional comparison of Mru_Cascade with Eco_Cascade should
provide crucial information regarding the molecular features of Cascade-mediated
host defence.
Figure 3- 14: Raw negative-stain EM and cryo-EM micrographs of
Mru_Cascade.
(a) Representative raw micrograph of negatively-stained Mru_Cascade (Scale bar,
100 nm). (b) Raw cryo-EM micrograph of Mru_Cascade (Scale bar, 100 nm).
3.12 Nucleic acid binding by Mru_Cascade (sub)complex
To investigate Cascade assembly strategies and functions in the M. ruber system, we
performed EMSA experiments by detecting the binding affinities between
Mru_Cascade and Mru_CasACE with different DNA targets containing the sequence
complementary to the spacer of the crRNA. Although both Cascade-crRNA complex
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and CasACE-crRNA were able to bind to dsDNA and ssDNA targets,
CasACE-crRNA displayed relatively weak binding affinities under equivalent
conditions (Figure 3- 15).
To test whether the Mru_Cascade complex specifically targets DNA substrate
containing PAM sequence, EMSA experiments were performed by detecting the
binding affinities between Mru_Cascade and Mru_CasACE with similar DNA targets
either with or without the PAM sequence. Based on bioinformatics analysis (Westra
et al., 2012c), 5’-CAT-3’ was chosen as the PAM sequence for M. ruber in this study.
As expected, both Cascade-crRNA complex and CasACE-crRNA subcomplex
displayed significant higher binding affinities towards long DNA targets containing
the PAM sequence (72-nt), than the short DNA targets without PAM sequence
(32-nt), indicating that PAM sequence is essential for efficient DNA target binding.
We speculate that the weak binding observed between Mru_Cascade and short DNA
target could be non-specific. Notably, the similar binding affinity displayed by
Mru_Cascade and Mru_CasACE subcomplex suggests that MruCse2 may be
transiently associated with bound crRNA in vivo and could play a functional role in
facilitating the recruitment and/or binding of G-rich crRNA for Mru_Cascade
assembly.
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Figure 3- 15: Target recognition by Mru_Cascade and its subcomplex.
(a) EMSA experiments showing the binding between Mru_Cascade (containing
G-rich crRNA) and the target ssDNA or dsDNA with (long sequence) and without
(short sequence) protospacer-flanking sequences, respectively. (b) EMSA
experiments showing the binding between Mru_CasACE (containing non G-rich
crRNA) and the long and short target sequences, respectively. The final
concentrations of Mru_Cascade/CasACE and DNA target are 2 μM and 4 μM,
respectively.
3.13 Foreign DNA is capable of stripping off MruCse2
To understand the different nucleic acid binding properties between MruCse2 and
other Cse2s, we performed competitive EMSA by using ssDNA with complementary
sequence to strip off the ssRNA, which was already bound to MruCse2. Notably,
ssDNA was able to strip off the ssRNA from the ssRNA-MruCse2 complex (Figure
3- 16a). By contrast, ssDNA with complementary sequence was not able to compete
with TfuCse2 for ssRNA binding, indicating the diverse functions of Cse2s from
different bacteria strains (Figure 3- 16b).
To further investigate the unique function of MruCse2 in Cascade-crRNA complex
formation, we incubated M. ruber G-rich-crRNA-Cascade and foreign dsDNA with
PAM sequence, complementary to Mru_crRNA, foreign dsDNA with mutant PAM
sequence, foreign dsDNA with mutant protospacer sequence and foreign dsDNA with
non-related sequence, respectively. As expected, Cse2 and Cas5e were stripped off
from the preformed M. ruber G-rich-crRNA-Cascade only by complementary dsDNA
target, not by other mutant or unrelated sequences, as determined by size exclusion
chromatography (Figure 3- 16c-g). These results suggest that Mru_Cascade tends to
dissociate into subcomplex upon binding to complementary dsDNA target (Figure
3- 16c, d). By contrast, Mru_Cascade complex remains stable when challenged with
mutant or unrelated dsDNA sequences (Figure 3- 16e-g), which not only confirms the
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functional role of PAM sequence in target recognition but also suggests that only
sequence-specific pairing between Cascade and target DNA could lead to Cascade
complex dissociation.
In addition, the findings that Cse2 and Cas5e were readily stripped off from the
preformed M. ruber G-rich-crRNA-Cascade and that the remaining subcomplex
(CasACE-crRNA) still has the ability to bind with the foreign dsDNA (Figure 3- 15)
suggest that MruCse2 may play a role in handing over the crRNA to the CasACE
subcomplex and the dissociation of Cse2 and Cas5e upon target binding may help
facilitate presenting crRNA to the invading DNA elements. Consistent with our
results, limited proteolysis of E. coli K-12 Cascade complex showed that Cse2 is
sensitive to protease treatment after Cascade binding to the foreign dsDNA
(Wiedenheft et al., 2011a). Therefore, in Mru_Cascade system, Cse2 should be
released from the Cascade-crRNA complex shortly after the formation of
Cascade-crRNA/dsDNA complex.
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Figure 3- 16: Foreign DNA is capable of stripping off MruCse2.
(a) EMSA on ssDNA competing with MruCse2 for ssRNA binding. Complementary
ssDNA is able to strip ssRNA (derived from Mru_spRNA 3) off from the
MruCse2-ssRNA complex. (b) EMSA on ssDNA competing with TfuCse2 for ssRNA
binding. Complementary ssDNA is not able to strip ssRNA (derived from Tfu_spRNA 1)
off from the TfuCse2-ssRNA complex. (c) Size exclusion elution profiles of M. ruber
G-rich crRNA-Cascade complex before (dash line) and after (solid line) incubation with
foreign dsDNA1 (with PAM sequence, complementary to Mru_crRNA, labeled in blue).
(d) SDS-PAGE analysis of M. ruber G-rich crRNA-Cascade complex before (sample 1)
and after (sample 2) incubating with foreign dsDNA1. (e) Size exclusion elution profile
and SDS-PAGE analysis of M. ruber G-rich crRNA-Cascade complex challenged by
foreign dsDNA2 with mutant PAM sequence (5’-AGG-3’ in this study). The mutant PAM
sequence is labeled in yellow. (f) Size exclusion elution profile and SDS-PAGE analysis
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of M. ruber G-rich crRNA-Cascade complex challenged by foreign dsDNA3 with mutant
protospacer sequence. The mutant protospacer sequence is labeled in green. (g) Size
exclusion elution profile and SDS-PAGE analysis of M. ruber G-rich crRNA-Cascade
complex challenged by foreign dsDNA4 with non-related sequence (labeled in red).
3.14 Discussion and future work
In prokaryotic systems, the most widespread type I CRISPR/Cas system can be
classified into six different subtypes, each of them encoding a unique set of
subtype-specific genes (Makarova et al., 2011b). Although similar seahorse-like
Cascade complexes have been identified in Type I-F (Wiedenheft et al., 2011b), Type
I-C (Nam et al., 2012c) and Type I-A (Lintner et al., 2011) CRISPR/Cas systems,
Cse2s or Cse2 homologues are missing or fused to other components in these systems,
which suggests that Cse2 is not an indispensable component for Cascade-crRNA
complex formation, at least in some CRISPR/Cas systems. Previous research has
been focused on the structural and functional analysis of E. coli type I-E Cascade
system (Brouns et al., 2008; Jackson et al., 2014b; Mulepati et al., 2014; Wiedenheft
et al., 2011a; Zhao et al., 2014). Eco_Cascade is built up by Cse1 and Cse2, which are
proposed to recognize and interact with the target DNA, crRNA binding subunits
Cas7, Cas5e and pre-crRNA cleaving endonuclease protein Cas6e (Jore et al., 2011;
Mulepati et al., 2012; Nam et al., 2012a). This arrangement guarantees a streamlined
processing of the pre-crRNA transcripts, crRNA protection and the scanning for the
complementary DNA target. However, different mechanisms may be employed in
different organisms, even though they are from the same CRISPR subtype. Notably,
unlike Eco_Cascade, purified Tfu_Cascade was reported to be unstable in the absence
of DNA substrate, whose Cse1 component is easily disassociated from the
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pre-assembled Tfu_Cascade (Huo et al., 2014). Hence, in different prokaryotic strains,
Cse2 may display different functions to deal with dramatically different
environmental conditions. In some bacteria and archaea strains, Cse2 may play a role
in stabilizing the target and displaced strands of DNA (Jackson et al., 2014b;
Mulepati et al., 2014; Zhao et al., 2014), whereas in other strains, Cse2 may merely
play a passive role in isolating crRNA from being accessible by other unrelated
DNAs. The function of Cse2 may be more complicated than originally thought.
In E. coli CRISPR/Cas system, Cse2 is released from Cascade complex and was
sensitive to proteolysis-mediated degradation after it hands over crRNA to the
invading dsDNA with complementary sequence (Wiedenheft et al., 2011a).
Consistently, our competitive EMSA assay showed that ssDNA complementary to the
crRNA sequence is able to strip off the ssRNA from MruCse2-ssRNA complex
(Figure 3- 16a). In addition, we noticed that MruCse2 displays binding preference to
ssRNA instead of ssDNA or RNA/DNA hybrid (Figure 3- 6a). These results suggest
that MruCse2 may not directly participate in the stabilization of crRNA-target DNA
complex or the positioning of the displaced ssDNA. The distinct nature of crRNA
G-rich sequence binding by MruCse2 prompted us to speculate that G-rich crRNA
sequence allows Mru_crRNA to form strong hydrogen bonds with the invading DNA
sequence, which may alleviate MruCse2’s involvement in R-loop stabilization.
In this study, we have analyzed M. ruber type I-E CRISPR/Cas system, which shows
remarkable differences in Cascade assembly and target recognition. The availability
of in vivo reconstituted Mru_Cascade complexes allowed us to address new assembly
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mechanism that could have not been addressed before. Our chromatographic results
indicate that Mru_Cascade readily forms a stable complex when expressed with
G-rich crRNA co-expressed (Figure 3- 13a), which agree well with the experiments
showing that Cse2 displays a strong binding affinity to G-rich spRNA (Figure 3- 7a).
By contrast, in the non G-rich crRNA case, Cse2 and Cas5e were dissociated from the
Cascade complex, leaving the crRNA-containing subcomplex comprising
Cse1-Cas7-Cas6e intact, which is still capable of targeting the invading DNA (Figure
3- 13b and Figure 3- 15). The data showing the addition of DNA target to strip off
Cse2 and Cas5e from the purified Cascade-crRNA allows us to investigate the role of
Cse2 in Cascade assembly and target binding. In Eco_Cascade system, Cse2 dimer
could move along the Cas7 helix and undergoes a significant conformational change
upon DNA target binding (Jackson et al., 2014b; Mulepati et al., 2014; Zhao et al.,
2014). We speculate that MruCse2 could be immediately released from the
Cascade-crRNA complex after the formation of R-loop in Mru_Cascade system.
However, in the M. ruber system, different mechanisms in targeting foreign nucleic
acids might be established in different (sub)complexes containing G-rich or non
G-rich crRNA sequences. With G-rich crRNA, MruCse2 should play the role for
crRNA binding and handing-over to CasACE subcomplex, whereas in the presence of
non-G-rich crRNA, MruCse2 may not be directly involved in crRNA binding.
Consistent with our speculation, Cse2 subunit of Eco_Cascade was found sensitive to
proteolysis 20 minutes after binding to either DNA or RNA targets (Wiedenheft et al.,
2011a). Therefore, stripping of Cse2 could be more or less similar in both E. coli and
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M. ruber systems.
The recently determined crystal structure of Eco_Cascade complex revealed that
EcoCse2 dimer assembles along the belly of Eco_Cascade with two parallel tracks of
positively charged surfaces located on both faces of EcoCse2 dimer (Jackson et al.,
2014b; Zhao et al., 2014). Such high-resolution structure strongly suggests a
functional role of EcoCse2 dimer in stabilizing the target and displaced DNA strands
at certain stages (Jackson et al., 2014b; Zhao et al., 2014). However, these studies did
not provide any structural evidence that EcoCse2 dimer could participate in crRNA
binding directly. We speculate that current crystal structures of Eco_Cascade may
only provide a ‘snapshot’ of the whole spectrum of RNA-guided immune surveillance
mediated by Cascade complex and Cse2 dimer could be realigned along with the
crRNA after DNA target binding. MruCse2 dimer in complex with G-rich crRNA
may play an assistant role in facilitating the presentation of crRNA to invading DNA
elements, whereas MruCse2 dimer may play a less active role in non G-rich crRNA
mediated Mru_Cascade assembly and target DNA binding. However, the detailed
mechanisms of Mru_Cascade assembly and R-loop formation are still largely
unknown. Future works on Mru_Cascade structure determination, deep-sequencing of
the bound crRNAs within Mru_Cascade and its subcomplex, single-molecule twisting
experiments revealing the kinetics and extent of R-loop formation and dissociation
are required to address these questions.
The structural feature of G-rich binding property is found in a few proteins, among
which, the isolated KSRP KH3 domain prefers binding to single-stranded AGGGU
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derived from pre-let-7a sequence (Nicastro et al., 2012). In KSRP-KH3/ssRNA
complex structure, AGGGU ssRNA is recognized by the nucleic acid-recognition
groove of KSRP KH3 and the middle G3 is recognized by a K368 residue (Figure
3- 8). The introduction of arginine residue mutation at this position drives the
nucleotide preference from G to C. In the MruCse2 structure, there is no conserved
positively charged residue corresponding to K368 at this region. Hence, we speculate
that the nucleotide type at middle G3 could have less impact on MruCse2 binding
(Figure 3- 8).
The specific recognition of G-rich sequence by KSRP-KH3 is crucial and has a strong
impact on KSRP’s function in promoting pri-let-7 processing. However, the
functional role of G-rich sequence recognition by MruCse2 is still largely unknown.
Although G-rich sequences are abundant in M. ruber CRISPR array, they are not
universally conserved for other species, such as T. fusca and E. coli. TfuCse2 displays
fewer nucleotide sequence and type specificities, as it is able to bind not only to
ssRNA but also dsDNA and DNA/RNA hybrid (Figure 3- 6b). The different
nucleic-acid binding properties displayed by the two different Cse2s raise the issue of
whether the specific sequence and type of nucleic acid recognition shown by
MruCse2 is functionally important. Although there is a lack of direct functional
evidence, we speculate that the specific sequence recognition property of MruCse2
could facilitate the Cascade complex’s recruitment of pre-crRNA, enhance crRNA
processing and promote crRNA invasion to foreign dsDNA. Presumably, the Cse2
from each species has evolved to specifically recognize the single-stranded crRNA
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sequence from the same species. The low sequence conservation grants Cse2 the
flexibility to form unique groove/patches for specific sequence binding.
Taken together, our structural and functional studies of G-rich crRNA recognition by
MruCse2 and molecular characterization of Mru_Cascade in G-rich crRNA binding
preference have improved our understanding of the similarities and differences
among the diverse type I Cascade machineries.
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Chapter 4: Structural and Functional Characterization of
Thermobifida fusca Cse1
3.15 Introduction
The CRISPR/Cas systems use Cas proteins in complex with crRNAs to identify and
degrade target sequences complementary to the crRNA spacer, preventing successful
phage infection or plasmid transformation (Barrangou et al., 2007). A conserved PAM
sequence which is present only in the target, but not in the host CRISPR locus, is
thought to enable distinction between self and non-self dsDNA (Mojica et al., 2009;
Semenova et al., 2011a; Westra et al., 2013). In E. coli, the PAM is located upstream
of the target sequence (positions -3 to -1) and has exhibited important requirements
for Cascade target binding and viral resistance (Sorek et al., 2013). PAM recognition
seems to occur through protein-DNA interactions since the PAM sequence is not fully
complementary to the crRNA. Among all the Cas proteins in E. coli, Cse1 was shown
to be involved in the recognition of the PAM sequence, as it is located at one end of
the complex near the 5’ end of the crRNA, which is supported by both the cryo-EM
structure and the crystal structure of Eco_Cascade (Jackson et al., 2014b; Wiedenheft
et al., 2011a; Zhao et al., 2014). Hence, the structural analysis of Cse1, especially on
the target binding sites, should provide more information on genome surveillance and
detection of non-self DNA target.
Although five high resolution crystal structures of Cse1 (three from T. thermophilus,
one from A. ferrooxidans, and one from E. coli) have been solved, the target binding
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site was not revealed in these crystal structures due to its flexibility. Based on
molecular docking of TthCse1 into the cryo-EM structure of E. coli ssRNA-bound
Cascade (EMD-5315), a flexible loop called L1, is shown to reside just below the
crRNA-target duplex, and is considered to contact the PAM sequence (Mulepati et al.,
2012; Sashital et al., 2012), and this is further confirmed by the cryo-EM structure of
Eco_Cascade in complex with dsDNA (EMD-5929), although electron density of the
PAM is not revealed in the structure (Hochstrasser et al., 2014a). Notably, a three
amino acid motif, particularly a conserved phenylalanine residue in L1, has been
characterized to be involved in dsDNA destabilization, probably through DNA
intercalation and helical distortion (Sashital et al., 2012).
When the manuscript was under submission and review, the crystal structure of
Eco_Cascade was reported. In the pre-target-bound Eco_Cascade structure, the
L1-helix of Cse1 inserts snugly into a pore created by the thumb of Cas5e and makes
base-specific interactions with the 5’ handle of the crRNA (Jackson et al., 2014b);
while in the ssDNA-bound Eco_Cascade structure, the L1 loop is disordered,
suggesting that these regions are mobile in the absence of dsDNA (Mulepati et al.,
2014). In addition, cleavage assays showed that mutation of the Cse1 L1 loop
(N131A) substantially decreases target degradation by Cas3 (Hochstrasser et al.,
2014b). The structural analysis of Cas3-bound dsDNA-Cascade revealed that Cas3
co-localizes with Cse1 for dsDNA target binding (Hochstrasser et al., 2014b). These
structural findings, together with the observation that the Cse1 L1 loop is crucial for
Cas3-mediated in vitro DNA cleavage and in vivo interference (Hochstrasser et al.,
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2014b; Sashital et al., 2012), demonstrate that the Cse1 plays an essential role in
target recognition and Cas3 recruitment.
In this study, we utilized X-ray crystallography to study the structure of TfuCse1,
which reveals a well-defined dsDNA binding site and the structural details of the
conserved phenylalanine residue in L1. In addition, structural comparison of the
electrostatic surface of Cse1 shows a conserved positive patch, which is contiguous
with that of Cse2 and adjacent to Cas3 in the cryo-EM structure of dsDNA-bound
Cascade complex (Hochstrasser et al., 2014a). Furthermore, mutation of this positive
patch abolishes dsDNA binding by Cse1, suggesting that the positive patch on Cse1
might be involved in R-loop formation and/or stabilization, as well as the subsequent
recruitment of Cas3 for target cleavage.
4.2 Expression and purification of TfuCse1
The recombinant protein was purified to homogeneity by nickel-chelating and
size-exclusion chromatography, as described in Chapter 2. The expression levels of
recombinant TfuCse1 were very high and the protein was highly soluble with only a
minimum amount of the total expressed protein lost in the insoluble cell fraction. The
apparent molecular weight of the his-tagged protein as observed on SDS-PAGE was
in agreement with the calculated molecular weight of 63 kD (Figure 4-1). The protein
eluted as a single monodispersed peak from gel filtration chromatography, which is a
prerequisite to continue with crystallographic studies of the protein (Figure 4- 1).
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Figure 4- 1: Purification of TfuCse1.
Chromatogram of TfuCse1 purification by gel filtration chromatography and peak
fractions containing pure TfuCse1.
4.3 Crystallographic study of TfuCse1
4.3.1 Crystallization and structure solution of TfuCse1
The crystals of TfuCse1 were grown in crystallization conditions containing 10% (v/v)
PEG 8000, 100 mM KCl, 10 mM MgSO4, 100 mM sodium cacodylate (pH 7.0). The
optimized crystal of TfuCse1 and the diffraction pattern of the crystal are presented in
Figure 4- 2. After collecting the diffraction data, we determined the crystal structure
of TfuCse1 by molecular replacement using that of AfeCse1 (PDB ID: 4H3T), which
has a sequence identity of 33%, as the search model (Figure 4- 3). The detailed data
collection and refinement statistics are given in Table 4- 1. In brief, the crystal
belonged to a monoclinic space group C2 (a = 207.3 Å, b = 132.5 Å, c = 103.0 Å, α =
γ = 90°, β = 93.75°) with three molecules present in an asymmetric unit. The structure
was refined to a resolution of ~3.3 Å with an Rwork of 19.0 – 22.3% and Rfree of 27.8 –
30.0%. An Rwork/Rfree gap of ~7% is acceptable for a relatively low-resolution crystal
structure.
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Figure 4- 2: Crystallization of TfuCse1.
(a) SDS-PAGE analysis of the purified TfuCse1 protein used for crystallization. (b)
Crystals of TfuCse1. (c) X-ray diffraction pattern of TfuCse1 crystal.
Table 4- 1: Data collection and refinement statistics




a, b, c (Å) 207.3, 132.5, 103.0
Β (˚) 93.75
Wavelength (Å) 1.075
Resolution (Å) a 50~3.30 (3.36~3.30)
Rsym (%) 11.9 (60.6)
I/σ(I) 17.0 (2.5)
Completeness (%) a 99.6 (95.5)
Redundancy 7.2 (5.3)




Resolution Range (Å) 50~3.30 (3.40~3.30)
No. reflections 35,245









Bond lengths (Å) 0.013
Bond angles (º) 1.797
% favored (disallowed) in
Ramachandran plot 86.4 (0)
a Values for the highest-resolution shell are in parentheses.
4.3.2 Overall structure of TfuCse1
The structure of TfuCse1 reveals two separate domains: an N-terminal domain (NTD,
residues 1-409) that adopts a fold consisting 15 α-helices and 10 β-strands which is
unique to Cse1 proteins based on the Protein Data Bank when searched using the Dali
server (Holm and Rosenstrom, 2010), and a C-terminal four-helix bundle (residues
410-555) with each helix orientated in an alternate direction. A disordered region is
observed in the C-terminal domain (residues 513-519) which has no electron density
in the map, indicating the flexibility of this region (Figure 4- 4a).
Structural comparison between the known structures of Cse1 and that of TfuCse1 was
performed by structure and sequence alignment of TfuCse1 against AfeCse1 (PDB ID:
4H3T), TthCse1 (PDB ID: 4AN8), and EcoCse1 (PDB ID: 1VY9) as illustrated in
Figure 4- 3 and Figure 4- 4. The structural alignment showed an overall good tertiary
structural agreement among these Cse1 proteins with Z-scores of 46.4, 36.9 and 28.4,
and r.m.s.d of 1.2 Å (335Cα atoms), 3.9 Å (290 Cα atoms), and 4.6 Å (199 Cα atoms),
respectively (Figure 4- 4a).
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Figure 4- 3: Sequence alignment of Cse1 from T. fusca, A. ferrooxidans, T.
thermophilus and E. coli.
The conserved residues are highlighted in green while the partially conserved
residues are highlighted in yellow. The three amino acid motif involved in PAM
recognition are bolded in red and the critical residues are labeled with a star (*) at the
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bottom. The residues in the conserved positive patch are bolded in blue and labeled
with a triangle (Δ). The secondary structures are shown above the sequences.
Figure 4- 4: Structural comparison of Cse1 homologues.
(a) Cartoon representation of the crystal structures of Cse1 arranged in the same
orientation. The N-terminal domain is labeled in cyan, the C-terminal domain in
yellow, and L1 in red. (b) Electrostatic surfaces of Cse1, in the same orientation, with
the conserved positive patch circled.
4.4 DNA binding activity of TfuCse1
The presence of co-purified nucleic acids in the isolated TfuCse1 protein prompted us
to investigate whether TfuCse1 has DNA-binding ability. To test the effect of
TfuCse1 on specific binding of non-self targets containing correct PAM sequence, we
conducted EMSA using a 72-nt long target DNA (32-nt protospacer flanked by 20-nt
on each side). As expected, TfuCse1 is able to bind both ssDNA and dsDNA, with
higher binding affinity for dsDNA (Figure 4- 5a) and the dsDNA binding increases
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over the course of the TfuCse1 titration (Figure 4- 5b). These data suggest that
TfuCse1 may destabilize dsDNA targets, allowing the crRNA to access the seed and
nucleate crRNA-target duplex formation. In addition, the dsDNA target was truncated
to investigate the specific DNA sequence for TfuCse1 binding. As illustrated in
Figure 4- 5c, the TfuCse1 showed no binding affinity to the double-stranded
protospacer, suggesting that specific dsDNA binding by TfuCse1 depends on the
PAM recognition. Notably, the binding affinity of TfuCse1 with dsDNA increases
with increasing length of the dsDNA.
Figure 4- 5: TfuCse1 DNA binding activity.
(a) EMSA screen for DNA binding by TfuCse1. Target: ssDNA strand containing the
protospacer complementary to the spacer 1 in the crRNA. Non-target: ssDNA
complementary to the target. dsDNA: formed by annealing the target and non-target
strand. (b) EMSA illustrating increase in dsDNA bound with increase concentration
126
of TfuCse1. (c) EMSA for different truncations of dsDNA binding by TfuCse1. The
sequences of the dsDNA used are listed in Table S-1.
4.5 Structural insights into dsDNA binding site of Cse1 L1
Structural alignment of the known structures of Cse1 against that of TfuCse1 reveals
a defined structure of L1 in TfuCse1 structure, which is flexible and not observed in
the other Cse1 single protein structures (Figure 4- 6). In TfuCse1 structure, L1
consists of a short α-helix that is N-terminally adjacent to the conserved
phenylalanine F142 (Figure 4- 7a). A similar helix is also observed in EcoCse1 in the
crystal structure of Cascade complex (PDB ID: 1VY8) (Figure 4- 4a) (Jackson et al.,
2014b). To better understand the function of L1 in DNA binding, we docked the
crystal structure of TfuCse1 into the cryo-EM reconstruction of E. coli dsDNA-bound
Cascade (EMD-5929), and found that the short α-helix is located near the bound
dsDNA target in the complex (Figure 4- 7b), together with the adjacent conserved
residues which is located just below the 5’ end of the crRNA-target duplex (Figure
4- 7c). These observations suggest that the short α-helix and the residues residing
close to the crRNA-target duplex are important for dsDNA binding and/or
stabilization. To investigate this hypothesis, TfuCse1 mutants were generated and
EMSAwas conducted to analyze the binding affinity of the wild-type TfuCse1 and its
mutants for the 72-nt dsDNAwith correct PAM and protospacer.
Figure 4- 6: Detailed structure of TfuCse1 L1 loop.
Electron densities for TfuCse1 L1 loop are shown in
red mesh contours. The map was calculated using
Fo-Fc coefficients and phases from the refined
structure, but with the residues omitted from the Fc
calculation. The map is contoured at 3σ. The
TfuCse1 L1 loop is shown in stick model.
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Figure 4- 7: Importance of Cse1 L1 in DNA binding.
(a) Structural alignment of Cse1, zoomed in highlighting L1 and the critical residues
involved in DNA binding. TfuCse1 (magenta); AfeCse1 (yellow); TthCse1 (cyan).
(b-c) Docking of TfuCse1 into the ~9 Å E. coli dsDNA-bound Cascade (EMD-5929)
with the Cas3 density mapped from the ~20 Å Cas3-bound dsDNA-Cascade structure
(EMD-5930). (c) is rotated 120º about the y-axis with respect to (b). Zoom in of
figures depicting the interaction of the three amino acid motif and the α6 helix in L1
with (b) the target dsDNA and (c) the crRNA-target DNA. (d) EMSA comparing
binding affinity by mutants of TfuCse1 to the wild-type.
While the F143A mutation has little effect on dsDNA binding, mutation of F142 and
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T144 to alanine causes substantial defects in dsDNA binding, and the tri-alanine
mutation of F142A/F143A/T144A results in similar reduction in binding as compared
to the single alanine mutation of F142A or T144A (Figure 4- 7d). Notably, the helix
deletion mutant (ΔGEL: removal of residues G139, E140, and L141) showed only
slight defect in binding to dsDNA (Figure 4- 7d), indicating that the helix itself is not
directly involved in dsDNA binding. Consistent with the structural observation,
sequence alignment of Cse1 proteins showed that the critical F142 residue is highly
conserved, whereas the second critical residue T144 involved in dsDNA is less
conserved across species, although polar residue is abundant at this location (Figure
4- 3).
4.6 Functional role of conserved positive patch on Cse1 in
dsDNA binding
The observation that the mutation of the conserved phenylalanine, which is involved
in PAM interaction, does not completely abolish the binding to dsDNA, suggests that
there should exist additional DNA binding sites on TfuCse1 (Figure 4- 7d). Consistent
with our speculation, a conserved positive patch proximate to the L1 loop was
discovered from the electrostatic surfaces of all reported Cse1 structures (Figure
4- 4b), suggesting that this patch may participate in DNA binding. Structural and
sequence alignment of Cse1 proteins revealed several positively charged residues
residing in this region (Figure 4- 3 and Figure 4- 8a). To further investigate the role of
this conserved positive patch in DNA binding and Cascade assembly, the crystal
structures of TfuCse1 and TfuCse2 (PDB ID: 4H79) were docked onto the cryo-EM
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structures of the Eco_Cascade in apo-form and in dsDNA-bound form (EMD-5314
and EMD-5929; Figure 4- 8b). Notably, compared with a discontinuous positively
charged surface along the pre-target-bound state, a contiguous positively charged
patch that is in proximity to the Cas3 binding site on Cse1 was observed along the
Cascade surface after dsDNA binding (Figure 4- 8b), further suggesting that this
patch should be involved in target dsDNA binding. Consistent with our observations,
cryo-EM studies have shown that target binding triggers structural rearrangements of
the Cse1 and Cse2 subunits, and the crystal structure of ssDNA-bound Cascade
revealed that the target strand is bound primarily with the guide but also interacted
with the Cas7, Cse1 and Cse2 subunits (Mulepati et al., 2014; Wiedenheft et al.,
2011a). In addition, the introduction of alanine mutations to these positively charged
residues significantly reduced the binding affinity of TfuCse1 with both ssDNA and
dsDNA, and the introduction of multiple alanine mutations completely abolished
nucleic acid binding ability by TfuCse1 (Figure 4- 8c). These data suggest that the
conserved positively charged patch of Cse1, which is contiguous to that of Cse2
dimer, plays an important role in the target nucleic acid binding.
130
Figure 4- 8: Role of conserved positive patch on TfuCse1 in DNA binding.
(a) Positive residues in the conserved patch of TfuCse1 illustrated as sticks in the
structure. (b) Docking of TfuCse1 and TfuCse2 onto the (left) apo-Cascade
(EMD-5314) and (right) dsDNA-bound Cascade (EMD-5929). Discontinuous
positive patch from Cse2 toCse1 was observed in the apo-Cascade, whereas a
131
contiguous positive patch from Cse2 to Cse1 in the dsDNA-bound Cascade was
noticed, as indicated by the dotted black line. Proximity of Cas3 binding site to the
conserved positive patch on Cse1. (c) EMSA comparing binding affinity of wild-type
and mutants of TfuCse1 to the ssDNA and dsDNA.
4.7 Discussion and future work
4.7.1 DNA binding ability of TfuCse1
In the previous studies, the E. coli CasBCDE-crRNA subcomplex alone displays no
dsDNA binding activity, while dsDNA binding increases over the course of the Cse1
titration, indicating that the target dsDNA binding depends on incorporation of Cse1
into the complex. However, the DNA binding activity of the isolated Cse1 protein has
not been reported (Mulepati et al., 2012; Sashital et al., 2012). Notably, our data
suggests that the isolated TfuCse1 protein could bind to both ssDNA and dsDNA
(Figure 4- 5), and the higher binding affinity for dsDNA is due to that the type I-E
CRISPR/Cas system targets dsDNA (Gasiunas et al., 2014; Gebruers et al., 2008;
Hochstrasser et al., 2014a; Jore et al., 2011; Sinkunas et al., 2011; Sorek et al., 2013;
Westra et al., 2012a; Westra et al., 2012c). The different DNA binding activities by
TfuCse1 and EcoCse1 could be explained by structural differences between these two
proteins. The less prominent continuous positively charged surface on the structure of
EcoCse1 compared with TfuCse1 (Figure 4- 4b), could account for the requirement of
other subunits in the Eco_Cascade complex for stable dsDNA binding (Hochstrasser
et al., 2014a).
4.7.2 Structural Characterization of TfuCse1 L1
Compared to the wild-type TfuCse1, the mutant proteins displayed significant weaker
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binding affinity to dsDNA, except F143A (Figure 4- 7d). The different binding
affinity to dsDNA can be explained by the proximities and orientations of the residues
in L1 with respect to the crRNA-target in the Cascade complex. In this Cse1-docked
dsDNA-bound Cascade structure, the L1 α-helix and residues F142 to T144 are
located close to the crRNA-target, and the R-group of the highly conserved F142
residue overlaps with the electron density of the bound dsDNA (Figure 4- 7b, c).
Furthermore, both the side chains of F142 and T144 residues point towards the bound
dsDNA, whereas the side chain of F143 points away from the crRNA-target DNA,
indicating the non-essential role of F143 in dsDNA binding (Figure 4- 7c). Consistent
with our results, functional analysis of the residues C-terminally adjacent to the
conserved phenylalanine residue in EcoCse1 showed that V130 (which aligns to F143
in TfuCse1) is not involved in DNA binding, whereas the residue N131 (which aligns
to T144 in TfuCse1) is involved in DNA binding (Sashital et al., 2012). Hence, the
residue C-terminally proximate to the conserved phenylalanine in L1 plays a less
active role in dsDNA binding, whereas the residue two positions away from the
conserved phenylalanine appears to be significant for dsDNA binding.
4.7.3 Structural role of the conserved F142 residue of TfuCse1
The observation that the crystal structure of TfuCse1 harboring a well-defined L1
structure and the cryo-EM structure of Cascade complex showing the close
interactions between L1, especially the conserved F142 residue, and the target
dsDNA (Figure 4- 7b, c) (Hochstrasser et al., 2014a), together with the EMSA
experiment showing that mutation of F142A causes substantial defects in dsDNA
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binding, indicate that the highly conserved aromatic residue in L1, F142 plays an
important role in crRNA-guided dsDNA targeting. Theoretically, the aromatic ring of
this residue could penetrate into the paired dsDNA to form π-stacking with the purine
or pyrimidine rings, thus disrupting the dsDNA paring. Consistent with our results,
the mutation of the conserved phenylalanine residue of EcoCse1 to alanine causes
substantial defects in dsDNA binding, suggesting that this aromatic residue may
participate in DNA intercalation and helical distortion. Moreover, such a DNA
interrogation mechanism has been observed in many aromatic-ring mediated dsDNA
intercalation and helical distortions (Banerjee et al., 2006; Horton et al., 2006;
Sashital et al., 2012). In Cascade, similar helical distortions could subsequently result
in destabilization of the DNA double helix, triggering seed nucleation to occur
through complementary base pairing (Sashital et al., 2012).
4.7.4 Structural role of T144 residue of TfuCse1
Interestingly, based on the EMSA results, the non-conserved polar residue two
positions after the conserved F142 in Cse1 appears to be important for dsDNA
binding (Hochstrasser et al., 2014a; Sashital et al., 2012). In the Cse1-docked
dsDNA-bound Cascade structure, this residue is proximate to the dsDNA, indicating
that this residue is likely to interact with PAM directly or indirectly (Figure 4- 7b).
Notably, the introduction of triple F142A/F143A/T144A mutation had similar effect
on dsDNA binding as compared with the single mutation of F142A or T144A (Figure
4- 7d), suggesting that F142 and T144 may perform a similar role in PAM recognition.
Hence, mutation to either one would abolish this binding activity. Hence, we
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speculate that the T144 residue may recognize the PAM sequence through
electrostatic interaction with the bases and stabilize the intercalation mediated by the
conserved aromatic residue. Therefore, F142 and T144 are responsible for target
dsDNA recognition/binding by intercalating the target dsDNA and stabilizing the
intercalation, respectively. High-resolution structures of crRNA-ssDNA-bound
Cse1would provide more insights into the function of these residues involved in PAM
recognition (Figure 4- 9). In addition, we speculate that the sequence variable feature
of T144 amongst the divergent Cse1 proteins could enable the Cascade complex from
different species to recognize a slightly different PAM sequence. Although PAM
sequence was validated in E. coli Cascade system, at least four different PAM
sequences can be tolerated for interference (Westra et al., 2012c). The highly variable
structures and low sequence similarities among the Cas proteins even within the same
CRISPR/Cas subfamilies suggest that the PAM sequence in type I-E could be variable.
Therefore, further studies can be focused on how different residues at position 144 in
TfuCse1 may affect the PAM sequence recognition through high throughput
sequencing assays.
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Figure 4- 9: Cartoon view of TfuCse1 docked into Eco_Cascade crystal structure
(PDB ID: 4QYZ).
TfuCse1 was superimposed on EcoCse1, indicating the interaction of the three amino
acid motif and the α6 helix in L1 (highlighted in red) with the crRNA and target
ssDNA. (a) with the same view of Figure 4- 7b, and (b) with the same view of Figure
4- 7c.
4.7.5 Structural role of TfuCse1 L1
Besides the conserved phenylalanine residue, the helix in TfuCse1 L1, which is
located directly adjacent the target dsDNA (Figure 4- 7b), was shown to be involved
in dsDNA binding (Figure 4- 7d). These results indicate that the helix might be
responsible for stabilization of the target dsDNA. The absence of the helix structure
in L1 in other Cse1 structures could be explained by the presence of at least one
proline residue that causes this region to be more flexible (Figure 4- 3). These
structures may undergo a conformational change from a flexible loop to a helix upon
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target dsDNA binding, as observed in other DNA binding proteins such as Cmr2, one
of the subunits in the Cmr effector complex of the type III-B CRISPR/Cas system,
and RecA, an ATPase involved in homologous recombination (Chen et al., 2008;
Cocozaki et al., 2012). In Cascade, this loop-to-helix transition may stabilize the bond
with dsDNA, enabling recognition of the PAM sequence and intercalation of the
target dsDNA. In addition, the observation that the EcoCse1 L1-helix is well-defined
in the crystal structure of pre-target-bound Cascade indicates that the EcoCse1 L1
motif plays an important role for the incorporation of Cse1 into Cascade. To
investigate the role of TfuCse1 L1-helix in Cascade assembly, future studies on
Tfu_Cascade assembly and structure determination are required.
4.7.6 R-loop formation and/or stabilization by TfuCse1
Superposition of the apo Cascade model with the crystal structure of ssDNA-bound
Cascade reveals a concerted conformational rearrangement in which two Cse2
subunits each moves ~16 Å toward the four-helix bundle of Cse1 which undergoes a
~30° rotation away from Cse2.2 (Mulepati et al., 2014). This conformational change
leads to the formation of a contiguous positive patch from the Cse2 dimer to the
conserved positive patch on Cse1 (Figure 4- 8b). TfuCse2 has been shown to bind to
nucleic acids non-specifically and is proposed to be involved in R-loop formation and
stabilization (Agari et al., 2008; Nam et al., 2012a; Westra et al., 2012b; Westra et al.,
2012c). Hence, by forming a contiguous positive patch with Cse2, Cse1 may also
participate in the R-loop formation and/or stabilization through interacting with the
negatively charged phosphate backbone of DNA. Consistent with our hypothesis,
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multiple mutations to this conserved positive patch on Cse1 completely abolished
ssDNA and dsDNA binding (Figure 4- 8c), suggesting that the conserved positive
patch on Cse1 probably plays a role in stabilizing the interaction with the target DNA.
Attempts were made to assemble the Tfu_Cascade complex with multiple strategies;
however, Cse1 was easily dissociated from the pre-assembled Cascade complex.
Consistent with our observation, the Tfu_Cascade was reported to be unstable without
a protospacer- and PAM-containing dsDNA as the substrate (Huo et al., 2014). In
addition, the positive patch on Cse1 is adjacent to the Cas3 binding site according to
the Cse1-docked dsDNA-bound Cascade structure (Figure 4- 8b), suggesting that
Cascade may recruit the Cas3 helicase-nuclease through interactions with the positive
patch on Cse1. Once recruited, Cas3 nicks the displaced strand from the 3’-end of the
PAM and then loads onto the newly formed ssDNA end and continues to
progressively degrade the foreign DNA (Hochstrasser et al., 2014b; Mulepati and
Bailey, 2013; Sinkunas et al., 2013).
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4 Chapter 5: Conclusion and future work
Since the publication of the landmark paper by Barrangou et al. (Barrangou et al.,
2007), CRISPR/Cas systems have attracted widespread attention during the past two
years with respect to understanding many of the unique mechanistic features that are
associated with these remarkable systems. Although in silico studies initially revealed
an overwhelming variation in CRISPR/Cas systems, subsequent comparative
sequence analyses resulted in the classification of three major types (Makarova et al.,
2011b) and in potential scenarios for the evolution of CRISPR/Cas variants
(Makarova et al., 2011a). In addition, base on the recent structural analyses of Cas
proteins and crRNP complexes, there are unanticipated similarities between the type I
and type III crRNP complexes, but the single-protein Cas9-crRNP complex from type
II systems is structurally unrelated to other crRNP complexes. At the level of CRISPR
interference, although the general picture has become clear, several research gaps in
our mechanistic understanding regarding self versus non-self discrimination and
target degradation by trans-activating nucleases (such as Cas3) remain poorly
understood. Moreover, molecular insights of CRISPR/Cas systems rely heavily on the
availability of high-resolution crystal structures. Although a steadily growing number
of structures are available for individual Cas proteins, a major challenge is to obtain
atomic-resolution models of the crRNP complexes. Impressive progress has been
made for all three types of CRISPR/Cas systems, but future breakthroughs are
required to address the outstanding questions.
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This thesis describes the initial purification and characterization of some of the key
elements in CRISPR-mediated antiviral defence in M. ruber and T. fusca. In Chapter
3, we determined the MruCse2 structure and refined it to 2.8 Å. Two monomers of
MruCse2 were found in the asymmetric unit of the crystal, and the refined structure
of MruCse2 protomer reveals an α-helix bundle architecture with the dimension of 35
Å × 40 Å × 40 Å. The electrostatic surface calculations reveal a positive elongated
basic patch on one side of its surface, and the highly conserved residues are located at
the conserved basic patches with the side chains protruding from the elongated
groove, which are suggested to interact with nucleic acids directly. In addition,
MruCse2 dimer was perfectly docked at the top of the belly of the Eco_Cascade after
the superimposition of the MruCse2 dimer onto the EcoCse2 dimer in the
Eco_Cascade crystal structure (PDB ID: 4U7U), and the structural model shows that
most of the conserved positively charged residues of MruCse2 are located near the
bound crRNA molecule, suggesting a functional role of the conserved residues at the
surface of Cse2 dimer in nucleic acid binding. This was further validated by EMSA
assays.
In addition to these structural observations, MruCse2 and TfuCse2 displayed different
nucleic acid binding properties, which can be explained by the different size and
width of the basic patches on Cse2 proteins. The MruCse2 has a preference for
binding to ssRNA rather than other types of nucleic acids. Specifically, MruCse2
binds to G-rich ssRNA derived from Mru_spRNA, rather than other spacer sequences
in the form of ssRNA. This binding mode can be supported by the structural model of
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GGGGG binding by MruCse2.
It is interesting to reconstruct the Mru_Cascade complex in vitro, especially when we
found that the Cascade complex co-expressed with G-rich crRNA formed a stable
complex, while most of the complex dissociated into free Cse2, Cas5e and a
Mru_CasACE subcomplex with non G-rich crRNA. Based on EMSA assays, both
Cascade-crRNA complex and CasACE-crRNA subcomplex displayed significant
higher binding affinities towards long DNA targets containing the PAM sequence
(72-nt), than the short DNA targets without PAM sequence (32-nt), indicating that
PAM sequence is essential for efficient DNA target binding. Moreover, Cse2 and
Cas5e were stripped off from the preformed M. ruber G-rich-crRNA-Cascade by
complementary dsDNA target. Based on these functional data, we speculated a
working model of the functional role of MruCse2 in the RNA-guided immune
surveillance mediated by Cascade complex.
In Chapter 4, we determined the crystal structure of TfuCse1 by molecular
replacement using that of AfeCse1 (PDB ID: 4H3T), and the structure was refined to
a resolution of ~3.3 Å. Structural alignment of the known structures of Cse1 against
that of TfuCse1 reveals a defined structure of L1 in TfuCse1 structure, and L1
consists of a short α-helix that is N-terminally adjacent to the conserved
phenylalanine F142. We docked the crystal structure of TfuCse1 into the cryo-EM
reconstruction of E. coli dsDNA-bound Cascade (EMD-5929), and found that the
short α-helix is located near the bound dsDNA target in the complex, together with
the adjacent conserved residues which is located just below the 5’ end of the
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crRNA-target duplex. These observations suggest that the short α-helix and the
residues residing close to the crRNA-target duplex are important for dsDNA binding
and/or stabilization. This was further validated by EMSA assays.
In addition, a conserved positive patch proximate to the L1 loop was discovered from
the electrostatic surfaces of all reported Cse1 structures, suggesting that this patch
may participate in DNA binding. We docked the crystal structures of TfuCse1 and
TfuCse2 (PDB ID: 4H79) into the cryo-EM structures of the Eco_Cascade in
apo-form and in dsDNA-bound form (EMD-5314 and EMD-5929), respectively.
Remarkably, compared with a discontinuous positively charged patch along the
Cascade surface in the pre-target-bound state, a contiguous positively charged patch
that is in proximity to the Cas3 binding site on Cse1 was observed along the Cascade
surface after dsDNA binding. In addition, the introduction of alanine mutations to
these positively charged residues significantly reduced the binding affinity of
TfuCse1 with both ssDNA and dsDNA, suggesting that the conserved positively
charged patch of Cse1, which is contiguous to that of Cse2 dimer, plays an important
role in the target nucleic acid binding.
Taken together, our structural and functional studies on G-rich crRNA recognition by
MruCse2, the in vivo assembly of Mru_Cascade and molecular characterization of
Mru_Cascade in G-rich crRNA binding preference have highlighted the flexibility
and unexpectedness of individual Cas protein, Cascade assembly and target
recognition events adopted by different bacteria strains. Our determined structure of
TfuCse1 L1 and functional studies on TfuCse1 provide structural insights into the
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PAM recognition and target binding facilitated by TfuCse1. This information may
elucidate the role of TfuCse1 in R-loop formation/stabilization and the recruitment of
Cas3 for target cleavage.
However, one limitation of this study is that the mechanism underlying the G-rich
ssRNA binding is still unclear due to the lack of MruCse2+ssRNA complex structure.
Our attempts have been unfruitful, despite the fact that we have screened more than
~1,500 conditions for various ssRNA together with MruCse2. However, we have not
yet obtained any crystal. This result is most likely due to the low binding affinity
between MruCse2 and ssRNA. Further research should attempt to develop new
methods for the crystallization of the MruCse2-ssRNA complex.
The second limitation of this study is that the mechanism of Mru_Cascade in G-rich
crRNA binding preference and R-loop formation was not explored. To address this
problem, the structure determination of the Mru_Cascade either in apo form or in
complex with target DNA, deep-sequencing of the bound crRNAs within
Mru_Cascade and its subcomplex, single-molecule twisting experiments revealing the
kinetics and extent of R-loop formation and dissociation are required. Up until now,
important progress has been made on the structure determination. However, our
current data shows heterogeneous features of Mru_Cascade, suggesting that
subcomplexes coexist in one sample. Hence, future breakthroughs are required to
optimize the purification protocols.
The third limitation of this study is that the mechanism of TfuCse1 in R-loop
formation/stabilization and the recruitment of Cas3 for target cleavage are still
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unknown. Although the crystal structure of TfuCse1 has illustrated the mechanism of
dsDNA target binding by Cse1 based on the structural studies of the residues located
in L1, the details regarding the target recognition by Tfu_Cascade remain poorly
understood. Thus, the structure of Tfu_Cascade either in apo form or in complex with
target DNA and Cas3 are required to address these questions.
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1 GCGCGCATATGGTGCAAAAGGAAGTCAGTAGAGAACAG MruCse2+NdeI (fw)
2 GGCCCCTCGAGTTACTGCGCATCTTCACCCTCCATGGA MruCse2+XhoI (rv)
3 GCGCGGGATCCGTGCAAAAGGAAGTCAGTAGAGAACAG MruCse2+BamHI (fw)
4 GGCCCGCGGCCGCTTACTGCGCATCTTCACCCTCCATGGA MruCse2+NotI (rv)
5 GCGCGGGATCCTTGCCCACGTTTAATCTAATAACCCAG MruCse1+BamHI (fw)
6 GGCCCGCGGCCGCCTACTGACTTCCTTTTGCACCCACTAC MruCse1+NotI (rv)
7 GCGCGGGATCCATGAAACACCTGCTCGAGATTCACATC MruCas7+BamHI (fw)
8 GGCCCGCGGCCGCTCAGACCTCCAGCCCAAGGTTGGCCCT MruCas7+NotI (rv)
9 GCGCGGGATCCATGCCCACCCTGCTGTTGCGCCTGGCG MruCas5e+BamHI (fw)
10 GGCCCGCGGCCGCTCAAGCTGGAGTCGGCTCAGGTACACG MruCas5e+NotI (rv)
11 GCGCGGGATCCGTGTACCTGAGCCGACTCCAGCTTGAT MruCse6e+BamHI (fw)
12 GCGCGCATATGGTGTACCTGAGCCGACTCCAGCTTGAT MruCse6e+NdeHI (fw)
13 GGCCCGCGGCCGCCTACACCTTTGCGATGGAAAGCAGGCC MruCse6e+NotI (rv)
14 GCGCGTGTACAGGGAATACGCGGTGGGCAACGAGCAGG MruCRISPR(G5)+BsrGI (fw)
15 GGCCCCCTAGGGGCTATGGGAGAAGGACAGAAGTTGGA MruCRISPR(G5)+AvrII (rv)
16 GCGCGTGTACAGGGAATACTCATGTGTAGGAGACAGAT MruCRISPR(NG5)+BsrGI (fw)
17 GGCCCCCTAGGGTATATGGCCTGCGACAACATCAATGC MruCRISPR(NG5)+AvrII (rv)
18 GGAATTCCATATGATGACAACTGACGCACCCTC TfuCse1+NdeI (fw)
19 CCGCTCGAGTCACGATGCTGCCTCACCTG TfuCse1+XhoI (rv)
20 GCGCGCATATGGTGACCACCACCGAAACCCCGAAAACC TfuCse2+NdeI (fw)
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21 GGCCCCTCGAGTCATGAGTTGTCCTTTTCGGTCGTCGT TfuCse2+XhoI (rv)
22 GCGCGGGATCCGTGACCACCACCGAAACCCCGAAAACC TfuCse2+BamHI (fw)
23 GGCCCAAGCTTTCATGAGTTGTCCTTTTCGGTCGTCGT TfuCse2+HindIII (rv)
Restriction sites in red.
CRISPR(NG1) and CRISPR(NG5) mean single and five consecutive non G-rich crRNA sequences, respectively.
Site-directed
mutagenesis
24 CTGGCACGGATGGCCGCCGGCCTGGATGCG MruCse2_R28A/R29A (fw)
25 AGCATCGAGCAGGCCTTTATCGCCCTG MruCse2_R126A (fw)
26 CAGTTGCCCTACGCCCTGCGCCAGATG MruCse2_R141A (fw)
27 CAGTTGCCCTACGCCCTGGCCCAGATGGTG MruCse2_R141A/R143A (fw)
28 AAAAGCATCGAGGCGCGCTTTATCGCC MruCse2_Q125A (fw)
29 TGGCGCGCCTCGCCAGAGGAGCAGGC TfuCse2_R45A (fw)
30 TGGCGCGCCTCCGCGCAGGAGCAGGC TfuCse2_R46A (fw)
31 CCGCTCCGCAAAGCCTTTGTGCAAGTC TfuCse2_R132A (fw)
32 CTCTCGCTCAGGCGTTGCGCGAAATC TfuCse2_R148A (fw)
33 GCTCAGAGGTTGGCCGAAATCGTCACC TfuCse2_R150A (fw)
34 TGGCGCGCCTCGCCGCAGGAGCAGGC TfuCse2_R45A/R46A (fw)
35 CTCTCGCTCAGGCGTTGGCCGAAATCGTCACC TfuCse2_R148A/R150A (fw)
36 CAACGGGGAGCTGGCCTTCACCATG TfuCse1_F142A (fw)
37 GAGCTGTTCGCCACCATGCGG TfuCse1_F143A (fw)
38 CTGTTCTTCGCCATGCGGGCCCGCGGCGTG TfuCse1_T144A (fw)
39 CAACGGGGAGCTGGCCGCCGCCATGCGGGCCCGCGGCGTG TfuCse1_F142A/F143A/T144A (fw)
40 GATGTCCCCAACGGGGAGCTGTTCTTCACCATG TfuCse1_ΔGEL (fw)
41 CTGCCCGTGGCATACCGGGACGGCACCGCAAAAGAACTG TfuCse1_Q19A/E25A (fw)
42 CACTTTTGGCCGCACTCGTCGGCGAC TfuCse1_R41A/R42A (fw)
43 TCTTCACCATGGCGGCCGCCGGCGTGGCCGCCCTCAGCTTCG TfuCse1_R146A/R148A/D151A/R1
52A (fw)
Substitution mutation in red. Deletion mutation strikethrough. Reverse complementary sequence of those listed are designed as the reverse primers.
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Northern Blot 44 Biotin-TTGAGCGCCCACCCCTGCTCGTTGCCCACCGC M. ruber CRISPR spacer 1 (rv)
45 Biotin-TTCGATGGCAACTACTTTGAGACTGGGTTCTG M. ruber CRISPR spacer 2 (rv)
46 Biotin-CGATGCCCCCGCACTGAGCGTGGACGACATCG M. ruber CRISPR spacer 3 (rv)
47 Biotin-GCGTGGGCACCAGAACAAAGCGGCCCGACTCC M. ruber CRISPR spacer 4 (rv)
48 Biotin-CTATGGGAGAAGGACAGAAGTTGGAACCACAT M. ruber CRISPR spacer 5 (rv)
49 Biotin-ACAGATACTTCGTATCTGTCTCCTACACATGA M. ruber CRISPR spacer 6 (rv)
50 Biotin-GATTGCAAAGGCTTCTGTGGTGGAAGACAAGC M. ruber CRISPR spacer 7 (rv)
51 Biotin-GCGGCCATCGTGCGGCGCGCAAAATCCGAGGG M. ruber CRISPR spacer 8 (rv)
52 Biotin-GGCAAGAAGCGGCCATGGAATGGGGCCCTGAA M. ruber CRISPR spacer 9 (rv)





foreign dsDNA1 (fw): target withM.







foreign dsDNA2 (fw): target with







foreign dsDNA3 (fw): target withM.













Putative PAM position in red. Spacer/Protospacer and mutant sequences underlined.
EMSA 62 Biotin-CGAUGUCGUCCACGCUCAGUGCGGGGGCAUCG M. ruber CRISPR spacer 3 transcript
(fw)
63 Biotin-CGATGTCGTCCACGCTCAGTGCGGGGGCATCG M. ruber CRISPR spacer 3 (fw)
64 Biotin-CGATGCCCCCGCACTGAGCGTGGACGACATCG M. ruber CRISPR spacer 3 (rv)
65 Biotin-AACUCGCCAGUUACGGGCCGCACACUGACGAU T. fusca CRISPR spacer 1 transcript
(fw)
66 Biotin-AACTCGCCAGTTACGGGCCGCACACTGACGAT T. fusca CRISPR spacer 1 (fw)
67 Biotin-ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTT T. fusca CRISPR spacer 1 (rv)
68 Biotin-GGGGG G5
69 Biotin-GGAGG G5 mutant
70 Biotin-GGCGG G5 mutant
71 Biotin-GGUGG G5 mutant
72 Biotin-AGGGG G5 mutant
73 Biotin-CGGGG G5 mutant
74 Biotin-UGGGG G5 mutant
75 Biotin-GAGGG G5 mutant
76 Biotin-GCGGG G5 mutant
77 Biotin-GUGGG G5 mutant
78 Biotin-GGCCGG G5 mutant
79 Biotin-GGCCCGG G5 mutant
80 AUGAAAUGCGUAUGCCGCUGCGUCGACCAUGU M. ruber spRNA1: CRISPR spacer
15 transcript (fw)
81 GCGGUGGGCAACGAGCAGGGGUGGGCGCUCAA M. ruber spRNA2: CRISPR spacer 1
transcript (fw)
82 GCGCGCUACCCGCCAGGUCAUGCCAGUUCCCUC M. ruber spRNA3: CRISPR spacer
167
39 transcript (fw)
83 CGAUGUCGUCCACGCUCAGUGCGGGGGCAUCG M. ruber spRNA4: CRISPR spacer 3
transcript (fw)
84 CAGCUCUACACCCAGCACAUCGGAUCCGGCAC M. ruber spRNA5: CRISPR spacer
66 transcript (fw)
85 ACUGCCCAAGCGUGACAAAAAAGGACGCUUCA M. ruber spRNA6: CRISPR spacer
35 transcript (fw)
86 CAGAACCCAGUCUCAAAGUAGUUGCCAUCGAA M. ruber spRNA7: CRISPR spacer 2
transcript (fw)
87 ACCAACGCAUGGCCGCUAUACGACUACGCCAU M. ruber spRNA8: CRISPR spacer
16 transcript (fw)
88 ACUGUGGAUGGCUCCCGUGAUCUGCGGGGUGC M. ruber spRNA9: CRISPR spacer 7
transcript (fw)




long dsDNA1 (fw): target withM.





92 CGATGCCCCCGCACTGAGCGTGGACGACATCG short dsDNA1 (fw): target withM.
ruber protospacer 3
93 CGATGTCGTCCACGCTCAGTGCGGGGGCATCG short dsDNA1 (rv)
94 GGTTATGGCTTGTGCGCCCCGCGGCCATCGTGCGGCGCG
CAAAATCCGAGGGCATGCGCTCCCGACCTGGAG
long dsDNA2 (fw): target withM.






96 GCGGCCATCGTGCGGCGCGCAAAATCCGAGGG short dsDNA2 (fw): target withM.
ruber protospacer 10
97 CCCTCGGATTTTGCGCGCCGCACGATGGCCGC short dsDNA2 (rv)
98 GCCTCCGTGAGGCTTTTGACATCGTCAGTGTGCGGCCCGTAACTGGCGAGTT
CGCGCTGGCCGTAGATGGCC
ds72 (fw): target with T. fusca PAM,




100 ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTT ds32 (fw): target with T. fusca
protospacer 1
101 AACTCGCCAGTTACGGGCCGCACACTGACGAT ds32 (rv)
102 ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTTCGC ds35 (fw): target with T. fusca PAM
andprotospacer 1
103 GCGAACTCGCCAGTTACGGGCCGCACACTGACGAT ds35 (rv)
104 ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTTCGCGCTGG ds40 (fw): target with T. fusca PAM,
protospacer 1 and flanking sequences
105 CCAGCGCGAACTCGCCAGTTACGGGCCGCACACTGACGAT ds40 (rv)
106 ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTTCGCGCTGGCCGTA ds45 (fw): target with T. fusca PAM,
protospacer 1 and flanking sequences
107 TACGGCCAGCGCGAACTCGCCAGTTACGGGCCGCACACTGACGAT ds45 (rv)
108 ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTTCGCGCTGGCCGTAGATGG ds50 (fw): target with T. fusca PAM,
protospacer 1 and flanking sequences
109 CCATCTACGGCCAGCGCGAACTCGCCAGTTACGGGCCGCACACTGACGAT ds50 (rv)
110 CGTGAGGCTTTTGACATCGTCAGTGTGCGGCCCGTAACTGGCGAGTTCGCGC
TGGCCGTAGATGG
ds65 (fw): target with T. fusca PAM,




G-rich sequences in red.






112 TAATACGACTCACTATAGGCGATGTCGTCCACGCTCAGTGCGGGGGCATCG T7 promoter + M. ruber CRISPR
spacer 3 (fw)
113 CGATGCCCCCGCACTGAGCGTGGACGACATCGCCTATAGTGAGTCGTATTA T7 promoter + M. ruber CRISPR
spacer 3 (rv)
114 TAATACGACTCACTATAGGAACTCGCCAGTTACGGGCCGCACACTGACGAT T7 promoter + T. fusca CRISPR
spacer 1 (fw)
115 ATCGTCAGTGTGCGGCCCGTAACTGGCGAGTTCCTATAGTGAGTCGTATTA T7 promoter + T. fusca CRISPR
spacer 1 (rv)
116 TAATACGACTCACTATAGGGGGGG T7 promoter + G5 (fw)
117 CCCCCCCTATAGTGAGTCGTATTA T7 promoter + G5 (rv)
118 TAATACGACTCACTATAGGGGAGG T7 promoter + G5 mutant (fw)
119 CCTCCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
120 TAATACGACTCACTATAGGGGCGG T7 promoter + G5 mutant (fw)
121 CCGCCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
122 TAATACGACTCACTATAGGGGTGG T7 promoter + G5 mutant (fw)
123 CCACCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
124 TAATACGACTCACTATAGGAGGGG T7 promoter + G5 mutant (fw)
125 CCCCTCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
126 TAATACGACTCACTATAGGCGGGG T7 promoter + G5 mutant (fw)
127 CCCCGCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
128 TAATACGACTCACTATAGGTGGGG T7 promoter + G5 mutant (fw)
129 CCCCACCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
130 TAATACGACTCACTATAGGGAGGG T7 promoter + G5 mutant (fw)
131 CCCTCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
132 TAATACGACTCACTATAGGGCGGG T7 promoter + G5 mutant (fw)
133 CCCGCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
170
134 TAATACGACTCACTATAGGGTGGG T7 promoter + G5 mutant (fw)
135 CCCACCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
136 TAATACGACTCACTATAGGGGCCGG T7 promoter + G5 mutant (fw)
137 CCGGCCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
138 TAATACGACTCACTATAGGGGCCCGG T7 promoter + G5 mutant (fw)
139 CCGGGCCCCTATAGTGAGTCGTATTA T7 promoter + G5 mutant (rv)
T7 promoter in blue, and G-rich sequences in red.
RNA cleavage
assay
140 CCGUUCAUCCCCGCGGGUGCGGGGAAUAC M. ruber repeat RNA (fw)
Table S-2: Plasmids constructs in this thesis
Plasmids Description and order of genes (5'-3') Restriction sites Primers Source
pET-28b T7 RNA polymerase based expression vector, KanR Novagen
pACYCduet-1 T7 RNA polymerase based expression vector, CamR Novagen
pMal-c2 Cloning vector, AmpR NEB
pGEX-6p1 Cloning vector, AmpR GE
Healthcare
pQLinkN Cloning vector, AmpR Addgene
1 MruCse2 in pET28b, His6-tag (N-term) NdeI/XhoI 1+2 This study
2 MruCse2_R28A/R29A in pET28b, His6-tag (N-term) NdeI/XhoI 31± This study
3 MruCse2_R126A in pET28b, His6-tag (N-term) NdeI/XhoI 32± This study
4 MruCse2_R141A in pET28b, His6-tag (N-term) NdeI/XhoI 33± This study
5 MruCse2_R141A/R143A in pET28b, His6-tag (N-term) NdeI/XhoI 34± This study
6 MruCse2_Q125A in pET28b, His6-tag (N-term) NdeI/XhoI 35± This study
7 MruCse2_Q125A/R141A in pET28b, His6-tag (N-term) NdeI/XhoI 33±&35± This study
8 TfuCse2 in pET28b, His6-tag (N-term) NdeI/XhoI 24+25 This study
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9 TfuCse2_R45A in pET28b, His6-tag (N-term) NdeI/XhoI 36± This study
10 TfuCse2_R46A in pET28b, His6-tag (N-term) NdeI/XhoI 37± This study
11 TfuCse2_R132A in pET28b, His6-tag (N-term) NdeI/XhoI 38± This study
12 TfuCse2_R148A in pET28b, His6-tag (N-term) NdeI/XhoI 39± This study
13 TfuCse2_R150A in pET28b, His6-tag (N-term) NdeI/XhoI 40± This study
14 TfuCse2_R45A/R46A in pET28b, His6-tag (N-term) NdeI/XhoI 41± This study
15 TfuCse2_R148A/R150A in pET28b, His6-tag (N-term) NdeI/XhoI 42± This study
16 TfuCse2_R45A/R46A/R132A/R148A/R150A in pET28b, His6-tag (N-term) NdeI/XhoI 38±&41±&42± This study
17 TfuCse2 in pMal-c2, MBP-tag (N-term) BamHI/HindIII 26+27 This study
18 MruCas7-Cse2-Cas5e-Cse1 in pQLinkN, no tag BamHI/NotI 3,4,5,6,7,8,9,10 This study
19 MruCas6e with His6-tag (N-term)-CRISPR (G5) in pACYCDuet-1 BamHI/NotI/BsrGI/AvrII 11,13,16,17 This study
20 MruCas6e with His6-tag (N-term)-CRISPR (NG5) in pACYCDuet-1 BamHI/NotI/BsrGI/AvrII 11,13,20,21 This study
21 MruCas6e in pET28b, His6-tag (N-term) NdeI/NotI 12,13 This study
22 TfuCse1 in pET28b, His6-tag (N-term) NdeI/XhoI 22+23 This study
23 TfuCse1_F142A in pET28b, His6-tag (N-term) NdeI/XhoI 43± This study
24 TfuCse1_F143A in pET28b, His6-tag (N-term) NdeI/XhoI 44± This study
25 TfuCse1_T144A in pET28b, His6-tag (N-term) NdeI/XhoI 45± This study
26 TfuCse1_F142A/F143A/T144A in pET28b, His6-tag (N-term) NdeI/XhoI 46± This study
27 TfuCse1_ΔGEL in pET28b, His6-tag (N-term) NdeI/XhoI 47± This study
28 TfuCse1_Q19A/E25A/R41A/R42A in pET28b, His6-tag (N-term) NdeI/XhoI 48±&49± This study
29 TfuCse1_R146A/R148A/D151A/R152A in pET28b, His6-tag (N-term) NdeI/XhoI 50± This study
±means forward and reverse primers (reverse complementary sequences are not shown in the table)
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Table S-3: Expression condition of Cas proteins fromM. ruber and T. fusca





3018 Cse2 pET28b KanR LB 0.4 mM IPTG 20°C o/n
3014 Cas6e pET28b KanR LB 0.4 mM IPTG 20°C o/n
3019/3018/3016/3015 Cse1/Cse2/Cas7/Cas5e pQLinkN AmpR LB 0.4 mM IPTG 20°C o/n
3014 Cas6e pACYCduet-1 CamR LB 0.4 mM IPTG 20°C o/n





1600 Cse1 pET28b KanR LB 0.4 mM IPTG 20°C o/n
1599 Cse2 pET28b KanR LB 0.4 mM IPTG 20°C o/n
1599 Cse2 pMal-c2 AmpR LB 0.4 mM IPTG 20°C o/n
Table S-4: Crystallization kits used for initial screening
Hampton Research Qiagen Crystalgen Emerald
BioSystems
Grid Screen AS JCSG+ Suite CryoMax Wizard I
Grid Screen PEG 6000 PACT Suite NaMax Wizard II
Grid Screen NaCl Classics Suite MPDMax
Crystal Screen 1 Classics II Suite PhosMax
Crystal Screen 2 ComPAS Suite AsMax
Crystal Screen Lite Anions Suite MemMax
Index Cations Suite
Screen Cryo PH Clear Suite
Natrix PH Clear II Suite
Protein Complex Suite
Nucleix Suite
MbClass Suite
MbClass II Suite
